CK2A1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00170 | S43 | GPS6|SIGNOR|PSP|Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O00264 | S181 | Sugiyama | PGRMC1 HPR6.6 PGRMC | TFKYHHVGKLLKEGEEPtVysDEEEPKDEsARKND______ |
| O00264 | S57 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFtPAE |
| O00327 | S90 | GPS6 | BMAL1 ARNTL BHLHE5 MOP3 PASD3 | IKNAREAHsQIEKRRRDKMNsFIDELASLVPTCNAMSRKLD |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O14737 | S119 | SIGNOR|PSP | PDCD5 TFAR19 | VSQQTEKTTTVKFNRRKVMDsDEDDDy______________ |
| O14950 | T135 | PSP | MYL12B MRLC2 MYLC2B | TGTIQEDYLRELLttMGDRFtDEEVDELyREAPIDKKGNFN |
| O14958 | S385 | SIGNOR|iPTMNet|PSP | CASQ2 | VLSGKINTEDDDEDDDDDDNsDEEDNDDsDDDDDE______ |
| O14958 | S393 | PSP | CASQ2 | EDDDEDDDDDDNsDEEDNDDsDDDDDE______________ |
| O15055 | S696 | PSP | PER2 KIAA0347 | IVHVGDKKPQPELEMVEDAAsGPEsLDCLAGPALACGLSQE |
| O15055 | S700 | PSP | PER2 KIAA0347 | GDKKPQPELEMVEDAAsGPEsLDCLAGPALACGLSQEKEPF |
| O15259 | S121 | SIGNOR|PSP | NPHP1 NPH1 | VTISRENITEVGAPTEEEEEsEsEDsEDSGGEEEDAEEEEE |
| O15259 | S123 | SIGNOR|PSP | NPHP1 NPH1 | ISRENITEVGAPTEEEEEsEsEDsEDSGGEEEDAEEEEEEK |
| O15259 | S126 | SIGNOR|PSP | NPHP1 NPH1 | ENITEVGAPTEEEEEsEsEDsEDSGGEEEDAEEEEEEKEEN |
| O15266 | S106 | SIGNOR|iPTMNet|PSP | SHOX PHOG | GTARVAEGIYECKEKREDVKsEDEDGQTKLKQRRSRTNFTL |
| O15379 | S424 | SIGNOR|iPTMNet|PSP | HDAC3 | YSRPEAPNEFYDGDHDNDKEsDVEI________________ |
| O15392 | T48 | PSP | BIRC5 API4 IAP4 | LEGCACtPERMAEAGFIHCPtENEPDLAQCFFCFKELEGWE |
| O15460 | S346 | Sugiyama | P4HA2 UNQ290/PRO330 | PFKEEDEWDSPHIVRYyDVMsDEEIERIKEIAKPKLARATV |
| O43156 | S828 | SIGNOR|PSP | TTI1 KIAA0406 SMG10 | DIEQFLLNYLKEKDVADGNVsDFDNEEEEQSVPPKVDENDT |
| O43242 | S6 | PSP | PSMD3 | _______________MKQEGsARRRGADKAKPPPGGGEQEP |
| O43395 | T494 | SIGNOR|PSP | PRPF3 HPRP3 PRP3 | PKVRISNLMRVLGTEAVQDPtKVEAHVRAQMAKRQKAHEEA |
| O43719 | S642 | Sugiyama | HTATSF1 | EDsDEKEEEEDtyEKVFDDEsDEKEDEEyADEKGLEAADKK |
| O43719 | S748 | PSP | HTATSF1 | GGFGSVEEGPLSTGSSFILssDDDDDDI_____________ |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43889 | S46 | SIGNOR|PSP | CREB3 LZIP | APDEAVRAPLDWALPLSEVPsDWEVDDLLCSLLSPPASLNI |
| O43896 | S1092 | SIGNOR|ELM|iPTMNet | KIF1C KIAA0706 | RPPGPRYPPYttPPRMRRQRsAPDLKESGAAV_________ |
| O60231 | S103 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | AEREARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRK |
| O60231 | S106 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRK |
| O60341 | S131 | SIGNOR|PSP | KDM1A AOF2 KDM1 KIAA0601 LSD1 | sRRKRAKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKL |
| O60341 | S137 | SIGNOR|PSP | KDM1A AOF2 KDM1 KIAA0601 LSD1 | KVEyREMDEsLANLsEDEyysEEERNAKAEKEKKLPPPPPQ |
| O60671 | S280 | PSP | RAD1 REC1 | EDGQICFVEYYCCPDEEVPEsEs__________________ |
| O60671 | S282 | PSP | RAD1 REC1 | GQICFVEYYCCPDEEVPEsEs____________________ |
| O60841 | S113 | Sugiyama | EIF5B IF2 KIAA0741 | sKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTAKPKVEM |
| O60841 | S137 | Sugiyama | EIF5B IF2 KIAA0741 | EDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKAQKS |
| O60841 | S214 | Sugiyama | EIF5B IF2 KIAA0741 | LQsRKGQKKNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAE |
| O60927 | S73 | Sugiyama | PPP1R11 HCGV TCTE5 | MGRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRG |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O60936 | T149 | SIGNOR|iPTMNet|PSP | NOL3 ARC NOP | RASDPDEAGGPEGsEAVQsGtPEEPEPELEAEAsKEAEPEP |
| O75376 | S2436 | PSP | NCOR1 KIAA1047 | QNRIWEREPAPLLSAQYEtLsDsDD________________ |
| O75379 | S30 | SIGNOR|ELM|iPTMNet | VAMP4 | NDDDVTGsVKsERRNLLEDDsDEEEDFFLRGPSGPRFGPRN |
| O75496 | S184 | PSP | GMNN | DNFESLDNQEFDSEEETVEDsLVEDSEIGTCAEGTVssstD |
| O75582 | S757 | PSP | RPS6KA5 MSK1 | KAPLAKRRKMKKTsTsTETRssssESSHSSSsHSHGKTTPT |
| O75582 | S758 | PSP | RPS6KA5 MSK1 | APLAKRRKMKKTsTsTETRssssESSHSSSsHSHGKTTPTK |
| O75582 | S759 | PSP | RPS6KA5 MSK1 | PLAKRRKMKKTsTsTETRssssESSHSSSsHSHGKTTPTKT |
| O75582 | S760 | PSP | RPS6KA5 MSK1 | LAKRRKMKKTsTsTETRssssESSHSSSsHSHGKTTPTKTL |
| O75582 | T793 | PSP | RPS6KA5 MSK1 | KTTPTKTLQPSNPADsNNPEtLFQFSDsVA___________ |
| O75676 | S324 | SIGNOR|PSP | RPS6KA4 MSK2 | LDWVALAARKIPAPFRPQIRsELDVGNFAEEFTRLEPVysP |
| O75822 | S127 | SIGNOR|PSP | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O75925 | S466 | SIGNOR|PSP | PIAS1 DDXBP1 | SHHQSSNKNKKVEVIDLTIDsssDEEEEEPSAKRTCPsLsP |
| O75925 | S467 | SIGNOR|PSP | PIAS1 DDXBP1 | HHQSSNKNKKVEVIDLTIDsssDEEEEEPSAKRTCPsLsPt |
| O75925 | S468 | SIGNOR|PSP | PIAS1 DDXBP1 | HQSSNKNKKVEVIDLTIDsssDEEEEEPSAKRTCPsLsPts |
| O75943 | S678 | PSP | RAD17 R24L | PQPFSAQGDMEENIIIEDyEsDGt_________________ |
| O76021 | S361 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | PEHGKKKRGRGKAQVKAtNEsEDEIPQLVPIGKKtPANEKV |
| O76061 | S288 | GPS6|ELM|PSP | STC2 | PNAHARGRVGGLGAQGPsGssEWEDEQSEYSDIRR______ |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | S153 | Sugiyama | ZRANB2 ZIS ZNF265 | KYRGKAVGPAsILKEVEDKEsEGEEEDEDEDLsKyKLDEDE |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95477 | S1255 | GPS6|ELM|PSP | ABCA1 ABC1 CERP | SSYGISEttLEEIFLKVAEEsGVDAETSDGTLPARRNRRAF |
| O95477 | T1242 | GPS6|ELM|PSP | ABCA1 ABC1 CERP | FHEIDDRLSDLGISSYGISEttLEEIFLKVAEEsGVDAETS |
| O95477 | T1243 | GPS6|ELM|PSP | ABCA1 ABC1 CERP | HEIDDRLSDLGISSYGISEttLEEIFLKVAEEsGVDAETSD |
| O95786 | S854 | GPS6|SIGNOR|PSP | RIGI DDX58 | LGDAFKECFVSRPHPKPKQFssFEKRAKIFCARQNCSHDWG |
| O95786 | S855 | GPS6|SIGNOR|PSP | RIGI DDX58 | GDAFKECFVSRPHPKPKQFssFEKRAKIFCARQNCSHDWGI |
| O95786 | T770 | GPS6|SIGNOR|PSP | RIGI DDX58 | KEQINMYKEKMMNDsILRLQtWDEAVFREKILHIQTHEKFI |
| O95816 | S73 | Sugiyama | BAG2 | KEILLEMIHSIQNSQDMRQIsDGEREELNLTANRLMGRTLT |
| O95863 | S11 | SIGNOR | SNAI1 SNAH | __________MPRSFLVRKPsDPNRKPNYSELQDSNPEFTF |
| O95863 | S92 | SIGNOR|PSP | SNAI1 SNAH | IAWASLRLQEsPRVAELTSLsDEDsGKGsQPPsPPsPAPsS |
| O95905 | S503 | PSP | ECD | FDADSFLNYFDKILGPRPNEsDsDDLDDEDFECLDsDDDLD |
| O95905 | S505 | PSP | ECD | ADSFLNYFDKILGPRPNEsDsDDLDDEDFECLDsDDDLDFE |
| O95905 | S518 | PSP | ECD | PRPNEsDsDDLDDEDFECLDsDDDLDFETHEPGEEASLKGT |
| P00374 | S145 | GPS6|PSP | DHFR | AMNHPGHLKLFVTRIMQDFEsDTFFPEIDLEKYKLLPEYPG |
| P00374 | S168 | GPS6|PSP | DHFR | FFPEIDLEKYKLLPEYPGVLsDVQEEKGIKYKFEVyEKND_ |
| P00558 | S256 | PSP | PGK1 PGKA MIG10 OK/SW-cl.110 | IGGGMAFtFLKVLNNMEIGTsLFDEEGAKIVKDLMSKAEKN |
| P00736 | S206 | GPS6|SIGNOR|ELM|iPTMNet|PSP | C1R | THSCQAECSSELYTEASGYIsSLEYPRSYPPDLRCNYSIRV |
| P01106 | S264 | PSP | MYC BHLHE39 | SSPQGSPEPLVLHEEtPPTtssDsEEEQEDEEEIDVVSVEK |
| P01106 | S265 | PSP | MYC BHLHE39 | SPQGSPEPLVLHEEtPPTtssDsEEEQEDEEEIDVVSVEKR |
| P01106 | S267 | SIGNOR|PSP | MYC BHLHE39 | QGSPEPLVLHEEtPPTtssDsEEEQEDEEEIDVVSVEKRQA |
| P01106 | S362 | PSP | MYC BHLHE39 | LDSVRVLRQISNNRKCtsPRssDTEENVKRRtHNVLERQRR |
| P01106 | S363 | PSP | MYC BHLHE39 | DSVRVLRQISNNRKCtsPRssDTEENVKRRtHNVLERQRRN |
| P01106 | T73 | iPTMNet | MYC BHLHE39 | SELQPPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVT |
| P01375 | S2 | ELM | TNF TNFA TNFSF2 | ___________________MsTESMIRDVELAEEALPKKTG |
| P02649 | S314 | PSP | APOE | WAGLVEKVQAAVGTSAAPVPsDNH_________________ |
| P02671 | S542 | PSP | FGA | tAstGKTFPGFFsPMLGEFVsEtEsRGsEsGIFtNtKEsss |
| P02671 | S609 | PSP | FGA | YNRGDstFESKSYKMADEAGsEADHEGTHsTKRGHAKSRPV |
| P03372 | S167 | PSP | ESR1 ESR NR3A1 | PAFYRPNsDNRRQGGRERLAsTNDKGSMAMESAKETRYCAV |
| P03372 | S282 | GPS6|SIGNOR|PSP | ESR1 ESR NR3A1 | GRMLKHKRQRDDGEGRGEVGsAGDMRAANLWPsPLMIKRSK |
| P03372 | S559 | GPS6|SIGNOR|PSP | ESR1 ESR NR3A1 | LLLEMLDAHRLHAPTsRGGAsVEETDQSHLATAGSTSsHsL |
| P04004 | T69 | GPS6|SIGNOR|ELM|iPTMNet|PSP | VTN | SCCTDYTAECKPQVTRGDVFtMPEDEYtVYDDGEEKNNATV |
| P04004 | T76 | GPS6|SIGNOR|ELM|iPTMNet|PSP | VTN | AECKPQVTRGDVFtMPEDEYtVYDDGEEKNNATVHEQVGGP |
| P04198 | S261 | GPS6|SIGNOR|ELM|iPTMNet|PSP | MYCN BHLHE37 NMYC | GRQTSGGDHKALSTSGEDTLsDsDDEDDEEEDEEEEIDVVT |
| P04198 | S263 | GPS6|SIGNOR|ELM|iPTMNet|PSP | MYCN BHLHE37 NMYC | QTSGGDHKALSTSGEDTLsDsDDEDDEEEDEEEEIDVVTVE |
| P04637 | S149 | PSP | TP53 P53 | ALNKMFCQLAKTCPVQLWVDstPPPGtRVRAMAIYKQSQHM |
| P04637 | S392 | SIGNOR|iPTMNet|PSP | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04637 | S46 | PSP | TP53 P53 | LPENNVLsPLPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRM |
| P04637 | S6 | PSP | TP53 P53 | _______________MEEPQsDPsVEPPLsQEtFsDLWKLL |
| P04637 | T150 | PSP | TP53 P53 | LNKMFCQLAKTCPVQLWVDstPPPGtRVRAMAIYKQSQHMT |
| P04637 | T155 | SIGNOR|iPTMNet|PSP | TP53 P53 | CQLAKTCPVQLWVDstPPPGtRVRAMAIYKQSQHMTEVVRR |
| P04637 | T18 | iPTMNet | TP53 P53 | ___MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPLPsQ |
| P04637 | T55 | PSP | TP53 P53 | LPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRMPEAAPPVAP |
| P04818 | S124 | GPS6|PSP | TYMS TS OK/SW-cl.29 | KGVKIWDANGsRDFLDsLGFsTREEGDLGPVyGFQWRHFGA |
| P05114 | S7 | SIGNOR|PSP | HMGN1 HMG14 | ______________MPKRKVssAEGAAKEEPKRRsARLsAK |
| P05114 | S8 | SIGNOR|PSP | HMGN1 HMG14 | _____________MPKRKVssAEGAAKEEPKRRsARLsAKP |
| P05114 | S86 | PSP | HMGN1 HMG14 | ANQETKEDLPAENGEtKtEEsPAsDEAGEKEAKsD______ |
| P05114 | S89 | SIGNOR|PSP | HMGN1 HMG14 | ETKEDLPAENGEtKtEEsPAsDEAGEKEAKsD_________ |
| P05114 | S99 | SIGNOR|PSP | HMGN1 HMG14 | GEtKtEEsPAsDEAGEKEAKsD___________________ |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S304 | Sugiyama | RPLP0 | AttAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05412 | S243 | ELM|PSP | JUN | QALKEEPQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNR |
| P05412 | S249 | SIGNOR|ELM|iPTMNet|PSP | JUN | PQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNRIAASKC |
| P05412 | T231 | GPS6|SIGNOR|ELM|iPTMNet|PSP | JUN | LPQQMPVQHPRLQALKEEPQtVPEMPGEtPPLsPIDMEsQE |
| P05455 | S366 | GPS6|SIGNOR|ELM|PSP|Sugiyama | SSB | AQPGsGKGKVQFQGKKtKFAsDDEHDEHDENGAtGPVKRAR |
| P05549 | S429 | SIGNOR|PSP | TFAP2A AP2TF TFAP2 | MDKMYLSNNPNSHTDNNAKSsDKEEKHRK____________ |
| P06127 | S482 | GPS6|SIGNOR|ELM|iPTMNet|PSP | CD5 LEU1 | LSAyPALEGALHRSSMQPDNssDsDyDLHGAQRL_______ |
| P06127 | S483 | GPS6|SIGNOR|ELM|iPTMNet|PSP | CD5 LEU1 | SAyPALEGALHRSSMQPDNssDsDyDLHGAQRL________ |
| P06127 | S485 | GPS6|SIGNOR|ELM|iPTMNet|PSP | CD5 LEU1 | yPALEGALHRSSMQPDNssDsDyDLHGAQRL__________ |
| P06401 | S81 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PGR NR3C3 | PRPCQGQDPSDEKTQDQQSLsDVEGAYSRAEATRGAGGSSS |
| P06454 | T13 | ELM | PTMA TMSA | ________MsDAAVDtssEIttKDLKEKKEVVEEAENGRDA |
| P06454 | T14 | ELM | PTMA TMSA | _______MsDAAVDtssEIttKDLKEKKEVVEEAENGRDAP |
| P06454 | T8 | ELM | PTMA TMSA | _____________MsDAAVDtssEIttKDLKEKKEVVEEAE |
| P06493 | S39 | GPS6|SIGNOR|ELM|PSP | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | yKGRHKTTGQVVAMKKIRLEsEEEGVPstAIREIsLLKELR |
| P06744 | S185 | SIGNOR|ELM|iPTMNet|PSP | GPI | LMVTEALKPYSsGGPRVWYVsNIDGTHIAKTLAQLNPESSL |
| P06748 | S125 | PSP|Sugiyama | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P07900 | S231 | SIGNOR|ELM | HSP90AA1 HSP90A HSPC1 HSPCA | SQFIGyPITLFVEKERDKEVsDDEAEEKEDKEEEKEKEEKE |
| P07900 | S263 | GPS6|SIGNOR|ELM|PSP|Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S726 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | DDtsAAVtEEMPPLEGDDDtsRMEEVD______________ |
| P07900 | T36 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | EVETFAFQAEIAQLMSLIINtFySNKEIFLRELIsNssDAL |
| P07900 | T725 | PSP | HSP90AA1 HSP90A HSPC1 HSPCA | ADDtsAAVtEEMPPLEGDDDtsRMEEVD_____________ |
| P07910 | S260 | SIGNOR|ELM|iPTMNet|PSP | HNRNPC HNRPC | ssVKKDETNVKMEsEGGADDsAEEGDLLDDDDNEDRGDDQL |
| P08047 | T579 | SIGNOR|ELM|iPTMNet | SP1 TSFP1 | GDHGAQLGLHGAGGDGIHDDtAGGEEGENSPDAQPQAGRRT |
| P08195 | S406 | PSP | SLC3A2 MDU1 | QQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNAT |
| P08195 | S408 | PSP | SLC3A2 MDU1 | ILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNATGN |
| P08195 | S410 | PSP | SLC3A2 MDU1 | SLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNATGNRW |
| P08195 | S527 | PSP | SLC3A2 MDU1 | MTVKGQsEDPGsLLsLFRRLsDQRsKERSLLHGDFHAFSAG |
| P08195 | S531 | PSP | SLC3A2 MDU1 | GQsEDPGsLLsLFRRLsDQRsKERSLLHGDFHAFSAGPGLF |
| P08235 | S111 | PSP | NR3C2 MCR MLR | ELESKELSATVAESMGLYMDsVRDADYSYEQQNQQGSMSPA |
| P08235 | S459 | PSP | NR3C2 MCR MLR | TSFKGNPTVNPFPFMDGSYFsFMDDKDYYSLSGILGPPVPG |
| P08238 | S226 | GPS6|SIGNOR|ELM|PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sQFIGyPItLyLEKEREKEIsDDEAEEEKGEKEEEDKDDEE |
| P08238 | S255 | GPS6|SIGNOR|ELM|PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEKEEEDKDDEEKPKIEDVGsDEEDDsGKDKKKKTKKIKEK |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S718 | PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EEPNAAVPDEIPPLEGDEDAsRMEEVD______________ |
| P08473 | S6 | SIGNOR|PSP | MME EPN | _______________MGKsEsQMDItDINtPKPKKKQRWTP |
| P08575 | S1001 | SIGNOR | PTPRC CD45 | DYNRVPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINAS |
| P08575 | S1004 | SIGNOR | PTPRC CD45 | RVPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINASFIM |
| P08575 | S1005 | SIGNOR | PTPRC CD45 | VPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINASFIMS |
| P08575 | S1009 | SIGNOR | PTPRC CD45 | HELEMSKESEHDsDEssDDDsDSEEPSKYINASFIMSYWKP |
| P08758 | S136 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | sRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRMLVVL |
| P08833 | S126 | PSP | IGFBP1 IBP1 | QESDASAPHAAEAGSPEsPEsTEITEEELLDNFHLMAPsEE |
| P08833 | S144 | PSP | IGFBP1 IBP1 | PEsTEITEEELLDNFHLMAPsEEDHSILWDAISTYDGSKAL |
| P08833 | S194 | PSP | IGFBP1 IBP1 | EPCRIELYRVVESLAKAQETsGEEIsKFYLPNCNKNGFYHS |
| P09497 | S11 | SIGNOR|iPTMNet | CLTB | __________MADDFGFFSSsEsGAPEAAEEDPAAAFLAQQ |
| P09497 | S13 | SIGNOR|iPTMNet | CLTB | ________MADDFGFFSSsEsGAPEAAEEDPAAAFLAQQES |
| P09629 | S132 | PSP | HOXB7 HOX2C | EQRDSDLAAESNFRIYPWMRssGTDRKRGRQTYTRYQTLEL |
| P09629 | S133 | SIGNOR|ELM|iPTMNet|PSP | HOXB7 HOX2C | QRDSDLAAESNFRIYPWMRssGTDRKRGRQTYTRYQTLELE |
| P09629 | T203 | PSP | HOXB7 HOX2C | IWFQNRRMKWKKENKTAGPGttGQDRAEAEEEEEE______ |
| P09629 | T204 | SIGNOR|ELM|iPTMNet|PSP | HOXB7 HOX2C | WFQNRRMKWKKENKTAGPGttGQDRAEAEEEEEE_______ |
| P09651 | S199 | GPS6|ELM|PSP | HNRNPA1 HNRPA1 | KALSKQEMAsAsssQRGRsGsGNFGGGRGGGFGGNDNFGRG |
| P09958 | S773 | PSP | FURIN FUR PACE PCSK3 | DRGLISYKGLPPEAWQEECPsDsEEDEGRGERTAFIKDQSA |
| P09958 | S775 | PSP | FURIN FUR PACE PCSK3 | GLISYKGLPPEAWQEECPsDsEEDEGRGERTAFIKDQSAL_ |
| P0DMV8 | T636 | PSP | HSPA1A HSP72 HSPA1 HSX70 | GPGPGGFGAQGPKGGsGsGPtIEEVD_______________ |
| P0DP23 | S102 | SIGNOR|ELM|PSP | CALM1 CALM CAM CAM1 | sEEEIREAFRVFDKDGNGyIsAAELRHVMTNLGEKLtDEEV |
| P0DP23 | S82 | SIGNOR|PSP | CALM1 CALM CAM CAM1 | GTIDFPEFLTMMARKMKDtDsEEEIREAFRVFDKDGNGyIs |
| P0DP23 | T118 | SIGNOR|PSP | CALM1 CALM CAM CAM1 | NGyIsAAELRHVMTNLGEKLtDEEVDEMIREADIDGDGQVN |
| P0DP23 | T80 | SIGNOR|ELM|PSP | CALM1 CALM CAM CAM1 | GNGTIDFPEFLTMMARKMKDtDsEEEIREAFRVFDKDGNGy |
| P10242 | S11 | GPS6|SIGNOR|ELM|iPTMNet|PSP | MYB | __________MARRPRHSIYssDEDDEDFEMCDHDYDGLLP |
| P10242 | S12 | GPS6|SIGNOR|ELM|iPTMNet|PSP | MYB | _________MARRPRHSIYssDEDDEDFEMCDHDYDGLLPK |
| P10243 | S7 | PSP | MYBL1 AMYB | ______________MAKRsRsEDEDDDLQYADHDYEVPQQK |
| P10244 | T18 | PSP | MYBL2 BMYB | ___MSRRTRCEDLDELHyQDtDsDVPEQRDsKCKVKWTHEE |
| P10646 | S30 | GPS6|ELM|PSP | TFPI LACI TFPI1 | ALWASVCLLLNLAPAPLNADsEEDEEHTIITDTELPPLKLM |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11274 | S1264 | GPS6|ELM | BCR BCR1 D22S11 | QVLLYFLQLEAIPAPDSKRQsILFSTEV_____________ |
| P11387 | S10 | SIGNOR|PSP | TOP1 | ___________MsGDHLHNDsQIEADFRLNDsHKHKDKHKD |
| P11387 | S506 | PSP | TOP1 | ALRAGNEKEEGETADTVGCCsLRVEHINLHPELDGQEYVVE |
| P11388 | S1365 | SIGNOR|PSP | TOP2A TOP2 | DEDFVPsDAsPPKtKTsPKLsNKELKPQKsVVsDLEADDVK |
| P11388 | S1377 | GPS6|SIGNOR|ELM|iPTMNet|PSP | TOP2A TOP2 | KtKTsPKLsNKELKPQKsVVsDLEADDVKGsVPLsssPPAt |
| P11388 | S1469 | iPTMNet|PSP | TOP2A TOP2 | sGVsQKPDPAKTKNRRKRKPstsDDsDsNFEKIVSKAVTSK |
| P11388 | S1525 | GPS6|SIGNOR|ELM|iPTMNet|PSP | TOP2A TOP2 | AVAPRAKSVRAKKPIKYLEEsDEDDLF______________ |
| P11388 | T1343 | SIGNOR|ELM|iPTMNet | TOP2A TOP2 | KTKFTMDLDsDEDFsDFDEKtDDEDFVPsDAsPPKtKTsPK |
| P11413 | T145 | SIGNOR | G6PD | MNALHLGsQANRLFYLALPPtVYEAVTKNIHESCMsQIGWN |
| P11473 | S208 | GPS6|SIGNOR|ELM|iPTMNet|PSP | VDR NR1I1 | DHCITSSDMMDSSSFSNLDLsEEDSDDPSVTLELSQLSMLP |
| P11717 | S2409 | GPS6|SIGNOR|ELM|PSP | IGF2R MPRI | GHITTKSVKALssLHGDDQDsEDEVLtIPEVKVHSGRGAGA |
| P11717 | S2484 | GPS6|SIGNOR|ELM|PSP | IGF2R MPRI | SSSAQQKTVSStKLVsFHDDsDEDLLHI_____________ |
| P11831 | S77 | GPS6|SIGNOR|ELM|PSP | SRF | EREAAAAAATTPAPTAGALYsGsEGDsEsGEEEELGAERRG |
| P11831 | S79 | GPS6|SIGNOR|ELM|PSP | SRF | EAAAAAATTPAPTAGALYsGsEGDsEsGEEEELGAERRGLK |
| P11831 | S83 | GPS6|SIGNOR|ELM|iPTMNet|PSP | SRF | AAATTPAPTAGALYsGsEGDsEsGEEEELGAERRGLKRsLs |
| P11831 | S85 | SIGNOR|PSP | SRF | ATTPAPTAGALYsGsEGDsEsGEEEELGAERRGLKRsLsEM |
| P11836 | S231 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | IVENEWKRTCSRPKsNIVLLsAEEKKEQTIEIKEEVVGLtE |
| P11836 | S289 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | EEEEEETETNFPEPPQDQESsPIENDSSP____________ |
| P11836 | T250 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | LsAEEKKEQTIEIKEEVVGLtEtssQPKNEEDIEIIPIQEE |
| P12259 | S692 | SIGNOR|ELM|iPTMNet | F5 | SKKLRLKFRDVKCIPDDDEDsyEIFEPPESTVMATRKMHDR |
| P12259 | S720 | GPS6|ELM|PSP | F5 | ESTVMATRKMHDRLEPEDEEsDADYDYQNRLAAALGIRSFR |
| P12821 | S1299 | SIGNOR|PSP | ACE DCP DCP1 | RLFSIRHRSLHRHSHGPQFGsEVELRHS_____________ |
| P12830 | S838 | SIGNOR|iPTMNet | CDH1 CDHE UVO | ADTDPTAPPYDSLLVFDYEGsGsEAAsLSsLNssEsDKDQD |
| P12830 | S847 | iPTMNet|PSP | CDH1 CDHE UVO | YDSLLVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGN |
| P12830 | S850 | PSP | CDH1 CDHE UVO | LLVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGNRFK |
| P12830 | S851 | SIGNOR|ELM|iPTMNet | CDH1 CDHE UVO | LVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGNRFKK |
| P12830 | S853 | SIGNOR|iPTMNet|PSP | CDH1 CDHE UVO | FDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGNRFKKLA |
| P13349 | S133 | SIGNOR|ELM|iPTMNet|PSP | MYF5 BHLHC2 | NPNQRLPKVEILRNAIRYIEsLQELLREQVENYYSLPGQSC |
| P13349 | S49 | SIGNOR|ELM|iPTMNet|PSP | MYF5 BHLHC2 | GDEFVPRVAAFGAHKAELQGsDEDEHVRAPTGHHQAGHCLM |
| P13569 | S422 | SIGNOR|PSP | CFTR ABCC7 | EEGFGELFEKAKQNNNNRKtsNGDDsLFFSNFSLLGTPVLK |
| P13569 | S427 | PSP | CFTR ABCC7 | ELFEKAKQNNNNRKtsNGDDsLFFSNFSLLGTPVLKDINFK |
| P13569 | S511 | SIGNOR|PSP | CFTR ABCC7 | CSQFSWIMPGTIKENIIFGVsyDEYRYRSVIKACQLEEDIS |
| P13569 | T1471 | SIGNOR | CFTR ABCC7 | PHRNSSKCKSKPQIAALKEEtEEEVQDTRL___________ |
| P13569 | T421 | PSP | CFTR ABCC7 | WEEGFGELFEKAKQNNNNRKtsNGDDsLFFSNFSLLGTPVL |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13807 | S10 | SIGNOR|iPTMNet | GYS1 GYS | ___________MPLNRTLsMssLPGLEDWEDEFDLENAVLF |
| P13807 | S645 | SIGNOR | GYS1 GYS | PNEADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRN |
| P13807 | S647 | iPTMNet | GYS1 GYS | EADAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGP |
| P13807 | S649 | SIGNOR | GYS1 GYS | DAAQGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLE |
| P13807 | S652 | iPTMNet | GYS1 GYS | QGyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLEEDG |
| P13807 | S653 | SIGNOR|iPTMNet | GYS1 GYS | GyRyPRPAsVPPsPsLsRHssPHQsEDEEDPRNGPLEEDGE |
| P13807 | S698 | SIGNOR|iPTMNet | GYS1 GYS | DEEAAKDRRNIRAPEWPRRAsCTsSTSGSKRNsVDtAtsss |
| P13807 | S701 | iPTMNet | GYS1 GYS | AAKDRRNIRAPEWPRRAsCTsSTSGSKRNsVDtAtsssLst |
| P13807 | T713 | SIGNOR|iPTMNet | GYS1 GYS | WPRRAsCTsSTSGSKRNsVDtAtsssLstPsEPLsPtssLG |
| P13861 | S78 | Sugiyama | PRKAR2A PKR2 PRKAR2 | sLGHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRV |
| P13861 | S80 | Sugiyama | PRKAR2A PKR2 PRKAR2 | GHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRVsV |
| P14317 | T16 | SIGNOR|iPTMNet|PSP | HCLS1 HS1 | _____MWKSVVGHDVSVSVEtQGDDWDtDPDFVNDISEKEQ |
| P14317 | T23 | SIGNOR|iPTMNet|PSP | HCLS1 HS1 | KSVVGHDVSVSVEtQGDDWDtDPDFVNDISEKEQRWGAKTI |
| P14598 | S208 | ELM|PSP | NCF1 NOXO2 SH3PXD1A | KSESGWWFCQMKAKRGWIPAsFLEPLDSPDETEDPEPNyAG |
| P14598 | S283 | ELM|PSP | NCF1 NOXO2 SH3PXD1A | WWVIRKDDVTGYFPSMyLQKsGQDVsQAQRQIKRGAPPRRs |
| P14598 | S348 | ELM|PSP | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14625 | S306 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TETVEEPMEEEEAAKEEKEEsDDEAAVEEEEEEKKPKTKKV |
| P15884 | S54 | GPS6|ELM | TCF4 BHLHB19 ITF2 SEF2 | KNGPTSLASGHFTGSNVEDRsssGSWGNGGHPsPSRNYGDG |
| P15884 | S55 | GPS6|ELM | TCF4 BHLHB19 ITF2 SEF2 | NGPTSLASGHFTGSNVEDRsssGSWGNGGHPsPSRNYGDGT |
| P15884 | S56 | GPS6|ELM | TCF4 BHLHB19 ITF2 SEF2 | GPTSLASGHFTGSNVEDRsssGSWGNGGHPsPSRNYGDGTP |
| P16220 | S94 | PSP | CREB1 | QPSVIQSPQVQTVQISTIAEsEDsQEsVDsVTDsQKRREIL |
| P16220 | S97 | PSP | CREB1 | VIQSPQVQTVQISTIAEsEDsQEsVDsVTDsQKRREILsRR |
| P16949 | S16 | iPTMNet | STMN1 C1orf215 LAP18 OP18 | _____MAssDIQVKELEKRAsGQAFELILsPRsKEsVPEFP |
| P16949 | S63 | iPTMNet | STMN1 C1orf215 LAP18 OP18 | KDLsLEEIQKKLEAAEERRKsHEAEVLKQLAEKREHEKEVL |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17096 | S102 | SIGNOR|ELM|iPTMNet|PSP | HMGA1 HMGIY | KPRGRPKKLEKEEEEGIsQEssEEEQ_______________ |
| P17096 | S103 | SIGNOR|ELM|iPTMNet|PSP | HMGA1 HMGIY | PRGRPKKLEKEEEEGIsQEssEEEQ________________ |
| P17096 | S99 | SIGNOR|ELM|iPTMNet | HMGA1 HMGIY | PGRKPRGRPKKLEKEEEEGIsQEssEEEQ____________ |
| P17677 | S202 | SIGNOR|iPTMNet | GAP43 | PAAEDAAAKATAQPPTEtGEssQAEENIEAVDETKPKESAR |
| P17677 | S203 | SIGNOR|iPTMNet | GAP43 | AAEDAAAKATAQPPTEtGEssQAEENIEAVDETKPKESARQ |
| P17931 | S12 | iPTMNet | LGALS3 MAC2 | _________MADNFsLHDALsGSGNPNPQGWPGAWGNQPAG |
| P17931 | S6 | iPTMNet | LGALS3 MAC2 | _______________MADNFsLHDALsGSGNPNPQGWPGAW |
| P17936 | S138 | SIGNOR|ELM|iPTMNet|PSP | IGFBP3 IBP3 | SAVSRLRAYLLPAPPAPGNAsEsEEDRsAGsVEsPSVSsTH |
| P17936 | S140 | SIGNOR|ELM|iPTMNet|PSP | IGFBP3 IBP3 | VSRLRAYLLPAPPAPGNAsEsEEDRsAGsVEsPSVSsTHRV |
| P17936 | S194 | PSP | IGFBP3 IBP3 | IIKKGHAKDsQRYKVDYESQsTDtQNFssEsKRETEYGPCR |
| P18031 | S352 | iPTMNet | PTPN1 PTP1B | QWVKEEtQEDKDCPIKEEKGsPLNAAPYGIEsMsQDtEVRS |
| P18031 | S378 | iPTMNet | PTPN1 PTP1B | PYGIEsMsQDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKD |
| P18031 | S386 | iPTMNet | PTPN1 PTP1B | QDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKDEDHALSYW |
| P18146 | S378 | SIGNOR|ELM|iPTMNet | EGR1 KROX24 ZNF225 | HIRIHTGQKPFQCRICMRNFsRSDHLTTHIRTHtGEKPFAC |
| P18146 | T391 | SIGNOR|iPTMNet | EGR1 KROX24 ZNF225 | RICMRNFsRSDHLTTHIRTHtGEKPFACDICGRKFARSDER |
| P18146 | T526 | SIGNOR|iPTMNet | EGR1 KROX24 ZNF225 | FPAQVSSFPSSAVTNSFSAStGLSDMTATFSPRTIEIC___ |
| P18846 | S36 | SIGNOR|ELM|iPTMNet|PSP | ATF1 | PGSAVQGAHISHIAQQVSSLsEsEEsQDsSDsIGssQKAHG |
| P18846 | S38 | SIGNOR | ATF1 | SAVQGAHISHIAQQVSSLsEsEEsQDsSDsIGssQKAHGIL |
| P18846 | S41 | SIGNOR|PSP | ATF1 | QGAHISHIAQQVSSLsEsEEsQDsSDsIGssQKAHGILARR |
| P18846 | S44 | SIGNOR | ATF1 | HISHIAQQVSSLsEsEEsQDsSDsIGssQKAHGILARRPsY |
| P18846 | S47 | PSP | ATF1 | HIAQQVSSLsEsEEsQDsSDsIGssQKAHGILARRPsYRKI |
| P18846 | S50 | PSP | ATF1 | QQVSSLsEsEEsQDsSDsIGssQKAHGILARRPsYRKILKD |
| P18846 | S51 | PSP | ATF1 | QVSSLsEsEEsQDsSDsIGssQKAHGILARRPsYRKILKDL |
| P18846 | S63 | SIGNOR | ATF1 | DsSDsIGssQKAHGILARRPsYRKILKDLsSEDTRGRKGDG |
| P18848 | S184 | PSP | ATF4 CREB2 TXREB | PLSPGVLSSTPDHSFSLELGsEVDITEGDRKPDYTAYVAMI |
| P18848 | S215 | SIGNOR|PSP | ATF4 CREB2 TXREB | PDYTAYVAMIPQCIKEEDTPsDNDsGICMsPESYLGSPQHS |
| P18858 | S66 | SIGNOR|ELM|iPTMNet|PSP | LIG1 | VsEsDsPVKRPGRKAARVLGsEGEEEDEALsPAKGQKPALD |
| P18887 | S408 | PSP | XRCC1 | DCHRMRRRLPSQRYLMAGPGsssEEDEAsHsGGsGDEAPKL |
| P18887 | S409 | PSP | XRCC1 | CHRMRRRLPSQRYLMAGPGsssEEDEAsHsGGsGDEAPKLP |
| P18887 | S410 | PSP | XRCC1 | HRMRRRLPSQRYLMAGPGsssEEDEAsHsGGsGDEAPKLPQ |
| P18887 | S416 | PSP | XRCC1 | LPSQRYLMAGPGsssEEDEAsHsGGsGDEAPKLPQKQPQTK |
| P18887 | S418 | PSP | XRCC1 | SQRYLMAGPGsssEEDEAsHsGGsGDEAPKLPQKQPQTKtK |
| P18887 | S421 | PSP | XRCC1 | YLMAGPGsssEEDEAsHsGGsGDEAPKLPQKQPQTKtKPtQ |
| P18887 | S461 | iPTMNet | XRCC1 | QAAGPssPQKPPtPEEtKAAsPVLQEDIDIEGVQsEGQDNG |
| P18887 | S475 | GPS6|SIGNOR|ELM|iPTMNet|PSP | XRCC1 | EEtKAAsPVLQEDIDIEGVQsEGQDNGAEDsGDtEDELRRV |
| P18887 | S485 | GPS6|SIGNOR|ELM|iPTMNet|PSP | XRCC1 | QEDIDIEGVQsEGQDNGAEDsGDtEDELRRVAEQKEHRLPP |
| P18887 | S518 | GPS6|SIGNOR|ELM|PSP | XRCC1 | QKEHRLPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPE |
| P18887 | S525 | GPS6|ELM|PSP | XRCC1 | PGQEENGEDPyAGstDENtDsEEHQEPPDLPVPELPDFFQG |
| P18887 | S578 | PSP | XRCC1 | ERRKLIRYVTAFNGELEDYMsDRVQFVITAQEWDPSFEEAL |
| P18887 | T488 | GPS6|SIGNOR|ELM|PSP | XRCC1 | IDIEGVQsEGQDNGAEDsGDtEDELRRVAEQKEHRLPPGQE |
| P18887 | T519 | GPS6|SIGNOR|ELM|iPTMNet|PSP | XRCC1 | KEHRLPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPEL |
| P18887 | T523 | GPS6|SIGNOR|ELM|PSP | XRCC1 | LPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPELPDFF |
| P18887 | Y515 | PSP | XRCC1 | VAEQKEHRLPPGQEENGEDPyAGstDENtDsEEHQEPPDLP |
| P19447 | S751 | GPS6|SIGNOR|ELM|PSP | ERCC3 XPB XPBC | GEFGSRSSQASRRFGTMSSMsGADDTVYMEYHSSRSKAPSK |
| P20042 | S2 | SIGNOR|iPTMNet|PSP | EIF2S2 EIF2B | ___________________MsGDEMIFDPtMsKKKKKKKKP |
| P20042 | S67 | SIGNOR|iPTMNet|PSP | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20810 | S655 | SIGNOR|PSP | CAST | TKKSEDSKKPADDQDPIDALsGDLDsCPstTETsQNTAKDK |
| P21127 | S283 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | AQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSAESGSGS |
| P21673 | S146 | SIGNOR|ELM|iPTMNet|PSP | SAT1 SAT | HFLVAEWNEPSINFYKRRGAsDLsSEEGWRLFKIDKEYLLK |
| P21673 | S149 | SIGNOR|ELM|iPTMNet|PSP | SAT1 SAT | VAEWNEPSINFYKRRGAsDLsSEEGWRLFKIDKEYLLKMAT |
| P21673 | T10 | ELM|iPTMNet | SAT1 SAT | ___________MAKFVIRPAtAADCSDILRLIKELAKYEYM |
| P22314 | S13 | ELM | UBA1 A1S9T UBE1 | ________MSSsPLSKKRRVsGPDPKPGsNCsPAQsVLsEV |
| P22736 | S152 | PSP | NR4A1 GFRP1 HMR NAK1 | YGSPCSAPsPStPSFQPPQLsPWDGSFGHFSPSQTYEGLRA |
| P23760 | S205 | PSP | PAX3 HUP2 | KHSIDGILSERAsAPQsDEGsDIDsEPDLPLKRKQRRSRTT |
| P24046 | S402 | iPTMNet | GABRR1 | KLPCTSGLPPPRtAMLDGNYsDGEVNDLDNYMPENGEKPDR |
| P24534 | S106 | SIGNOR|iPTMNet | EEF1B2 EEF1B EF1B | DttGsGAtDsKDDDDIDLFGsDDEEEsEEAKRLREERLAQY |
| P24534 | S112 | SIGNOR|iPTMNet | EEF1B2 EEF1B EF1B | AtDsKDDDDIDLFGsDDEEEsEEAKRLREERLAQYESKKAK |
| P25205 | S711 | Sugiyama | MCM3 | RRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEt |
| P25490 | S118 | SIGNOR|PSP | YY1 INO80S | HHHQEVILVQTREEVVGGDDsDGLRAEDGFEDQILIPVPAP |
| P25686 | S247 | PSP | DNAJB2 HSJ1 HSPF3 | VTSRSGGTQVQQtPAsCPLDsDLsEDEDLQLAMAYSLsEME |
| P25686 | S250 | PSP | DNAJB2 HSJ1 HSPF3 | RSGGTQVQQtPAsCPLDsDLsEDEDLQLAMAYSLsEMEAAG |
| P25686 | S264 | PSP | DNAJB2 HSJ1 HSPF3 | PLDsDLsEDEDLQLAMAYSLsEMEAAGKKPAGGREAQHRRQ |
| P25788 | S243 | SIGNOR|ELM|iPTMNet | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | S250 | SIGNOR|ELM|Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P25963 | S283 | GPS6|SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | TRIQQQLGQLTLENLQMLPEsEDEEsyDtEsEFTEFtEDEL |
| P25963 | S288 | GPS6|SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | QLGQLTLENLQMLPEsEDEEsyDtEsEFTEFtEDELPyDDC |
| P25963 | S293 | GPS6|SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | TLENLQMLPEsEDEEsyDtEsEFTEFtEDELPyDDCVFGGQ |
| P25963 | S32 | SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P25963 | T291 | GPS6|SIGNOR|ELM|iPTMNet|PSP | NFKBIA IKBA MAD3 NFKBI | QLTLENLQMLPEsEDEEsyDtEsEFTEFtEDELPyDDCVFG |
| P25963 | T299 | PSP | NFKBIA IKBA MAD3 NFKBI | MLPEsEDEEsyDtEsEFTEFtEDELPyDDCVFGGQRLTL__ |
| P27348 | S232 | SIGNOR|PSP | YWHAQ | KDstLIMQLLRDNLTLWtsDsAGEECDAAEGAEN_______ |
| P27540 | S77 | SIGNOR|iPTMNet|PSP | ARNT BHLHE2 | sKFLRCDDDQMsNDKERFARsDDEQsSADKERLARENHSEI |
| P27695 | S123 | SIGNOR|iPTMNet | APEX1 APE APE1 APEX APX HAP1 REF1 | KLPAELQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVs |
| P27695 | S290 | ELM | APEX1 APE APE1 APEX APX HAP1 REF1 | MMNARSKNVGWRLDYFLLSHsLLPALCDSKIRSKALGSDHC |
| P27824 | S554 | ELM|Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P27824 | S564 | ELM | CANX | GEEKLEEKQKsDAEEDGGtVsQEEEDRKPKAEEDEILNRsP |
| P27986 | S608 | SIGNOR|PSP | PIK3R1 GRB1 | GVRQKKLNEWLGNENtEDQysLVEDDEDLPHHDEKTWNVGS |
| P28482 | S246 | PSP | MAPK1 ERK2 PRKM1 PRKM2 | PIFPGKHYLDQLNHILGILGsPsQEDLNCIINLKARNYLLS |
| P28482 | S248 | PSP | MAPK1 ERK2 PRKM1 PRKM2 | FPGKHYLDQLNHILGILGsPsQEDLNCIINLKARNYLLSLP |
| P29590 | S518 | SIGNOR | PML MYL PP8675 RNF71 TRIM19 | EARLARssPEQPRPstsKAVsPPHLDGPPsPRsPVIGsEVF |
| P29590 | S560 | PSP | PML MYL PP8675 RNF71 TRIM19 | PNSNHVAsGAGEAEERVVVIsssEDsDAENSSSRELDDsss |
| P29590 | S561 | PSP | PML MYL PP8675 RNF71 TRIM19 | NSNHVAsGAGEAEERVVVIsssEDsDAENSSSRELDDsssE |
| P29590 | S562 | PSP | PML MYL PP8675 RNF71 TRIM19 | SNHVAsGAGEAEERVVVIsssEDsDAENSSSRELDDsssEs |
| P29590 | S565 | SIGNOR|PSP | PML MYL PP8675 RNF71 TRIM19 | VAsGAGEAEERVVVIsssEDsDAENSSSRELDDsssEssDL |
| P29692 | S162 | SIGNOR|PSP|Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30203 | S480 | PSP | CD6 | PKEVFMLPIQVQAPPPEDSDsGsDsDYEHYDFSAQPPVALT |
| P30203 | S482 | PSP | CD6 | EVFMLPIQVQAPPPEDSDsGsDsDYEHYDFSAQPPVALTTF |
| P30203 | S484 | PSP | CD6 | FMLPIQVQAPPPEDSDsGsDsDYEHYDFSAQPPVALTTFYN |
| P30260 | S154 | SIGNOR|PSP | CDC27 ANAPC3 D0S1430E D17S978E | GSECYQKSLSLNPFLWSPFEsLCEIGEKPDPDQTFKFTSLQ |
| P30291 | S121 | GPS6|SIGNOR|PSP | WEE1 | GADEAGGGAEGDSWEEEGFGsSsPVKsPAAPyFLGssFsPV |
| P30305 | S186 | GPS6|SIGNOR|ELM|PSP | CDC25B CDC25HU2 | ItNsQAPDGRRKsEAGSGAAssSGEDKENDGFVFKMPWKPT |
| P30305 | S187 | GPS6|SIGNOR|ELM|PSP | CDC25B CDC25HU2 | tNsQAPDGRRKsEAGSGAAssSGEDKENDGFVFKMPWKPTH |
| P30307 | T236 | SIGNOR|PSP | CDC25C | sMPENLNRPRLKQVEKFKDNtIPDKVKKKYFsGQGKLRKGL |
| P30519 | S79 | SIGNOR|iPTMNet | HMOX2 HO2 | KGNIKKELFKLATTALYFTYsALEEEMERNKDHPAFAPLYF |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P30622 | S1364 | SIGNOR|PSP | CLIP1 CYLN1 RSN | VEMMSEAALNGNGDDLNNYDsDDQEKQsKKKPRLFCDICDC |
| P30793 | S81 | PSP | GCH1 DYT5 GCH | EEDNELNLPNLAAAYSSILSsLGENPQRQGLLKTPWRAASA |
| P31327 | T1022 | Sugiyama | CPS1 | TLRQLGKKTVVVNCNPETVstDFDECDKLyFEELSLERILD |
| P31749 | S129 | GPS6|SIGNOR|ELM|PSP | AKT1 PKB RAC | GLKKQEEEEMDFRsGsPsDNsGAEEMEVsLAKPKHRVtMNE |
| P31751 | S131 | PSP | AKT2 | KQRAPGEDPMDyKCGsPsDssttEEMEVAVSKARAKVTMND |
| P32004 | S1181 | SIGNOR|ELM|PSP | L1CAM CAML1 MIC5 | VDsEARPMKDEtFGEyRsLEsDNEEKAFGssQPsLNGDIKP |
| P32004 | T1172 | PSP | L1CAM CAML1 MIC5 | sVKDKEDtQVDsEARPMKDEtFGEyRsLEsDNEEKAFGssQ |
| P32121 | T382 | GPS6|SIGNOR|ELM|iPTMNet|PSP | ARRB2 ARB2 ARR2 | APETDVPVDTNLIEFDTNYAtDDDIVFEDFARLRLKGMKDD |
| P33527 | T249 | SIGNOR|PSP | ABCC1 MRP MRP1 | VRGYRQPLEGSDLWSLNKEDtSEQVVPVLVKNWKKECAKTR |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34932 | S415 | Sugiyama | HSPA4 APG2 HSPH2 | TDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTFy |
| P35221 | S641 | GPS6|SIGNOR|PSP | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35222 | S29 | SIGNOR|iPTMNet | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | ELDMAMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGK |
| P35222 | T102 | SIGNOR|ELM|iPTMNet | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | IDGQyAMTRAQRVRAAMFPEtLDEGMQIPStQFDAAHPtNV |
| P35222 | T112 | SIGNOR|ELM|iPTMNet | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | QRVRAAMFPEtLDEGMQIPStQFDAAHPtNVQRLAEPSQML |
| P35222 | T393 | SIGNOR|ELM|iPTMNet | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | PsQRLVQNCLWtLRNLSDAAtKQEGMEGLLGTLVQLLGSDD |
| P35226 | S110 | SIGNOR|PSP | BMI1 PCGF4 RNF51 | EMKRRRDFYAAHPSADAANGsNEDRGEVADEDKRIITDDEI |
| P35568 | S24 | SIGNOR|ELM | IRS1 | PPEsDGFSDVRKVGYLRKPKsMHKRFFVLRAAsEAGGPARL |
| P35568 | S330 | SIGNOR | IRS1 | AtsPAsMVGGKPGsFRVRAssDGEGtMsRPAsVDGsPVsPs |
| P35568 | S99 | SIGNOR | IRS1 | KNKHLVALYtRDEHFAIAADsEAEQDSWYQALLQLHNRAKG |
| P35568 | T502 | SIGNOR|iPTMNet | IRS1 | HYILsRGGNGHRCtPGtGLGtsPALAGDEAASAADLDNRFR |
| P35568 | T811 | SIGNOR | IRS1 | LSTsSGRLLYAATADDSSSStSSDSLGGGYCGARLEPSLPH |
| P35568 | T88 | SIGNOR | IRS1 | SCFNINKRADSKNKHLVALYtRDEHFAIAADsEAEQDSWYQ |
| P35579 | S1916 | PSP | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | S1943 | SIGNOR|PSP|Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P35580 | S1952 | PSP | MYH10 | GPIsFsssRSGRRQLHLEGAsLELsDDDtEsKtsDVNEtQP |
| P35580 | S1956 | PSP | MYH10 | FsssRSGRRQLHLEGAsLELsDDDtEsKtsDVNEtQPPQsE |
| P35580 | S1965 | PSP | MYH10 | QLHLEGAsLELsDDDtEsKtsDVNEtQPPQsE_________ |
| P35580 | S1975 | PSP | MYH10 | LsDDDtEsKtsDVNEtQPPQsE___________________ |
| P35580 | T1960 | PSP | MYH10 | RSGRRQLHLEGAsLELsDDDtEsKtsDVNEtQPPQsE____ |
| P35638 | S14 | GPS6|SIGNOR|ELM|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | _______MAAESLPFSFGTLssWELEAWYEDLQEVLssDEN |
| P35638 | S15 | GPS6|SIGNOR|ELM|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | ______MAAESLPFSFGTLssWELEAWYEDLQEVLssDENG |
| P35638 | S30 | SIGNOR|ELM|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | FGTLssWELEAWYEDLQEVLssDENGGTYVSPPGNEEEESK |
| P35638 | S31 | GPS6|SIGNOR|ELM|iPTMNet|PSP | DDIT3 CHOP CHOP10 GADD153 | GTLssWELEAWYEDLQEVLssDENGGTYVSPPGNEEEESKI |
| P35659 | S32 | SIGNOR | DEK | GtPtQPAsEKEPEMPGPREEsEEEEDEDDEEEEEEEKEKsL |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36955 | S114 | PSP | SERPINF1 PEDF PIG35 | LGAEQRTESIIHRALYYDLIsSPDIHGTYKELLDTVTAPQK |
| P36955 | S24 | PSP | SERPINF1 PEDF PIG35 | LVLLLCIGALLGHSSCQNPAsPPEEGSPDPDSTGALVEEED |
| P37840 | S129 | GPS6|SIGNOR|ELM|iPTMNet|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P37840 | S87 | SIGNOR | SNCA NACP PARK1 | GGAVVTGVTAVAQKTVEGAGsIAAATGFVKKDQLGKNEEGA |
| P38398 | S1572 | SIGNOR|PSP | BRCA1 RNF53 | yLPRQDLEGTPYLESGISLFsDDPEsDPSEDRAPESARVGN |
| P39687 | S158 | ELM|PSP | ANP32A C15orf1 LANP MAPM PHAP1 | LLPQLtyLDGyDRDDKEAPDsDAEGYVEGLDDEEEDEDEEE |
| P39687 | S204 | ELM|PSP | ANP32A C15orf1 LANP MAPM PHAP1 | QVVEDEEDEDEEEEGEEEDVsGEEEEDEEGYNDGEVDDEED |
| P40337 | S33 | GPS6|PSP | VHL | VGAEEAGVEEYGPEEDGGEEsGAEEsGPEEsGPEELGAEEE |
| P40337 | S38 | GPS6|PSP | VHL | AGVEEYGPEEDGGEEsGAEEsGPEEsGPEELGAEEEMEAGR |
| P40337 | S43 | GPS6|PSP | VHL | YGPEEDGGEEsGAEEsGPEEsGPEELGAEEEMEAGRPRPVL |
| P40692 | S477 | PSP | MLH1 COCA2 | EMSEKRGPTSSNPRKRHREDsDVEMVEDDSRKEMTAACTPR |
| P41002 | S621 | SIGNOR|PSP | CCNF FBX1 FBXO1 | LGSFLDWSLDCCSGYEGDQEsEGEKEGDVTAPSGILDVTVV |
| P41208 | S158 | PSP | CETN2 CALT CEN2 | tDEELQEMIDEADRDGDGEVsEQEFLRIMKKTsLY______ |
| P41208 | T138 | PSP | CETN2 CALT CEN2 | tGKISFKNLKRVAKELGENLtDEELQEMIDEADRDGDGEVs |
| P41236 | S121 | SIGNOR|ELM|iPTMNet|PSP|Sugiyama | PPP1R2 IPP2 | ARKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFE |
| P41236 | S122 | SIGNOR|ELM|iPTMNet|PSP | PPP1R2 IPP2 | RKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFEM |
| P41236 | S87 | SIGNOR|ELM|iPTMNet|PSP | PPP1R2 IPP2 | KIDEPstPYHsMMGDDEDACsDtEAtEAMAPDILARKLAAA |
| P42166 | S67 | Sugiyama | TMPO LAP2 | ARNRPPLPAGTNsKGPPDFssDEEREPtPVLGsGAAAAGRS |
| P42167 | S67 | Sugiyama | TMPO LAP2 | ARNRPPLPAGTNSKGPPDFssDEEREPtPVLGsGAAAAGRS |
| P42224 | S727 | PSP | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P42575 | S157 | SIGNOR|PSP | CASP2 ICH1 NEDD2 | DLsLPFPVCESCPLYKKLRLstDtVEHsLDNKDGPVCLQVK |
| P42768 | S483 | SIGNOR|iPTMNet|PSP | WAS IMD2 | SEGLVGALMHVMQKRSRAIHssDEGEDQAGDEDEDDEWDD_ |
| P42768 | S484 | GPS6|SIGNOR|ELM|iPTMNet|PSP | WAS IMD2 | EGLVGALMHVMQKRSRAIHssDEGEDQAGDEDEDDEWDD__ |
| P42858 | S13 | PSP | HTT HD IT15 | ________MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQ |
| P42858 | S16 | PSP | HTT HD IT15 | _____MAtLEKLMKAFEsLKsFQQQQQQQQQQQQQQQQQQQ |
| P43629 | S385 | SIGNOR|PSP | KIR3DL1 CD158E NKAT3 NKB1 | SNKKNAAVMDQEPAGNRTANsEDsDEQDPEEVTYAQLDHCV |
| P43629 | S388 | SIGNOR|PSP | KIR3DL1 CD158E NKAT3 NKB1 | KNAAVMDQEPAGNRTANsEDsDEQDPEEVTYAQLDHCVFTQ |
| P45973 | S11 | SIGNOR | CBX5 HP1A | __________MGKKTKRtADssssEDEEEyVVEKVLDRRVV |
| P45973 | S12 | SIGNOR | CBX5 HP1A | _________MGKKTKRtADssssEDEEEyVVEKVLDRRVVK |
| P45973 | S13 | SIGNOR | CBX5 HP1A | ________MGKKTKRtADssssEDEEEyVVEKVLDRRVVKG |
| P45973 | S14 | SIGNOR | CBX5 HP1A | _______MGKKTKRtADssssEDEEEyVVEKVLDRRVVKGQ |
| P45984 | S407 | GPS6|SIGNOR|ELM|PSP | MAPK9 JNK2 PRKM9 SAPK1A | PSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR___ |
| P45984 | T404 | GPS6|SIGNOR|ELM|PSP | MAPK9 JNK2 PRKM9 SAPK1A | NATPSQSSSINDISSMSTEQtLAsDTDSSLDASTGPLEGCR |
| P46060 | S358 | SIGNOR|iPTMNet|PSP | RANGAP1 KIAA1835 SD | CEQLQEVLEGFNMAKVLASLsDDEDEEEEEEGEEEEEEAEE |
| P46527 | S83 | PSP | CDKN1B KIP1 p27 | DFQNHKPLEGKyEWQEVEKGsLPEFyyRPPRPPKGACKVPA |
| P46531 | S1900 | GPS6|PSP | NOTCH1 TAN1 | DGFTPLMIASCSGGGLEtGNsEEEEDAPAVISDFIYQGASL |
| P46531 | T1897 | GPS6 | NOTCH1 TAN1 | RGPDGFTPLMIASCSGGGLEtGNsEEEEDAPAVISDFIYQG |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P48426 | S304 | GPS6|SIGNOR|ELM|PSP | PIP4K2A PI5P4KA PIP5K2 PIP5K2A | ERAEQEEVECEENDGEEEGEsDGTHPVGTPPDSPGNTLNSS |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49321 | S497 | SIGNOR | NASP | tEGsEEDDKENDKtEEMPNDsVLENKsLQENEEEEIGNLEL |
| P49368 | S252 | Sugiyama | CCT3 CCTG TRIC5 | YIKNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEE |
| P49418 | T350 | SIGNOR|PSP | AMPH AMPH1 | PEISVTTPSQNEVPEVKKEEtLLDLDFDPFKPEVTPAGSAG |
| P49418 | T387 | SIGNOR|PSP | AMPH AMPH1 | GSAGVTHSPMSQTLPWDLWTtSTDLVQPASGGSFNGFTQPQ |
| P49427 | S203 | SIGNOR|ELM|PSP | CDC34 UBCH3 UBE2R1 | VPTTLAEYCVKTKAPAPDEGsDLFYDDYYEDGEVEEEADsC |
| P49427 | S222 | SIGNOR|ELM|PSP | CDC34 UBCH3 UBE2R1 | GsDLFYDDYYEDGEVEEEADsCFGDDEDDsGtEEs______ |
| P49427 | S231 | GPS6|SIGNOR|ELM|PSP | CDC34 UBCH3 UBE2R1 | YEDGEVEEEADsCFGDDEDDsGtEEs_______________ |
| P49427 | S236 | SIGNOR|ELM|PSP | CDC34 UBCH3 UBE2R1 | VEEEADsCFGDDEDDsGtEEs____________________ |
| P49427 | T233 | SIGNOR|ELM|PSP | CDC34 UBCH3 UBE2R1 | DGEVEEEADsCFGDDEDDsGtEEs_________________ |
| P49716 | S57 | SIGNOR|PSP | CEBPD | AEPGALGEPGAAAPAMYDDEsAIDFSAYIDSMAAVPTLELC |
| P49736 | S108 | PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | DAYEAEGLALDDEDVEELtAsQREAAERAMRQRDREAGRGL |
| P49736 | S13 | SIGNOR|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | ________MAEssEsFtMAssPAQRRRGNDPLtssPGRssR |
| P49736 | S139 | PSP|Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | QRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERAtE |
| P49736 | S27 | PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLP |
| P49736 | S40 | PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | GNDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtE |
| P49736 | S41 | PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | NDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtEG |
| P49736 | S53 | PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | RRtDALtssPGRDLPPFEDEsEGLLGtEGPLEEEEDGEELI |
| P49736 | T457 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | TVILANHVAKKDNKVAVGELtDEDVKMITSLSKDQQIGEKI |
| P49795 | S151 | ELM | RGS19 GAIP GNAI3IP | NQHVVDEKARLIyEDyVSILsPKEVSLDSRVREGINKKMQE |
| P49795 | S24 | SIGNOR|ELM|iPTMNet|PSP | RGS19 GAIP GNAI3IP | PHEAEKQITGPEEADRPPsMssHDTASPAAPSRNPCCLCWC |
| P49810 | S19 | SIGNOR|ELM|iPTMNet | PSEN2 AD4 PS2 PSNL2 STM2 | __MLTFMAsDsEEEVCDERtsLMsAEsPtPRSCQEGRQGPE |
| P49810 | S327 | SIGNOR | PSEN2 AD4 PS2 PSNL2 STM2 | LDPSSQGALQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGY |
| P49810 | S330 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | SSQGALQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGYPGE |
| P49810 | S335 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | LQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGYPGEELEEE |
| P49810 | S7 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | ______________MLTFMAsDsEEEVCDERtsLMsAEsPt |
| P49810 | S9 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PSEN2 AD4 PS2 PSNL2 STM2 | ____________MLTFMAsDsEEEVCDERtsLMsAEsPtPR |
| P49959 | S558 | SIGNOR|PSP | MRE11 HNGS1 MRE11A | SAFSADDLMSIDLAEQMANDsDDsISAATNKGRGRGRGRRG |
| P49959 | S561 | SIGNOR|PSP | MRE11 HNGS1 MRE11A | SADDLMSIDLAEQMANDsDDsISAATNKGRGRGRGRRGGRG |
| P49959 | S649 | GPS6|PSP | MRE11 HNGS1 MRE11A | QQPSRNVTTKNYsEVIEVDEsDVEEDIFPTTSKTDQRWSST |
| P49959 | S688 | SIGNOR|PSP | MRE11 HNGS1 MRE11A | STSSSKIMsQsQVsKGVDFEssEDDDDDPFMNTSSLRRNRR |
| P49959 | S689 | SIGNOR|PSP | MRE11 HNGS1 MRE11A | TSSSKIMsQsQVsKGVDFEssEDDDDDPFMNTSSLRRNRR_ |
| P50895 | S598 | PSP | BCAM LU MSK19 | CCRQRREKGAPPPGEPGLsHsGsEQPEQtGLLMGGAsGGAR |
| P51116 | S410 | Sugiyama | FXR2 FMR1L2 | LGFRPPGsGRGsGGsDKAGystDEssSSsLHATRTYGGSYG |
| P51116 | T411 | Sugiyama | FXR2 FMR1L2 | GFRPPGsGRGsGGsDKAGystDEssSSsLHATRTYGGSYGG |
| P51580 | S14 | Sugiyama | TPMT | _______MDGTRTSLDIEEysDtEVQKNQVLTLEEWQDKWV |
| P51580 | T16 | Sugiyama | TPMT | _____MDGTRTSLDIEEysDtEVQKNQVLTLEEWQDKWVNG |
| P51636 | S23 | SIGNOR|PSP | CAV2 | LETEKADVQLFMDDDsysHHsGLEyADPEKFADsDQDRDPH |
| P51636 | S36 | SIGNOR|PSP | CAV2 | DDsysHHsGLEyADPEKFADsDQDRDPHRLNSHLKLGFEDV |
| P51811 | S383 | ELM | XK XKR1 XRG1 | ILFMLVFYQFFHPCKKLFSSsVSEGFQRWLRCFCWACRQQK |
| P51858 | S133 | Sugiyama | HDGF HMG1L2 | EPEPEAAEGDGDKKGNAEGssDEEGKLVIDEPAKEKNEKGA |
| P51946 | T315 | ELM|PSP | CCNH | KGYEDDDYVsKKSKHEEEEWtDDDLVEsL____________ |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P52655 | S280 | SIGNOR|ELM | GTF2A1 TF2A1 | AQPAQTQAPLVLQVDGTGDTssEEDEDEEEDYDDDEEEDKE |
| P52655 | S281 | SIGNOR|ELM | GTF2A1 TF2A1 | QPAQTQAPLVLQVDGTGDTssEEDEDEEEDYDDDEEEDKEK |
| P52655 | S316 | SIGNOR|ELM | GTF2A1 TF2A1 | EEDKEKDGAEDGQVEEEPLNsEDDVsDEEGQELFDTENVVV |
| P52655 | S321 | SIGNOR|ELM | GTF2A1 TF2A1 | KDGAEDGQVEEEPLNsEDDVsDEEGQELFDTENVVVCQYDK |
| P52907 | S9 | SIGNOR|PSP | CAPZA1 | ____________MADFDDRVsDEEKVRIAAKFITHAPPGEF |
| P52952 | S164 | SIGNOR|iPTMNet | NKX2-5 CSX NKX2.5 NKX2E | LFSQAQVYELERRFKQQRYLsAPERDQLASVLKLTSTQVKI |
| P53539 | S27 | SIGNOR|PSP | FOSB G0S3 | GDYDSGSRCSSSPSAESQYLsSVDSFGSPPTAAASQECAGL |
| P53999 | S10 | iPTMNet | SUB1 PC4 RPO2TC1 | ___________MPKSKELVsssssGsDsDsEVDKKLKRKKQ |
| P53999 | S11 | ELM | SUB1 PC4 RPO2TC1 | __________MPKSKELVsssssGsDsDsEVDKKLKRKKQV |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | iPTMNet | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P53999 | S13 | ELM|iPTMNet | SUB1 PC4 RPO2TC1 | ________MPKSKELVsssssGsDsDsEVDKKLKRKKQVAP |
| P53999 | S15 | ELM|iPTMNet | SUB1 PC4 RPO2TC1 | ______MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEK |
| P53999 | S17 | ELM|iPTMNet|Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P53999 | S19 | ELM|iPTMNet | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P53999 | S9 | iPTMNet | SUB1 PC4 RPO2TC1 | ____________MPKSKELVsssssGsDsDsEVDKKLKRKK |
| P54105 | S102 | Sugiyama | CLNS1A CLCI ICLN | VNAKFEEEsKEPVADEEEEDsDDDVEPITEFRFVPSDKSAL |
| P54252 | S236 | SIGNOR|PSP | ATXN3 ATX3 MJD MJD1 SCA3 | NDGSGMLDEDEEDLQRALALsRQEIDMEDEEADLRRAIQLs |
| P54252 | S335 | SIGNOR|PSP | ATXN3 ATX3 MJD MJD1 SCA3 | PCERPATSSGALGSDLGDAMsEEDMLQAAVTMsLETVRNDL |
| P54252 | S347 | SIGNOR|PSP | ATXN3 ATX3 MJD MJD1 SCA3 | GSDLGDAMsEEDMLQAAVTMsLETVRNDLKTEGKK______ |
| P54274 | T122 | SIGNOR|PSP | TERF1 PIN2 TRBF1 TRF TRF1 | RNSAEAIIHGLSsLTACQLRtIYICQFLTRIAAGKTLDAQF |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P54845 | S117 | PSP | NRL D14S46E | ELLQGQGPVPVDGPHGYYPGsPEETGAQHVQLAERFSDAAL |
| P55010 | S174 | SIGNOR|iPTMNet | EIF5 | GKKEKEKKNRKGKDKENGSVsSSETPPPPPPPNEINPPPHT |
| P55010 | S389 | GPS6|SIGNOR|ELM|iPTMNet|PSP | EIF5 | KEIRVKAEPFIKWLKEAEEEssGGEEEDEDENIEVVySKAA |
| P55010 | S390 | GPS6|SIGNOR|ELM|iPTMNet|PSP | EIF5 | EIRVKAEPFIKWLKEAEEEssGGEEEDEDENIEVVySKAAs |
| P55010 | T207 | PSP | EIF5 | EINPPPHTMEEEEDDDWGEDttEEAQRRRMDEISDHAKVLt |
| P55010 | T208 | PSP | EIF5 | INPPPHTMEEEEDDDWGEDttEEAQRRRMDEISDHAKVLtL |
| P55042 | S214 | SIGNOR|ELM|iPTMNet|PSP | RRAD RAD | DDVPIILVGNKSDLVRSREVsVDEGRACAVVFDCKFIETSA |
| P55042 | S257 | SIGNOR|iPTMNet|PSP | RRAD RAD | HHNVQALFEGVVRQIRLRRDsKEANARRQAGTRRREsLGKK |
| P55042 | S273 | SIGNOR|iPTMNet|PSP | RRAD RAD | LRRDsKEANARRQAGTRRREsLGKKAKRFLGRIVARNsRKM |
| P55042 | S290 | SIGNOR|iPTMNet|PSP | RRAD RAD | RREsLGKKAKRFLGRIVARNsRKMAFRAKsKsCHDLSVL__ |
| P55042 | S299 | SIGNOR|PSP | RRAD RAD | KRFLGRIVARNsRKMAFRAKsKsCHDLSVL___________ |
| P55087 | S276 | SIGNOR|ELM | AQP4 | VEFKRRFKEAFSKAAQQTKGsYMEVEDNRsQVETDDLILKP |
| P55087 | S285 | SIGNOR|ELM | AQP4 | AFSKAAQQTKGsYMEVEDNRsQVETDDLILKPGVVHVIDVD |
| P55087 | S316 | SIGNOR|ELM | AQP4 | PGVVHVIDVDRGEEKKGKDQsGEVLssV_____________ |
| P55957 | S64 | SIGNOR|ELM|iPTMNet | BID | LPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQEDIIR |
| P55957 | T59 | SIGNOR|ELM|iPTMNet | BID | ALGHELPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQ |
| P56270 | S460 | SIGNOR|iPTMNet|PSP | MAZ ZNF801 | AAAAAAAAAVAAPPTAVGSLsGAEGVPVSsQPLPSQPW___ |
| P56270 | S469 | ELM | MAZ ZNF801 | VAAPPTAVGSLsGAEGVPVSsQPLPSQPW____________ |
| P60484 | S370 | GPS6|SIGNOR|ELM|iPTMNet|PSP | PTEN MMAC1 TEP1 | TVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDttDsDPENE |
| P60484 | S380 | GPS6|SIGNOR|ELM|PSP | PTEN MMAC1 TEP1 | SSsTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQI |
| P60484 | S385 | GPS6|SIGNOR|ELM|PSP | PTEN MMAC1 TEP1 | VtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV__ |
| P60484 | T366 | SIGNOR|iPTMNet | PTEN MMAC1 TEP1 | YFTKTVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDttDsD |
| P60484 | T382 | GPS6|SIGNOR|ELM|PSP | PTEN MMAC1 TEP1 | sTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItK |
| P60484 | T383 | SIGNOR|PSP | PTEN MMAC1 TEP1 | TSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV |
| P60983 | S53 | GPS6|SIGNOR|ELM|iPTMNet|PSP | GMFB | IMKIDKDKRLVVLDEELEGIsPDELKDELPERQPRFIVYsY |
| P61218 | S2 | ELM | POLR2F POLRF | ___________________MsDNEDNFDGDDFDDVEEDEGL |
| P61244 | S11 | GPS6|SIGNOR|ELM|PSP | MAX BHLHD4 | __________MsDNDDIEVEsDEEQPRFQSAADKRAHHNAL |
| P61244 | S129 | iPTMNet | MAX BHLHD4 | AQLQTNYPssDNsLYTNAKGsTIsAFDGGSDsSSEsEPEEP |
| P61244 | S132 | iPTMNet | MAX BHLHD4 | QTNYPssDNsLYTNAKGsTIsAFDGGSDsSSEsEPEEPQSR |
| P61244 | S2 | GPS6|SIGNOR|ELM|iPTMNet|PSP | MAX BHLHD4 | ___________________MsDNDDIEVEsDEEQPRFQSAA |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P67870 | S2 | ELM|PSP | CSNK2B CK2N G5A | ___________________MsssEEVSWISWFCGLRGNEFF |
| P67870 | S3 | ELM|PSP | CSNK2B CK2N G5A | __________________MsssEEVSWISWFCGLRGNEFFC |
| P68400 | Y182 | PSP | CSNK2A1 CK2A1 | VMIDHEHRKLRLIDWGLAEFyHPGQEYNVRVASRYFKGPEL |
| P78344 | S902 | SIGNOR|PSP | EIF4G2 DAP5 OK/SW-cl.75 | KALFQVNQWLTWLEtAEEEEsEEEAD_______________ |
| P83916 | T51 | SIGNOR|PSP | CBX1 CBX | VVKGKVEYLLKWKGFSDEDNtWEPEENLDCPDLIAEFLQSQ |
| P84090 | S24 | iPTMNet | ERH | TILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEEHLKRMN |
| P84090 | T18 | iPTMNet | ERH | ___MsHTILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEE |
| Q00266 | S114 | PSP | MAT1A AMS1 MATA1 | DSAKGFDFKTCNVLVALEQQsPDIAQCVHLDRNEEDVGAGD |
| Q00613 | T142 | GPS6|SIGNOR|ELM|iPTMNet | HSF1 HSTF1 | VSTLKSEDIKIRQDSVTKLLtDVQLMKGKQECMDSKLLAMK |
| Q00987 | S260 | PSP | MDM2 | sVsDQFsVEFEVEsLDsEDYsLsEEGQELsDEDDEVyQVtV |
| Q00987 | S269 | PSP | MDM2 | FEVEsLDsEDYsLsEEGQELsDEDDEVyQVtVyQAGESDTD |
| Q01082 | S2110 | SIGNOR|iPTMNet|PSP | SPTBN1 SPTB2 | QQEEEERKRRPPsPEPstKVsEEAEsQQQWDtsKGEQVsQN |
| Q01082 | T2159 | SIGNOR|iPTMNet|PSP | SPTBN1 SPTB2 | PRMAETVDTsEMVNGAtEQRtssKEssPIPsPtsDRKAKTA |
| Q01534 | T300 | SIGNOR|iPTMNet|PSP | TSPY1 TSPY | LWRNPLQYYKRMKPPEEGTEtSGDSQLLS____________ |
| Q01831 | S129 | PSP | XPC XPCC | AHHLKRGATMNEDSNEEEEEsENDWEEVEELSEPVLGDVRE |
| Q01831 | S94 | SIGNOR|PSP | XPC XPCC | KVAKVTVKSENLKVIKDEALsDGDDLRDFPsDLKKAHHLKR |
| Q01892 | S129 | SIGNOR|ELM|iPTMNet | SPIB | NFASQTLVPPAYAPYPSPVLsEEEDLPLDSPALEVsDsESD |
| Q01892 | S144 | SIGNOR|ELM|iPTMNet | SPIB | PSPVLsEEEDLPLDSPALEVsDsESDEALVAGPEGKGSEAG |
| Q01892 | S146 | SIGNOR|ELM|iPTMNet | SPIB | PVLsEEEDLPLDSPALEVsDsESDEALVAGPEGKGSEAGTR |
| Q01892 | S37 | SIGNOR|ELM|iPTMNet | SPIB | LYPDGVFYDLDSCKHSSYPDsEGAPDSLWDWTVAPPVPAtP |
| Q02078 | S289 | GPS6|ELM|PSP | MEF2A MEF2 | RKPDLRVVIPPSSKGMMPPLsEEEELELNTQRISSSQATQP |
| Q02790 | T143 | SIGNOR|iPTMNet | FKBP4 FKBP52 | PPNATLVFEVELFEFKGEDLtEEEDGGIIRRIQTRGEGYAK |
| Q02952 | S598 | Sugiyama | AKAP12 AKAP250 | CLEKGLAEVQQDGEAEEGAtsDGEKKREGVtPWAsFKKMVt |
| Q03014 | S163 | PSP | HHEX HEX PRH PRHX | RFSNDQTIELEKKFETQKYLsPPERKRLAKMLQLsERQVKT |
| Q03014 | S177 | PSP | HHEX HEX PRH PRHX | ETQKYLsPPERKRLAKMLQLsERQVKTWFQNRRAKWRRLKQ |
| Q03112 | S1037 | SIGNOR | MECOM EVI1 MDS1 PRDM3 | DKEDAYFTEIRNFIGNSNHGsQsPRNVEERMNGSHFKDEKA |
| Q03112 | S726 | SIGNOR | MECOM EVI1 MDS1 PRDM3 | SMYPFPDRDLRSLPLKMEPQsPGEVKKLQKGSSESPFDLTT |
| Q03135 | S88 | SIGNOR|ELM|iPTMNet | CAV1 CAV | FEDVIAEPEGTHsFDGIWKAsFTTFTVTKYWFYRLLSALFG |
| Q04206 | S529 | GPS6|SIGNOR|ELM|PSP | RELA NFKB3 | RPPDPAPAPLGAPGLPNGLLsGDEDFSsIADMDFsALLSQI |
| Q04206 | S543 | SIGNOR|iPTMNet | RELA NFKB3 | LPNGLLsGDEDFSsIADMDFsALLSQISS____________ |
| Q04724 | S239 | GPS6|SIGNOR|ELM|PSP | TLE1 | EFSNDIKKRKVDDKDSSHYDsDGDKsDDNLVVDVsNEDPss |
| Q04724 | S253 | SIGNOR|PSP | TLE1 | DSSHYDsDGDKsDDNLVVDVsNEDPssPRAsPAHsPRENGI |
| Q05940 | S511 | SIGNOR|ELM|iPTMNet | SLC18A2 SVMT VMAT2 | KTKMYTQNNIQSYPIGEDEEsEsD_________________ |
| Q05940 | S513 | SIGNOR|ELM | SLC18A2 SVMT VMAT2 | KMYTQNNIQSYPIGEDEEsEsD___________________ |
| Q06265 | S392 | SIGNOR|PSP | EXOSC9 PMSCL1 | KMDTGVEVsDIGsQDAPIILsDsEEEEMIILEPDKNPKKIR |
| Q06265 | S394 | SIGNOR|PSP | EXOSC9 PMSCL1 | DTGVEVsDIGsQDAPIILsDsEEEEMIILEPDKNPKKIRTQ |
| Q06413 | S59 | SIGNOR|ELM | MEF2C | CDCEIALIIFNSTNKLFQYAsTDMDKVLLKYTEYNEPHESR |
| Q06609 | T13 | PSP | RAD51 RAD51A RECA | ________MAMQMQLEANADtsVEEESFGPQPISRLEQCGI |
| Q06787 | S500 | PSP | FMR1 | GHGRRGPGYTSGTNSEAsNAsEtEsDHRDELsDWSLAPTEE |
| Q08945 | S510 | GPS6|SIGNOR|ELM|iPTMNet|PSP | SSRP1 FACT80 | DVAEEFDSNASASSSSNEGDsDRDEKKRKQLKKAKMAKDRK |
| Q08945 | S657 | SIGNOR|iPTMNet|PSP | SSRP1 FACT80 | MEKKSTPSRGsSSKSsSRQLsEsFKSKEFVssDEsssGENK |
| Q08945 | S688 | GPS6|SIGNOR|ELM|iPTMNet|PSP | SSRP1 FACT80 | sDEsssGENKSKKKRRRSEDsEEEELASTPPSSEDSASGSD |
| Q12798 | T138 | PSP | CETN1 CEN1 CETN | TGKISFKNLKRVANELGENLtDEELQEMIDEADRDGDGEVN |
| Q12913 | T1318 | SIGNOR | PTPRJ DEP1 | IVRSQKDsKVDLIyQNttAMtIyENLAPVTTFGKTNGYIA_ |
| Q12972 | S204 | SIGNOR|ELM | PPP1R8 ARD1 NIPP1 | EGNLDIQRPKRKRKNsRVtFsEDDEIINPEDVDPSVGRFRN |
| Q12972 | T161 | SIGNOR|ELM | PPP1R8 ARD1 NIPP1 | EKMGGEDDELKGLLGLPEEEtELDNLTEFNTAHNKRIsTLT |
| Q13085 | S29 | SIGNOR|ELM | ACACA ACAC ACC1 ACCA | QPLELNQHSRFIIGsVsEDNsEDEISNLVKLDLLEEKEGsL |
| Q13133 | S198 | SIGNOR|PSP | NR1H3 LXRA | KLKRQEEEQAHATSLPPRAssPPQILPQLSPEQLGMIEKLV |
| Q13144 | S717 | SIGNOR|iPTMNet | EIF2B5 EIF2BE | LRKNQQLQRFIQWLKEAEEEssEDD________________ |
| Q13144 | S718 | SIGNOR|iPTMNet | EIF2B5 EIF2BE | RKNQQLQRFIQWLKEAEEEssEDD_________________ |
| Q13148 | S379 | PSP | TARDBP TDP43 | MQREPNQAFGsGNNSYsGsNsGAAIGWGsAsNAGsGsGFNG |
| Q13148 | S409 | PSP | TARDBP TDP43 | sNAGsGsGFNGGFGssMDsKssGWGM_______________ |
| Q13148 | S410 | PSP | TARDBP TDP43 | NAGsGsGFNGGFGssMDsKssGWGM________________ |
| Q13153 | S223 | PSP | PAK1 | RsVIEPLPVtPtRDVAtsPIsPtENNttPPDALtRNTEKQK |
| Q13224 | S1479 | SIGNOR | GRIN2B NMDAR2B | NKNPRAFNGSSNGHVyEKLSsIESDV_______________ |
| Q13283 | S149 | SIGNOR|PSP | G3BP1 G3BP | DIFRyQDEVFGGFVtEPQEEsEEEVEEPEERQQtPEVVPDD |
| Q13323 | S35 | GPS6|ELM|PSP | BIK NBK | TLLYEQLLEPPTMEVLGMtDsEEDLDPMEDFDSLECMEGSD |
| Q13323 | T33 | PSP | BIK NBK | METLLYEQLLEPPTMEVLGMtDsEEDLDPMEDFDSLECMEG |
| Q13347 | S302 | Sugiyama | EIF3I EIF3S2 TRIP1 | KGHFGPINSVAFHPDGKSYssGGEDGyVRIHYFDPQYFEFE |
| Q13351 | T23 | SIGNOR|ELM | KLF1 EKLF | TAETALPSISTLTALGPFPDtQDDFLKWWRSEEAQDMGPGP |
| Q13371 | S18 | SIGNOR|PSP | PDCL PHLOP1 PhLP1 | ___MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPA |
| Q13371 | S19 | SIGNOR|PSP | PDCL PHLOP1 PhLP1 | __MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPAs |
| Q13371 | S20 | SIGNOR|PSP | PDCL PHLOP1 PhLP1 | _MTTLDDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPAss |
| Q13371 | S25 | SIGNOR|PSP | PDCL PHLOP1 PhLP1 | DDKLLGEKLQyyysssEDEDsDHEDKDRGRCAPAsssVPAE |
| Q13371 | S296 | PSP | PDCL PHLOP1 PhLP1 | EKEVLVLTSVRNsAtCHsEDsDLEID_______________ |
| Q13393 | S610 | PSP | PLD1 | YRSHHNLIHGLKPHFKLFHPssESEQGLTRPHADtGsIRsL |
| Q13393 | S611 | PSP | PLD1 | RSHHNLIHGLKPHFKLFHPssESEQGLTRPHADtGsIRsLQ |
| Q13422 | S101 | SIGNOR | IKZF1 IK1 IKAROS LYF1 ZNFN1A1 | DLRMLDASGEKMNGSHRDQGsSALSGVGGIRLPNGKLKCDI |
| Q13422 | S13 | SIGNOR | IKZF1 IK1 IKAROS LYF1 ZNFN1A1 | ________MDADEGQDMSQVsGKESPPVSDtPDEGDEPMPI |
| Q13422 | S295 | SIGNOR | IKZF1 IK1 IKAROS LYF1 ZNFN1A1 | KSSMPQKFLGDKGLsDtPYDssAsYEKENEMMKSHVMDQAI |
| Q13422 | S63 | SIGNOR | IKZF1 IK1 IKAROS LYF1 ZNFN1A1 | GQQSSKSDRVVASNVKVETQsDEENGRACEMNGEECAEDLR |
| Q13422 | T23 | SIGNOR | IKZF1 IK1 IKAROS LYF1 ZNFN1A1 | ADEGQDMSQVsGKESPPVSDtPDEGDEPMPIPEDLSTTSGG |
| Q13426 | T233 | PSP | XRCC4 | GETAICSEMTADRDPVYDEstDEEsENQTDLSGLASAAVSK |
| Q13428 | S279 | Sugiyama | TCOF1 | PAKRAKKPEEEsEssEEGsEsEEEAPAGTRSQVKASEKILQ |
| Q13428 | T210 | SIGNOR|PSP | TCOF1 | MVSAGQADSSSEDTSSSSDEtDVEGKPSVKPAQVKAssVst |
| Q13442 | S57 | Sugiyama | PDAP1 HASPP28 | EEEQKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGV |
| Q13442 | S60 | Sugiyama | PDAP1 HASPP28 | QKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGL |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13501 | S403 | PSP | SQSTM1 ORCA OSIL | yPHLPPEADPRLIESLsQMLsMGFsDEGGWLTRLLQTKNyD |
| Q13509 | S444 | PSP | TUBB3 TUBB4 | QYQDATAEEEGEMYEDDEEEsEAQGPK______________ |
| Q13530 | S380 | SIGNOR|PSP | SERINC3 DIFF33 TDE1 SBBI99 | QVDKLtLsGsDsVILGDtttsGAsDEEDGQPRRAVDNEKEG |
| Q13530 | S383 | SIGNOR|PSP | SERINC3 DIFF33 TDE1 SBBI99 | KLtLsGsDsVILGDtttsGAsDEEDGQPRRAVDNEKEGVQY |
| Q13541 | S112 | SIGNOR|iPTMNet|PSP|Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13547 | S421 | GPS6|SIGNOR|ELM|iPTMNet|PSP | HDAC1 RPD3L1 | PDKRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAK |
| Q13547 | S423 | GPS6|SIGNOR|ELM|iPTMNet|PSP | HDAC1 RPD3L1 | KRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAKRV |
| Q13563 | S812 | GPS6|SIGNOR|ELM|PSP | PKD2 TRPP1 TRPP2 | DHssLPRPMssRSFPRSLDDsEEDDDEDSGHSSRRRGsIss |
| Q13610 | S50 | Sugiyama | PWP1 | EEVKRLIAEAKEKLQEEGGGsDEEEtGsPsEDGMQsARTQA |
| Q13698 | S1575 | SIGNOR | CACNA1S CACH1 CACN1 CACNL1A3 | IQAGLRTIEEEAAPEICRtVsGDLAAEEELERAMVEAAMEE |
| Q13829 | S278 | PSP | TNFAIP1 BACURD2 EDP1 | TPRVPDNsLLEATSRSRSQAsPsEDEETFELRDRVRRIHVK |
| Q13829 | S280 | SIGNOR|PSP | TNFAIP1 BACURD2 EDP1 | RVPDNsLLEATSRSRSQAsPsEDEETFELRDRVRRIHVKRY |
| Q14005 | S743 | SIGNOR|iPTMNet|PSP | IL16 | NLFSPIMSENHGHMPLQPNAsLNEEEGTQGHPDGtPPKLDT |
| Q14204 | S1313 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | DREKCAKAKEALELtDtGLLsGSEERVQVALEELQDLKGVW |
| Q14432 | S408 | Sugiyama | PDE3A | QAIHKPRVNPVtsLsENytCsDsEESSEKDKLAIPKRLRRs |
| Q14449 | S358 | PSP | GRB14 | RLLKYGMQLYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVA |
| Q14449 | S362 | PSP | GRB14 | YGMQLYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFS |
| Q14449 | S366 | PSP | GRB14 | LYQNYMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFSGQKS |
| Q14449 | S370 | PSP | GRB14 | YMHPYQGRsGCSsQSIsPMRsIsENSLVAMDFSGQKSRVIE |
| Q14493 | T61 | SIGNOR|PSP | SLBP HBP | RPEDAEEAEHRGAERRPEsFttPEGPKPRSRCSDWASAVEE |
| Q14566 | S758 | Sugiyama | MCM6 | EDESALKRSELVNWYLKEIEsEIDsEEELINKKRIIEKVIH |
| Q14566 | S762 | Sugiyama | MCM6 | ALKRSELVNWYLKEIEsEIDsEEELINKKRIIEKVIHRLTH |
| Q14676 | S218 | PSP | MDC1 KIAA0170 NFBD1 | EEGHSPVLGGLGPPFAFNLNsDtDVEEGQQPATEEASSAAR |
| Q14676 | S299 | SIGNOR|PSP | MDC1 KIAA0170 NFBD1 | GNGVVPAGVILERsQPPGEDsDtDVDDDsRPPGRPAEVHLE |
| Q14676 | S329 | PSP | MDC1 KIAA0170 NFBD1 | PPGRPAEVHLERAQPFGFIDsDtDAEEERIPAtPVVIPMKK |
| Q14676 | S376 | SIGNOR|PSP | MDC1 KIAA0170 NFBD1 | VGTRGPGAPGLAHLQEsQAGsDtDVEEGKAPQAVPLEKSQA |
| Q14676 | S402 | PSP | MDC1 KIAA0170 NFBD1 | EGKAPQAVPLEKSQAsMVINsDtDDEEEVsAALTLAHLKEs |
| Q14676 | S453 | PSP | MDC1 KIAA0170 NFBD1 | EDMPQRVVLLQRsQtttERDsDtDVEEEELPVENREAVLKD |
| Q14676 | T220 | PSP | MDC1 KIAA0170 NFBD1 | GHSPVLGGLGPPFAFNLNsDtDVEEGQQPATEEASSAARRG |
| Q14676 | T301 | SIGNOR|PSP | MDC1 KIAA0170 NFBD1 | GVVPAGVILERsQPPGEDsDtDVDDDsRPPGRPAEVHLERA |
| Q14676 | T331 | PSP | MDC1 KIAA0170 NFBD1 | GRPAEVHLERAQPFGFIDsDtDAEEERIPAtPVVIPMKKRK |
| Q14676 | T378 | SIGNOR|PSP | MDC1 KIAA0170 NFBD1 | TRGPGAPGLAHLQEsQAGsDtDVEEGKAPQAVPLEKSQAsM |
| Q14676 | T404 | PSP | MDC1 KIAA0170 NFBD1 | KAPQAVPLEKSQAsMVINsDtDDEEEVsAALTLAHLKEsQP |
| Q14676 | T455 | SIGNOR|PSP | MDC1 KIAA0170 NFBD1 | MPQRVVLLQRsQtttERDsDtDVEEEELPVENREAVLKDHT |
| Q14694 | S576 | Sugiyama | USP10 KIAA0190 | sNGPKNHSVNEEEQEEQGEGsEDEWEQVGPRNKTSVTRQAD |
| Q14761 | S153 | SIGNOR|PSP | PTPRCAP LPAP | QCGEASSPEQVPVRAEEARDsDtEGDLVLGsPGPAsAGGsA |
| Q14839 | S308 | PSP | CHD4 | PKKVAPLKIKLGGFGSKRKRsssEDDDLDVEsDFDDAsINS |
| Q14839 | S310 | PSP | CHD4 | KVAPLKIKLGGFGSKRKRsssEDDDLDVEsDFDDAsINSYS |
| Q14839 | S428 | PSP | CHD4 | KWSCPHCEKEGIQWEAKEDNsEGEEILEEVGGDLEEEDDHH |
| Q14940 | S702 | SIGNOR|PSP | SLC9A5 NHE5 | NGKHRGLGFQDTAAVILTVEsEEEEEEsDssEtEKEDDEGI |
| Q14940 | S709 | SIGNOR|PSP | SLC9A5 NHE5 | GFQDTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARAT |
| Q14940 | S711 | SIGNOR|PSP | SLC9A5 NHE5 | QDTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSE |
| Q14940 | S712 | SIGNOR|PSP | SLC9A5 NHE5 | DTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSEV |
| Q14940 | T714 | SIGNOR|PSP | SLC9A5 NHE5 | AAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSEVLQ |
| Q15003 | S570 | PSP | NCAPH BRRN BRRN1 CAPH KIAA0074 | YDYNNPNDTSNFCPGLQAADsDDEDLDDLFVGPVGNSDLsP |
| Q15019 | S218 | SIGNOR|PSP|Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | RILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLLKASIPFS |
| Q15084 | S22 | PSP | PDIA6 ERP5 P5 TXNDC7 | ALLVLGLVSCTFFLAVNGLYsSSDDVIELTPSNFNREVIQS |
| Q15084 | S428 | PSP|Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15185 | S113 | GPS6|SIGNOR|ELM|PSP|Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S118 | GPS6|SIGNOR|ELM|PSP | PTGES3 P23 TEBP | WLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGDEDVDL |
| Q15287 | S53 | GPS6|ELM|PSP | RNPS1 LDC2 | DRSDEKSKDRSKDKGATKESsEKDRGRDKTRKRRSASSGSS |
| Q15555 | S236 | PSP | MAPRE2 RP1 | stPsRPssAKRAsssGsAsKsDKDLEtQVIQLNEQVHsLKL |
| Q15596 | S469 | PSP | NCOA2 BHLHE75 SRC2 TIF2 | HVSGMQATtPQGSNYALKMNsPsQSSPGMNPGQPTSMLsPR |
| Q15596 | S487 | PSP | NCOA2 BHLHE75 SRC2 TIF2 | MNsPsQSSPGMNPGQPTSMLsPRHRMsPGVAGsPRIPPSQF |
| Q15596 | S493 | PSP | NCOA2 BHLHE75 SRC2 TIF2 | SSPGMNPGQPTSMLsPRHRMsPGVAGsPRIPPSQFSPAGSL |
| Q15596 | S499 | PSP | NCOA2 BHLHE75 SRC2 TIF2 | PGQPTSMLsPRHRMsPGVAGsPRIPPSQFSPAGSLHSPVGV |
| Q15653 | S313 | PSP | NFKBIB IKBB TRIP9 | LRAHGAPEPEGEDEKSGPCSsSsDSDSGDEGDEYDDIVVHS |
| Q15653 | S315 | PSP | NFKBIB IKBB TRIP9 | AHGAPEPEGEDEKSGPCSsSsDSDSGDEGDEYDDIVVHSSR |
| Q15672 | S18 | SIGNOR|PSP | TWIST1 BHLHA38 TWIST | ___MMQDVSSSPVSPADDSLsNsEEEPDRQQPPSGKRGGRK |
| Q15672 | S20 | SIGNOR|PSP | TWIST1 BHLHA38 TWIST | _MMQDVSSSPVSPADDSLsNsEEEPDRQQPPSGKRGGRKRR |
| Q15906 | S41 | ELM | VPS72 TCFL1 YL1 | LEAEEEDEFYQTTYGGFTEEsGDDEYQGDQsDTEDEVDsDF |
| Q15906 | S51 | ELM | VPS72 TCFL1 YL1 | QTTYGGFTEEsGDDEYQGDQsDTEDEVDsDFDIDEGDEPSs |
| Q15906 | S59 | ELM | VPS72 TCFL1 YL1 | EEsGDDEYQGDQsDTEDEVDsDFDIDEGDEPSsDGEAEEPR |
| Q15906 | S71 | ELM | VPS72 TCFL1 YL1 | sDTEDEVDsDFDIDEGDEPSsDGEAEEPRRKRRVVtKAYKE |
| Q16181 | T228 | Sugiyama | SEPTIN7 CDC10 SEPT7 | KKQIMKEIQEHKIKIyEFPEtDDEEENKLVKKIKDRLPLAV |
| Q16543 | S13 | GPS6|SIGNOR|ELM|iPTMNet|PSP | CDC37 CDC37A | ________MVDysVWDHIEVsDDEDEtHPNIDTASLFRWRH |
| Q16623 | S14 | SIGNOR|ELM|iPTMNet|PSP | STX1A STX1 | _______MKDRTQELRtAKDsDDDDDVAVTVDRDRFMDEFF |
| Q16625 | S408 | ELM|PSP | OCLN | GRSKRTEQDHyEtDyttGGEsCDELEEDWIREYPPItSDQQ |
| Q16625 | T400 | PSP | OCLN | RAPAKGRAGRSKRTEQDHyEtDyttGGEsCDELEEDWIREY |
| Q16625 | T404 | ELM|PSP | OCLN | KGRAGRSKRTEQDHyEtDyttGGEsCDELEEDWIREYPPIt |
| Q16665 | T796 | SIGNOR|iPTMNet | HIF1A BHLHE78 MOP1 PASD8 | SDLACRLLGQSMDESGLPQLtSYDCEVNAPIQGsRNLLQGE |
| Q16666 | S132 | GPS6|SIGNOR|ELM|iPTMNet|PSP | IFI16 IFNGIP1 | sstVKtEGAEAtPGAQKRKKsTKEKAGPKGsKVsEEQtQPP |
| Q32P28 | S479 | Sugiyama | P3H1 GROS1 LEPRE1 PSEC0109 | LTMNSKLLNGSQRVVMDGVIsDHECQELQRLTNVAATSGDG |
| Q5VZL5 | S122 | Sugiyama | ZMYM4 KIAA0425 ZNF262 | VssIHtDDsLEVERRVtQHEsDNENEIQIQNKLKKDFPKQF |
| Q5VZL5 | T118 | Sugiyama | ZMYM4 KIAA0425 ZNF262 | KDNLVssIHtDDsLEVERRVtQHEsDNENEIQIQNKLKKDF |
| Q6NXS1 | S121 | PSP | PPP1R2B PPP1R2P3 | AKKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFE |
| Q6NXS1 | S122 | PSP | PPP1R2B PPP1R2P3 | KKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFEM |
| Q6NXS1 | S127 | PSP | PPP1R2B PPP1R2P3 | AEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFEMRRKLH |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6VY07 | S278 | SIGNOR|ELM|PSP | PACS1 KIAA1175 | IDHEGIKSKLSDRSPDIDNYsEEEEESFSSEQEGSDDPLHG |
| Q6ZMG9 | S341 | SIGNOR|PSP | CERS6 LASS6 | LIVKIACKAVSRGKVSKDDRsDIEsssDEEDSEPPGKNPHT |
| Q6ZMG9 | S345 | SIGNOR|PSP | CERS6 LASS6 | IACKAVSRGKVSKDDRsDIEsssDEEDSEPPGKNPHTATTT |
| Q6ZMG9 | S346 | SIGNOR|PSP | CERS6 LASS6 | ACKAVSRGKVSKDDRsDIEsssDEEDSEPPGKNPHTATTTN |
| Q6ZMG9 | S347 | SIGNOR|PSP | CERS6 LASS6 | CKAVSRGKVSKDDRsDIEsssDEEDSEPPGKNPHTATTTNG |
| Q712K3 | S233 | GPS6|SIGNOR|ELM|iPTMNet|PSP | UBE2R2 CDC34B UBC3B | DDIDDEDEEEEDADCYDDDDsGNEES_______________ |
| Q7Z4V5 | S369 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGR |
| Q7Z4V5 | S370 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGRG |
| Q86WR0 | S204 | Sugiyama | CCDC25 | RSYssLMKVENMSSNQDGNDsDEFM________________ |
| Q8IVP5 | S13 | SIGNOR|PSP | FUNDC1 | ________MATRNPPPQDyEsDDDsyEVLDLTEYARRHQWW |
| Q8N163 | T454 | SIGNOR | CCAR2 DBC1 KIAA1967 | PTLEEWEALCQQKAAEAAPPtQEAQGEtEPTEQAPDALEQA |
| Q8N5B7 | S350 | SIGNOR|PSP | CERS5 LASS5 | LIARIALKALIRGKVSKDDRsDVEsssEEEDVTTCTKSPCD |
| Q8N5B7 | S354 | SIGNOR|PSP | CERS5 LASS5 | IALKALIRGKVSKDDRsDVEsssEEEDVTTCTKSPCDSSSS |
| Q8N5B7 | S355 | SIGNOR|PSP | CERS5 LASS5 | ALKALIRGKVSKDDRsDVEsssEEEDVTTCTKSPCDSSSSN |
| Q8N5B7 | S356 | SIGNOR|PSP | CERS5 LASS5 | LKALIRGKVSKDDRsDVEsssEEEDVTTCTKSPCDSSSSNG |
| Q8N5P1 | T32 | PSP | ZC3H8 ZC3HDC8 | NPALGKtAtDsDERIDDEIDtEVEETQEEKIKLECEQIPKK |
| Q8N6T7 | S338 | PSP | SIRT6 SIR2L6 | EPCAQHNGsEPAsPKRERPtsPAPHRPPKRVKAKAVPS___ |
| Q8NE71 | S109 | SIGNOR|PSP|Sugiyama | ABCF1 ABC50 | DDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKGG |
| Q8NE71 | S140 | SIGNOR|PSP | ABCF1 ABC50 | PRGGKKTKGGNVFAALIQDQsEEEEEEEKHPPKPAKPEKNR |
| Q8NE71 | T108 | Sugiyama | ABCF1 ABC50 | VDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKG |
| Q8NEL9 | S104 | SIGNOR|PSP | DDHD1 KIAA1705 | LsDENYDFsSAESGSSLRYYsEGESGGGGSSLSLHPPQQPP |
| Q8NEL9 | S711 | SIGNOR | DDHD1 KIAA1705 | NPLPYEHMKPSFLNPAKEPtsVSENEGIstIPsPVtsPVLs |
| Q8NEL9 | S92 | SIGNOR | DDHD1 KIAA1705 | DDHNHHLALDPCLsDENYDFsSAESGSSLRYYsEGESGGGG |
| Q8NEY1 | S296 | Sugiyama | NAV1 KIAA1151 KIAA1213 POMFIL3 STEERIN1 | MSSLRGSQVTHSSLEMTCYDsDDANPRsVssLsNRssPLSW |
| Q8NHW5 | S304 | Sugiyama | RPLP0P6 | DTTAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAE8 | S221 | PSP | GADD45GIP1 MRPL59 PLINP1 PRG6 | ARAAALAAAVAQDPAASGAPss___________________ |
| Q8TEA8 | S179 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | QLSKLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGA |
| Q8TEA8 | S181 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | SKLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEG |
| Q8TEA8 | S182 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | KLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEGD |
| Q8TEA8 | S194 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | RAKGPsEssKERNtPRKEDRsAssGAEGDVssEREP_____ |
| Q8TEA8 | S196 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | KGPsEssKERNtPRKEDRsAssGAEGDVssEREP_______ |
| Q8TEA8 | S197 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | GPsEssKERNtPRKEDRsAssGAEGDVssEREP________ |
| Q8TEA8 | S204 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | ERNtPRKEDRsAssGAEGDVssEREP_______________ |
| Q8TEA8 | S205 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | RNtPRKEDRsAssGAEGDVssEREP________________ |
| Q8TEA8 | T187 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | QQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEGDVssER |
| Q8TF40 | S938 | PSP | FNIP1 KIAA1961 | KESSDKKIAVGTEWDIPRNEssDsALGDsEsEDTGHDMTRQ |
| Q8TF40 | S939 | PSP | FNIP1 KIAA1961 | ESSDKKIAVGTEWDIPRNEssDsALGDsEsEDTGHDMTRQV |
| Q8TF40 | S941 | PSP | FNIP1 KIAA1961 | SDKKIAVGTEWDIPRNEssDsALGDsEsEDTGHDMTRQVSS |
| Q8TF40 | S946 | PSP | FNIP1 KIAA1961 | AVGTEWDIPRNEssDsALGDsEsEDTGHDMTRQVSSYYGGE |
| Q8TF40 | S948 | PSP | FNIP1 KIAA1961 | GTEWDIPRNEssDsALGDsEsEDTGHDMTRQVSSYYGGEQE |
| Q8WVC0 | S66 | Sugiyama | LEO1 RDL | DQDERGDSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDN |
| Q8WXI9 | S129 | Sugiyama | GATAD2B KIAA1150 | ARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAA |
| Q92538 | S292 | SIGNOR|PSP | GBF1 KIAA0248 | TPISSASSEAASAVVSPSTDsGLEFssQttsKEDLtDLEQP |
| Q92538 | S297 | SIGNOR|PSP | GBF1 KIAA0248 | ASSEAASAVVSPSTDsGLEFssQttsKEDLtDLEQPGsPGy |
| Q92598 | S509 | SIGNOR|iPTMNet | HSPH1 HSP105 HSP110 KIAA0201 | IFTISTASMVEKVPtEENEMssEADMECLNQRPPENPDTDK |
| Q92626 | S1300 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | NITRVQSDVFRVAEFPHGyGsCDEIPRVDLRVWQDCCEDCR |
| Q92688 | T244 | SIGNOR|PSP | ANP32B APRIL PHAPI2 | DEDEDEEEEEGGKGEKRKREtDDEGEDD_____________ |
| Q92769 | S394 | GPS6|SIGNOR|ELM|PSP | HDAC2 | LPHAPGVQMQAIPEDAVHEDsGDEDGEDPDKRIsIRAsDKR |
| Q92769 | S422 | SIGNOR|ELM | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92769 | S424 | SIGNOR|ELM | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92882 | S213 | Sugiyama | OSTF1 | QGTDAVRtLsNAEDyLDDEDsD___________________ |
| Q92915 | S228 | SIGNOR|PSP | FGF14 FHF4 | EPSLHDVGETVPKPGVTPsKsTsASAIMNGGKPVNKSKTT_ |
| Q92915 | S230 | SIGNOR|PSP | FGF14 FHF4 | SLHDVGETVPKPGVTPsKsTsASAIMNGGKPVNKSKTT___ |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q93009 | S18 | SIGNOR|PSP | USP7 HAUSP | ___MNHQQQQQQQKAGEQQLsEPEDMEMEAGDTDDPPRITQ |
| Q96D46 | S468 | Sugiyama | NMD3 CGI-07 | EDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAEMLEDLH |
| Q96D46 | T470 | Sugiyama | NMD3 CGI-07 | EAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAEMLEDLHIs |
| Q96EB6 | S659 | SIGNOR|PSP | SIRT1 SIR2L1 | GNQYLFLPPNRYIFHGAEVYsDsEDDVLSSsSCGSNSDSGT |
| Q96EB6 | S661 | SIGNOR|PSP | SIRT1 SIR2L1 | QYLFLPPNRYIFHGAEVYsDsEDDVLSSsSCGSNSDSGTCQ |
| Q96FW1 | S16 | SIGNOR|PSP | OTUB1 OTB1 OTU1 HSPC263 | _____MAAEEPQQQKQEPLGsDsEGVNCLAyDEAIMAQQDR |
| Q96G74 | S177 | SIGNOR|PSP | OTUD5 | GVGAVGGGsPEREEVGAGyNsEDEyEAAAARIEAMDPATVE |
| Q96HZ4 | S183 | SIGNOR|iPTMNet|PSP | HES6 BHLHB41 | AGGAPGSPIPSPPGPGDDLCsDLEEAPEAELSQAPAEGPDL |
| Q96IZ0 | S231 | PSP | PAWR PAR4 | SsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDRSGFPR |
| Q96KQ7 | S211 | PSP | EHMT2 BAT8 C6orf30 G9A KMT1C NG36 | GNGQPPVPEKRPPEIQHFRMsDDVHsLGKVTSDLAKRRKLN |
| Q96NY9 | S87 | SIGNOR|PSP | MUS81 | QHFGDGLCRMLDERLQRHRtsGGDHAPDsPsGENsPAPQGR |
| Q96PX8 | S695 | SIGNOR|PSP | SLITRK1 KIAA1910 LRRC12 UNQ233/PRO266 | NGPYNADGAHRVYDCGSHSLsD___________________ |
| Q96QK1 | S759 | Sugiyama | VPS35 MEM3 TCCCTA00141 | TIQVLNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRL |
| Q96RL1 | S44 | PSP | UIMC1 RAP80 RXRIP110 | TTssVsVKRKRRLEDAFIVIsDsDGEEPKEENGLQKTKTKQ |
| Q96RL1 | S46 | PSP | UIMC1 RAP80 RXRIP110 | ssVsVKRKRRLEDAFIVIsDsDGEEPKEENGLQKTKTKQSN |
| Q96SB4 | S222 | ELM | SRPK1 | YLHTKCRIIHTDIKPENILLsVNEQYIRRLAAEATEWQRSG |
| Q96SB4 | S51 | GPS6|PSP | SRPK1 | RGsAPHSESDLPEQEEEILGsDDDEQEDPNDYCKGGYHLVK |
| Q96SB4 | S555 | GPS6|PSP | SRPK1 | WSTACMAFELATGDYLFEPHsGEEYTRDEDHIALIIELLGK |
| Q99250 | S1112 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | YMSFINNPSLTVTVPIAVGEsDFENLNTEEFSsEsDMEESK |
| Q99250 | S1124 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | TVPIAVGEsDFENLNTEEFSsEsDMEESKEKLNATSSSEGS |
| Q99250 | S1126 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | PIAVGEsDFENLNTEEFSsEsDMEESKEKLNATSSSEGSTV |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99638 | S341 | PSP | RAD9A | VLPsIsLsPGPQPPKsPGPHsEEEDEAEPStVPGtPPPKKF |
| Q99638 | S387 | PSP | RAD9A | GsILAPVRsPQGPsPVLAEDsEGEG________________ |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99808 | S254 | SIGNOR|PSP | SLC29A1 ENT1 | YYQQLKLEGPGEQEtKLDLIsKGEEPRAGKEEsGVsVsNsQ |
| Q9BPX3 | S674 | Sugiyama | NCAPG CAPG NYMEL3 | IEPFKTKKIKTLHCEGtEINsDDEQEsKEVEETATAKNVLK |
| Q9BPX3 | S973 | PSP | NCAPG CAPG NYMEL3 | QRKVTVsARTNRRCQTAEADsEsDHEVPEPESEMKMRLPRR |
| Q9BPX3 | S975 | PSP | NCAPG CAPG NYMEL3 | KVTVsARTNRRCQTAEADsEsDHEVPEPESEMKMRLPRRAK |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BRS2 | T410 | SIGNOR|PSP | RIOK1 RIO1 | ITHENMDAYLSKAMEIASQRtKEERssQDHVDEEVFKRAYI |
| Q9BSI4 | S396 | PSP | TINF2 TIN2 | PVCPPSLCSSVITIGDLVLDsDEEENGQGEGKESLENYQKT |
| Q9BW27 | S617 | Sugiyama | NUP85 NUP75 PCNT1 | TYELMRCLEDLTSRRPVHGEsDtEQLQDDDIETTKVEMLRL |
| Q9BW27 | T619 | Sugiyama | NUP85 NUP75 PCNT1 | ELMRCLEDLTSRRPVHGEsDtEQLQDDDIETTKVEMLRLSL |
| Q9BXJ9 | S855 | Sugiyama | NAA15 GA19 NARG1 NATH TBDN100 | ALAFMPPGYEEDMKItVNGDssAEAEELANEI_________ |
| Q9BXW9 | S882 | SIGNOR|PSP | FANCD2 FACD | IRKKGKIERKQKTDGSKTSssDtLsEEKNsECDPtPsHRGQ |
| Q9BXW9 | S886 | SIGNOR|PSP | FANCD2 FACD | GKIERKQKTDGSKTSssDtLsEEKNsECDPtPsHRGQLNKE |
| Q9BXW9 | S891 | SIGNOR|PSP | FANCD2 FACD | KQKTDGSKTSssDtLsEEKNsECDPtPsHRGQLNKEFTGKE |
| Q9BXW9 | S898 | SIGNOR|PSP | FANCD2 FACD | KTSssDtLsEEKNsECDPtPsHRGQLNKEFTGKEEKTSLLL |
| Q9BXW9 | T884 | SIGNOR|PSP | FANCD2 FACD | KKGKIERKQKTDGSKTSssDtLsEEKNsECDPtPsHRGQLN |
| Q9BXW9 | T896 | SIGNOR|PSP | FANCD2 FACD | GSKTSssDtLsEEKNsECDPtPsHRGQLNKEFTGKEEKTSL |
| Q9BYF1 | S787 | PSP | ACE2 UNQ868/PRO1885 | DRKKKNKARsGENPyAsIDIsKGENNPGFQNTDDVQTSF__ |
| Q9C0B1 | T150 | PSP | FTO KIAA1752 | AEIAAACETFLKLNDYLQIEtIQALEELAAKEKANEDAVPL |
| Q9H1E3 | S113 | Sugiyama | NUCKS1 NUCKS JC7 | RQAASKAASKQREMLMEDVGsEEEQEEEDEAPFQEKDsGsD |
| Q9H1E3 | S132 | Sugiyama | NUCKS1 NUCKS JC7 | GsEEEQEEEDEAPFQEKDsGsDEDFLMEDDDDsDyGSsKKK |
| Q9H257 | T531 | SIGNOR|PSP | CARD9 | MQKGWRQGEEDRENTTGSDNtDtEGS_______________ |
| Q9H257 | T533 | SIGNOR|PSP | CARD9 | KGWRQGEEDRENTTGSDNtDtEGS_________________ |
| Q9H2G2 | S347 | SIGNOR | SLK KIAA0204 STK2 | tENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVSEKt |
| Q9H2G2 | S348 | SIGNOR | SLK KIAA0204 STK2 | ENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVSEKtE |
| Q9H3N1 | S247 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EsAQPLKKVEEEQEADEEDVsEEEAEsKEGtNKDFPQNAIR |
| Q9H6T3 | S116 | PSP | RPAP3 | LDVDRILDELDKDDstHEsLsQEsEsEEDGIHVDSQKALVL |
| Q9H6T3 | S119 | PSP | RPAP3 | DRILDELDKDDstHEsLsQEsEsEEDGIHVDSQKALVLKEK |
| Q9H6T3 | S121 | PSP | RPAP3 | ILDELDKDDstHEsLsQEsEsEEDGIHVDSQKALVLKEKGN |
| Q9H6Y2 | S14 | Sugiyama | WDR55 | _______MDRTCEERPAEDGsDEEDPDsMEAPTRIRDtPED |
| Q9HA82 | S342 | SIGNOR|PSP | CERS4 LASS4 | LILRMLYSFMKKGQMEKDIRsDVEEsDssEEAAAAQEPLQL |
| Q9HA82 | S347 | SIGNOR|PSP | CERS4 LASS4 | LYSFMKKGQMEKDIRsDVEEsDssEEAAAAQEPLQLKNGAA |
| Q9HA82 | S349 | SIGNOR|PSP | CERS4 LASS4 | SFMKKGQMEKDIRsDVEEsDssEEAAAAQEPLQLKNGAAGG |
| Q9HA82 | S350 | SIGNOR|PSP | CERS4 LASS4 | FMKKGQMEKDIRsDVEEsDssEEAAAAQEPLQLKNGAAGGP |
| Q9HCF6 | S1195 | GPS6 | TRPM3 KIAA1616 LTRPC3 | IFSHMTMIFQHLCCRWRKHEsDPDERDYGLKLFITDDELKK |
| Q9HCN4 | S338 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | HPsDLILtRGTLDEEDEEADsDtDDIDHRVTEESHEEPAFQ |
| Q9HCU9 | S30 | SIGNOR|PSP | BRMS1 | TEEMEAEGDsAAEMNGEEEEsEEERSGSQTESEEESSEMDD |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQB0 | S58 | SIGNOR|ELM | TCF7L2 TCF4 | ERDLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDK |
| Q9NQB0 | S59 | SIGNOR|ELM | TCF7L2 TCF4 | RDLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDKS |
| Q9NQB0 | S60 | SIGNOR|ELM | TCF7L2 TCF4 | DLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDKSR |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NTJ3 | S28 | Sugiyama | SMC4 CAPC SMC4L1 | PSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsPAtAAEt |
| Q9NY61 | S155 | PSP | AATF CHE1 DED HSPC277 | ESKKSRsHsAKtPGFSVQsIsDFEKFTKGMDDLGSSEEEED |
| Q9NY61 | S288 | PSP | AATF CHE1 DED HSPC277 | GPEFSsALKNSHKALKALLRsLVGLQEELLFQYPDTRYLVD |
| Q9NY61 | S320 | PSP | AATF CHE1 DED HSPC277 | YPDTRYLVDGtKPNAGsEEIssEDDELVEEKKQQRRRVPAK |
| Q9NY61 | S321 | PSP | AATF CHE1 DED HSPC277 | PDTRYLVDGtKPNAGsEEIssEDDELVEEKKQQRRRVPAKR |
| Q9NYV6 | S170 | SIGNOR|PSP | RRN3 TIFIA | MIASHFVPPRVIIKEGDVDVsDsDDEDDNLPANFDTCHRAL |
| Q9NYV6 | S172 | SIGNOR|PSP | RRN3 TIFIA | ASHFVPPRVIIKEGDVDVsDsDDEDDNLPANFDTCHRALQI |
| Q9NZQ7 | T285 | PSP | CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 | RMMDVKKCGIQDtNsKKQsDtHLEEt_______________ |
| Q9NZQ7 | T290 | PSP | CD274 B7H1 PDCD1L1 PDCD1LG1 PDL1 | KKCGIQDtNsKKQsDtHLEEt____________________ |
| Q9UBE0 | S12 | Sugiyama | SAE1 AOS1 SUA1 UBLE1A | _________MVEKEEAGGGIsEEEAAQyDRQIRLWGLEAQK |
| Q9UBF6 | T10 | GPS6|SIGNOR|ELM|PSP | RNF7 RBX2 ROC2 SAG | ___________MADVEDGEEtCALAsHsGssGsKSGGDKMF |
| Q9UBN7 | S458 | PSP | HDAC6 KIAA0901 JM21 | LVRSTETVERDNMEEDNVEEsEEEGPWEPPVLPILTWPVLQ |
| Q9UBS4 | S78 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGLKDGH |
| Q9UD71 | S102 | SIGNOR | PPP1R1B DARPP32 | VQRIAESHLQSIsNLNENQAsEEEDELGELRELGYPREEDE |
| Q9UD71 | S45 | SIGNOR | PPP1R1B DARPP32 | VEMIRRRRPtPAMLFRLsEHssPEEEAsPHQRASGEGHHLK |
| Q9UD71 | S66 | iPTMNet | PPP1R1B DARPP32 | sPEEEAsPHQRASGEGHHLKsKRPNPCAYtPPSLKAVQRIA |
| Q9UER7 | S737 | SIGNOR|PSP | DAXX BING2 DAP6 | PGTCKTSVATQCDPEEIIVLsDsD_________________ |
| Q9UER7 | S739 | SIGNOR|PSP | DAXX BING2 DAP6 | TCKTSVATQCDPEEIIVLsDsD___________________ |
| Q9UGP8 | S574 | SIGNOR|PSP | SEC63 DNAJC23 SEC63L | GVVGNEAAVKEDEEEVsDKGsDsEEEETNRDsQSEKDDGsD |
| Q9UGP8 | S576 | SIGNOR|PSP | SEC63 DNAJC23 SEC63L | VGNEAAVKEDEEEVsDKGsDsEEEETNRDsQSEKDDGsDRD |
| Q9UGP8 | S748 | SIGNOR|PSP | SEC63 DNAJC23 SEC63L | QWDTAIEGDEDQEDSEGFEDsFEEEEEEEEDDD________ |
| Q9UHC3 | S5 | iPTMNet | ASIC3 ACCN3 SLNAC1 TNAC1 | ________________MKPTsGPEEARRPASDIRVFASNCS |
| Q9UHH9 | S347 | SIGNOR|PSP | IP6K2 IHPK2 TCCCIA00113 | YSSSLLVIYDGKERPEVVLDsDAEDLEDLsEEsADESAGAY |
| Q9UHH9 | S356 | SIGNOR|PSP | IP6K2 IHPK2 TCCCIA00113 | DGKERPEVVLDsDAEDLEDLsEEsADESAGAYAYKPIGASS |
| Q9UJU2 | S42 | PSP | LEF1 | EMIPFKDEGDPQKEKIFAEIsHPEEEGDLADIKSSLVNEsE |
| Q9UJU2 | S61 | PSP | LEF1 | IsHPEEEGDLADIKSSLVNEsEIIPASNGHEVARQAQTSQE |
| Q9UJY5 | S355 | SIGNOR|PSP | GGA1 | PAMPTRPGEQASPEQPSASVsLLDDELMSLGLSDPTPPSGP |
| Q9UKD2 | S229 | PSP | MRTO4 C1orf33 MRT4 | DSQSGRFQQMGDDLPESASEsTEEsDsEDDD__________ |
| Q9UKD2 | S233 | PSP | MRTO4 C1orf33 MRT4 | GRFQQMGDDLPESASEsTEEsDsEDDD______________ |
| Q9UKD2 | S235 | PSP | MRTO4 C1orf33 MRT4 | FQQMGDDLPESASEsTEEsDsEDDD________________ |
| Q9UKS6 | S276 | Sugiyama | PACSIN3 | SSSEKFHELHRDLHQGIEAAsDEEDLRWWRSTHGPGMAMNW |
| Q9UKX2 | S1921 | PSP | MYH2 MYHSA2 | KFRKLQHELEEAEERADIAEsQVNKLRVKSREVHTKVISEE |
| Q9ULV4 | S463 | SIGNOR|PSP | CORO1C CRN2 CRNN4 | EILKEIKSIKDTICNQDERIsKLEQQMAKIAA_________ |
| Q9UMD9 | S542 | GPS6|PSP | COL17A1 BP180 BPAG2 | DRLQGMAPAAGADLDKIGLHsDsQEELWMFVRKKLMMEQEN |
| Q9UMD9 | S544 | GPS6|PSP | COL17A1 BP180 BPAG2 | LQGMAPAAGADLDKIGLHsDsQEELWMFVRKKLMMEQENGN |
| Q9UNN4 | S356 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | IRVTDDDIGEIIQVDGSGDTssNEEIGSTRDADENEFLGNI |
| Q9UNN4 | S357 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | RVTDDDIGEIIQVDGSGDTssNEEIGSTRDADENEFLGNID |
| Q9UNN4 | S418 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | TNSSDNEDPQVNIVEEDPLNsGDDVsEQDVPDLFDTDNVIV |
| Q9UNN4 | S423 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | NEDPQVNIVEEDPLNsGDDVsEQDVPDLFDTDNVIVCQYDK |
| Q9UNN5 | S289 | GPS6|SIGNOR|ELM|iPTMNet|PSP | FAF1 UBXD12 UBXN3A CGI-03 | ssPAQTREQSEEQITDVHMVsDsDGDDFEDATEFGVDDGEV |
| Q9UNN5 | S291 | GPS6|SIGNOR|ELM|iPTMNet|PSP | FAF1 UBXD12 UBXN3A CGI-03 | PAQTREQSEEQITDVHMVsDsDGDDFEDATEFGVDDGEVFG |
| Q9UPP1 | S854 | SIGNOR|PSP | PHF8 KIAA1111 ZNF422 | sLDEQDSLGACFKDAEYIyPsLEsDDDDPALKSRPKKKKNS |
| Q9UQ88 | S271 | Sugiyama | CDK11A CDC2L2 CDC2L3 PITSLREB | AQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSAESGSGS |
| Q9UQE7 | S1067 | SIGNOR|PSP | SMC3 BAM BMH CSPG6 SMC3L1 | LVPGGKATLVMKKGDVEGsQsQDEGEGsGEsERGsGsQssV |
| Q9Y237 | S19 | SIGNOR|ELM|PSP | PIN4 | __MPPKGKSGSGKAGKGGAAsGSDSADKKAQGPKGGGNAVK |
| Q9Y365 | S284 | SIGNOR|PSP | STARD10 SDCCAG28 CGI-52 | DESAVAESREERMGGAGGEGsDDDtsLt_____________ |
| Q9Y3F4 | S254 | Sugiyama | STRAP MAWD UNRIP | EKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFS |
| Q9Y4R8 | S485 | PSP | TELO2 KIAA0683 | PAETPAEIVDGGVPQAQLAGsDsDLDsDDEFVPYDMSGDRE |
| Q9Y4R8 | S487 | SIGNOR|PSP | TELO2 KIAA0683 | ETPAEIVDGGVPQAQLAGsDsDLDsDDEFVPYDMSGDRELK |
| Q9Y4R8 | S491 | SIGNOR|PSP | TELO2 KIAA0683 | EIVDGGVPQAQLAGsDsDLDsDDEFVPYDMSGDRELKSSKA |
| Q9Y5B0 | S575 | SIGNOR|ELM|iPTMNet|PSP | CTDP1 FCP1 | ETESQNSELSGVTAGESLDQsMEEEEEEDtDEDDHLIYLEE |
| Q9Y5B0 | S740 | SIGNOR|ELM|iPTMNet|PSP | CTDP1 FCP1 | KVEEQLFPLRDDHTKAQRENsPAAFPDREGVPPTALFHPMP |
| Q9Y5B0 | S942 | PSP | CTDP1 FCP1 | LNEEDAASESSRESSNEDEGsSsEADEMAKALEAELNDLM_ |
| Q9Y5B0 | S944 | PSP | CTDP1 FCP1 | EEDAASESSRESSNEDEGsSsEADEMAKALEAELNDLM___ |
| Q9Y5B0 | T584 | PSP | CTDP1 FCP1 | SGVTAGESLDQsMEEEEEEDtDEDDHLIYLEEILVRVHTDY |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y618 | S2511 | PSP | NCOR2 CTG26 | PHHAWDEEPKPLLCSQYETLsDSE_________________ |
| Q9Y624 | S34 | iPTMNet | F11R JAM1 JCAM UNQ264/PRO301 | LFILAILLCSLALGSVTVHSsEPEVRIPENNPVKLSCAYSG |
| Q9Y696 | S236 | Sugiyama | CLIC4 | GIWRYLtNAysRDEFtNtCPsDKEVEIAysDVAKRLTK___ |
| Q9Y6K1 | S390 | SIGNOR|PSP | DNMT3A | YEVLQVASSRAGKLFPVCHDsDEsDTAKAVEVQNKPMIEWA |
| Q9Y6K1 | S393 | SIGNOR|PSP | DNMT3A | LQVASSRAGKLFPVCHDsDEsDTAKAVEVQNKPMIEWALGG |
| Q9Y6W5 | S482 | SIGNOR|PSP | WASF2 WAVE2 | RDVVGNDVAtILsRRIAVEYsDsEDDssEFDEDDWsD____ |
| Q9Y6W5 | S484 | SIGNOR|PSP | WASF2 WAVE2 | VVGNDVAtILsRRIAVEYsDsEDDssEFDEDDWsD______ |
| Q9Y6W5 | S488 | SIGNOR|PSP | WASF2 WAVE2 | DVAtILsRRIAVEYsDsEDDssEFDEDDWsD__________ |
| Q9Y6W5 | S489 | PSP | WASF2 WAVE2 | VAtILsRRIAVEYsDsEDDssEFDEDDWsD___________ |
| Q9Y6W5 | S497 | SIGNOR|PSP | WASF2 WAVE2 | IAVEYsDsEDDssEFDEDDWsD___________________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.148460e-09 | 8.940 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.598283e-08 | 7.252 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.955623e-08 | 7.158 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.290525e-07 | 6.889 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.980744e-06 | 5.303 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.504753e-06 | 5.346 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.364037e-06 | 5.078 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.657001e-05 | 4.437 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.223314e-05 | 4.085 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.690528e-04 | 3.772 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.432848e-04 | 3.614 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.133924e-04 | 3.504 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.325922e-04 | 3.364 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.568100e-04 | 3.254 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.592984e-04 | 3.252 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.832565e-04 | 3.234 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 7.181564e-04 | 3.144 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.762785e-04 | 3.010 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.406135e-03 | 2.852 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.314560e-03 | 2.881 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.540321e-03 | 2.812 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.645734e-03 | 2.784 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.709056e-03 | 2.767 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.031652e-03 | 2.692 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.073655e-03 | 2.683 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.366986e-03 | 2.626 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.453657e-03 | 2.610 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.862170e-03 | 2.543 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.037448e-03 | 2.517 | 1 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.368248e-03 | 2.473 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.861958e-03 | 2.413 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.861958e-03 | 2.413 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.861958e-03 | 2.413 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.663967e-03 | 2.436 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.861958e-03 | 2.413 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.414915e-03 | 2.467 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.861958e-03 | 2.413 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.284638e-03 | 2.368 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.422764e-03 | 2.354 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.420283e-03 | 2.355 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.494911e-03 | 2.347 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.583169e-03 | 2.339 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.342047e-03 | 2.272 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.480514e-03 | 2.261 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.978387e-03 | 2.098 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.978387e-03 | 2.098 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.978387e-03 | 2.098 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.973988e-03 | 2.157 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.843876e-03 | 2.105 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.950453e-03 | 2.158 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 7.214182e-03 | 2.142 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.725651e-03 | 2.172 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.950453e-03 | 2.158 | 1 | 1 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.950453e-03 | 2.158 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.613268e-03 | 2.118 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.101482e-03 | 2.041 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.142364e-03 | 2.039 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.142364e-03 | 2.039 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.142364e-03 | 2.039 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.148611e-03 | 2.039 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.943311e-03 | 2.049 | 1 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.329270e-03 | 2.030 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.963794e-03 | 2.002 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.626224e-03 | 2.017 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.626224e-03 | 2.017 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.626224e-03 | 2.017 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.028859e-02 | 1.988 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.033688e-02 | 1.986 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.046853e-02 | 1.980 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.149230e-02 | 1.940 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.434318e-02 | 1.843 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.356235e-02 | 1.868 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.434318e-02 | 1.843 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.434318e-02 | 1.843 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.431524e-02 | 1.844 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.423096e-02 | 1.847 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.502759e-02 | 1.823 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.554442e-02 | 1.808 | 1 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.725193e-02 | 1.763 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.761064e-02 | 1.754 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.870586e-02 | 1.728 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.870586e-02 | 1.728 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.912939e-02 | 1.718 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.917463e-02 | 1.717 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.018643e-02 | 1.695 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.032251e-02 | 1.692 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.156386e-02 | 1.666 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.175692e-02 | 1.662 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.239352e-02 | 1.650 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.229903e-02 | 1.652 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.241544e-02 | 1.649 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.313209e-02 | 1.636 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.326279e-02 | 1.633 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.478417e-02 | 1.606 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.512500e-02 | 1.600 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.537985e-02 | 1.596 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.571154e-02 | 1.590 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.985376e-02 | 1.525 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.985376e-02 | 1.525 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.819620e-02 | 1.550 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.001153e-02 | 1.523 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.023383e-02 | 1.520 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.099065e-02 | 1.509 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.099065e-02 | 1.509 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.107528e-02 | 1.508 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.401519e-02 | 1.468 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.401519e-02 | 1.468 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.309209e-02 | 1.480 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.161688e-02 | 1.500 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.377912e-02 | 1.471 | 1 | 1 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.368720e-02 | 1.473 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.420684e-02 | 1.466 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.435616e-02 | 1.464 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.541170e-02 | 1.451 | 1 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.556831e-02 | 1.449 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.556831e-02 | 1.449 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.614319e-02 | 1.442 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.614319e-02 | 1.442 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.694221e-02 | 1.432 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.915285e-02 | 1.407 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.915285e-02 | 1.407 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.087453e-02 | 1.389 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.156803e-02 | 1.381 | 1 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.237998e-02 | 1.373 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.340634e-02 | 1.362 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.435337e-02 | 1.353 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.443215e-02 | 1.352 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 4.443215e-02 | 1.352 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.579274e-02 | 1.339 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.582359e-02 | 1.339 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.582359e-02 | 1.339 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.160867e-02 | 1.287 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.194914e-02 | 1.284 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.771598e-02 | 1.321 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.822211e-02 | 1.317 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.160867e-02 | 1.287 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.922947e-02 | 1.308 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.406270e-02 | 1.267 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.406270e-02 | 1.267 | 1 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.647791e-02 | 1.248 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.721149e-02 | 1.243 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.721149e-02 | 1.243 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.721149e-02 | 1.243 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.857837e-02 | 1.232 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.857837e-02 | 1.232 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.027366e-02 | 1.220 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.202180e-02 | 1.207 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.235182e-02 | 1.205 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.323948e-02 | 1.199 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.453593e-02 | 1.190 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.168876e-02 | 1.145 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.329322e-02 | 1.135 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.329322e-02 | 1.135 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.329322e-02 | 1.135 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.168876e-02 | 1.145 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.565793e-02 | 1.183 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.943310e-02 | 1.158 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.427250e-02 | 1.129 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.479390e-02 | 1.126 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.763669e-02 | 1.110 | 1 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.062339e-02 | 1.043 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.062339e-02 | 1.043 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.078190e-02 | 1.093 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.078190e-02 | 1.093 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 8.078190e-02 | 1.093 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 7.936245e-02 | 1.100 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.439523e-02 | 1.074 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 8.461499e-02 | 1.073 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.474824e-02 | 1.072 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.936245e-02 | 1.100 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.029938e-02 | 1.044 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.936245e-02 | 1.100 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.525813e-02 | 1.069 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.005631e-02 | 1.097 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.028429e-02 | 1.044 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.062339e-02 | 1.043 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.014829e-02 | 1.096 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.930461e-02 | 1.101 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.168980e-02 | 1.038 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.168980e-02 | 1.038 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.187350e-02 | 1.037 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.383033e-02 | 1.028 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.542946e-02 | 1.020 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.542946e-02 | 1.020 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.542946e-02 | 1.020 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.542946e-02 | 1.020 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.542946e-02 | 1.020 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.542946e-02 | 1.020 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.542946e-02 | 1.020 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.013944e-01 | 0.994 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.059193e-01 | 0.975 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.681822e-02 | 1.014 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.681822e-02 | 1.014 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.029433e-01 | 0.987 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.023892e-01 | 0.990 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.107398e-01 | 0.956 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.107398e-01 | 0.956 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.049195e-01 | 0.979 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.106731e-01 | 0.956 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.511202e-02 | 1.022 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.094462e-01 | 0.961 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.096433e-01 | 0.960 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.698529e-02 | 1.013 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.698529e-02 | 1.013 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.022912e-01 | 0.990 | 1 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.013944e-01 | 0.994 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.062713e-01 | 0.974 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.592317e-02 | 1.018 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.592317e-02 | 1.018 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.817572e-01 | 0.741 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.817572e-01 | 0.741 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.817572e-01 | 0.741 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.817572e-01 | 0.741 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.817572e-01 | 0.741 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.817572e-01 | 0.741 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.224539e-01 | 0.912 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.224539e-01 | 0.912 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.224539e-01 | 0.912 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 2.598509e-01 | 0.585 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.598509e-01 | 0.585 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.598509e-01 | 0.585 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.564929e-01 | 0.806 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.212088e-01 | 0.916 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.920298e-01 | 0.717 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.920298e-01 | 0.717 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.920298e-01 | 0.717 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 3.304955e-01 | 0.481 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.304955e-01 | 0.481 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.304955e-01 | 0.481 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.304955e-01 | 0.481 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.304955e-01 | 0.481 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.436973e-01 | 0.843 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.436973e-01 | 0.843 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.284690e-01 | 0.641 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.921949e-01 | 0.716 | 1 | 1 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.653152e-01 | 0.576 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 2.653152e-01 | 0.576 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.653152e-01 | 0.576 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.944010e-01 | 0.404 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.944010e-01 | 0.404 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 3.944010e-01 | 0.404 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.944010e-01 | 0.404 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.944010e-01 | 0.404 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.944010e-01 | 0.404 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.624066e-01 | 0.789 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.177982e-01 | 0.662 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.177982e-01 | 0.662 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.381051e-01 | 0.860 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.381051e-01 | 0.860 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.180749e-01 | 0.928 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.180749e-01 | 0.928 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.021590e-01 | 0.520 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.021590e-01 | 0.520 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.021590e-01 | 0.520 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.534367e-01 | 0.814 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.305011e-01 | 0.884 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.305011e-01 | 0.884 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.019181e-01 | 0.695 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.694375e-01 | 0.771 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.694375e-01 | 0.771 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.223990e-01 | 0.912 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.571160e-01 | 0.804 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.226498e-01 | 0.652 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.386657e-01 | 0.470 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.386657e-01 | 0.470 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.386657e-01 | 0.470 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.386657e-01 | 0.470 | 1 | 1 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.386657e-01 | 0.470 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.522100e-01 | 0.345 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.522100e-01 | 0.345 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.522100e-01 | 0.345 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.977619e-01 | 0.526 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.655812e-01 | 0.576 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.745640e-01 | 0.426 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.745640e-01 | 0.426 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.249045e-01 | 0.488 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.249045e-01 | 0.488 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.249045e-01 | 0.488 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.970092e-01 | 0.706 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.205079e-01 | 0.919 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.799158e-01 | 0.745 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.799158e-01 | 0.745 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.575478e-01 | 0.589 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.575478e-01 | 0.589 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.361777e-01 | 0.866 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.098441e-01 | 0.509 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 3.520421e-01 | 0.453 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.045039e-01 | 0.297 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.045039e-01 | 0.297 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.790453e-01 | 0.421 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.790453e-01 | 0.421 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.790453e-01 | 0.421 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.828027e-01 | 0.738 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.547316e-01 | 0.450 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.437174e-01 | 0.353 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.437174e-01 | 0.353 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.721570e-01 | 0.565 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.057986e-01 | 0.392 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.057986e-01 | 0.392 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.057986e-01 | 0.392 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.006291e-01 | 0.522 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.338742e-01 | 0.476 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.338742e-01 | 0.476 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.582117e-01 | 0.801 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 4.321995e-01 | 0.364 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.321995e-01 | 0.364 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.766732e-01 | 0.322 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.766732e-01 | 0.322 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.766732e-01 | 0.322 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.518083e-01 | 0.258 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.518083e-01 | 0.258 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.518083e-01 | 0.258 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.518083e-01 | 0.258 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.518083e-01 | 0.258 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.518083e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.689827e-01 | 0.433 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.689827e-01 | 0.433 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.689827e-01 | 0.433 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.930541e-01 | 0.406 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.218587e-01 | 0.375 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.547506e-01 | 0.450 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.744069e-01 | 0.427 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.042210e-01 | 0.393 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.686842e-01 | 0.433 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.835969e-01 | 0.316 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.835969e-01 | 0.316 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.835969e-01 | 0.316 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.126478e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.393067e-01 | 0.357 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.706633e-01 | 0.431 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.084492e-01 | 0.294 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.945992e-01 | 0.226 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.945992e-01 | 0.226 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.945992e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.945992e-01 | 0.226 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.945992e-01 | 0.226 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 5.945992e-01 | 0.226 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.945992e-01 | 0.226 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 5.945992e-01 | 0.226 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.945992e-01 | 0.226 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.945992e-01 | 0.226 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.945992e-01 | 0.226 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.739818e-01 | 0.324 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.326594e-01 | 0.274 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.679764e-01 | 0.246 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.679764e-01 | 0.246 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.679764e-01 | 0.246 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.574333e-01 | 0.254 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.957405e-01 | 0.225 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.957405e-01 | 0.225 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.333070e-01 | 0.198 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.333070e-01 | 0.198 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.333070e-01 | 0.198 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.333070e-01 | 0.198 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.333070e-01 | 0.198 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.333070e-01 | 0.198 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 6.333070e-01 | 0.198 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.733858e-01 | 0.242 | 1 | 1 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.733858e-01 | 0.242 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.044065e-01 | 0.219 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.221437e-01 | 0.206 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.194462e-01 | 0.208 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.295851e-01 | 0.201 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.453803e-01 | 0.190 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.427729e-01 | 0.192 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.427729e-01 | 0.192 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.471927e-01 | 0.189 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.683210e-01 | 0.175 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.683210e-01 | 0.175 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.683210e-01 | 0.175 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.683210e-01 | 0.175 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.683210e-01 | 0.175 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.683210e-01 | 0.175 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.683210e-01 | 0.175 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.683210e-01 | 0.175 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.624567e-01 | 0.179 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.624567e-01 | 0.179 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.479581e-01 | 0.830 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.222923e-01 | 0.206 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.082688e-01 | 0.294 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.970092e-01 | 0.706 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.571160e-01 | 0.804 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.437174e-01 | 0.353 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.763844e-01 | 0.558 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.745640e-01 | 0.426 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 3.996051e-01 | 0.398 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.739410e-01 | 0.760 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.049810e-01 | 0.393 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.739818e-01 | 0.324 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.439499e-01 | 0.842 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.970092e-01 | 0.706 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.324232e-01 | 0.634 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.680026e-01 | 0.775 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.205079e-01 | 0.919 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.921949e-01 | 0.716 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.745640e-01 | 0.426 | 1 | 1 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.954884e-01 | 0.529 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.301485e-01 | 0.638 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.393067e-01 | 0.357 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.536591e-01 | 0.257 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.707570e-01 | 0.567 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.977619e-01 | 0.526 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.798587e-01 | 0.745 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.937866e-01 | 0.713 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.942575e-01 | 0.306 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 6.624567e-01 | 0.179 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.650673e-01 | 0.177 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.081179e-01 | 0.294 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.486929e-01 | 0.604 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.818321e-01 | 0.550 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.050582e-01 | 0.218 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.331933e-01 | 0.477 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.257058e-01 | 0.646 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.118143e-01 | 0.952 | 1 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.653152e-01 | 0.576 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.021590e-01 | 0.520 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.745640e-01 | 0.426 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.745640e-01 | 0.426 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.834868e-01 | 0.736 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.096378e-01 | 0.388 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.326594e-01 | 0.274 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.957405e-01 | 0.225 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.492488e-01 | 0.260 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.057986e-01 | 0.392 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.151978e-01 | 0.939 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.950645e-01 | 0.305 | 1 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.691727e-01 | 0.570 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.217997e-01 | 0.375 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.522100e-01 | 0.345 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.610563e-01 | 0.793 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.045039e-01 | 0.297 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.437174e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.766732e-01 | 0.322 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.766732e-01 | 0.322 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.518083e-01 | 0.258 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.364689e-01 | 0.626 | 1 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 5.733858e-01 | 0.242 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.345758e-01 | 0.871 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.437174e-01 | 0.353 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.513937e-01 | 0.454 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.221437e-01 | 0.206 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.870901e-01 | 0.231 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.043368e-01 | 0.393 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.735501e-01 | 0.563 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.996051e-01 | 0.398 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.766732e-01 | 0.322 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.447970e-01 | 0.352 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.942575e-01 | 0.306 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.431217e-01 | 0.192 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.427729e-01 | 0.192 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.471927e-01 | 0.189 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.454386e-01 | 0.837 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.165424e-01 | 0.380 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.454386e-01 | 0.837 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.486929e-01 | 0.604 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.498552e-01 | 0.602 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.311432e-01 | 0.365 | 1 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.301752e-01 | 0.638 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.564929e-01 | 0.806 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.624066e-01 | 0.789 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.440460e-01 | 0.613 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.019181e-01 | 0.695 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.345758e-01 | 0.871 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.096378e-01 | 0.388 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.045039e-01 | 0.297 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.790453e-01 | 0.421 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.437174e-01 | 0.353 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.304837e-01 | 0.637 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 5.080161e-01 | 0.294 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.957405e-01 | 0.225 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.957405e-01 | 0.225 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.333070e-01 | 0.198 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.333070e-01 | 0.198 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.010228e-01 | 0.221 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.602708e-01 | 0.180 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.581764e-01 | 0.801 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.698476e-01 | 0.244 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.079611e-01 | 0.294 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.705164e-01 | 0.768 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.634114e-01 | 0.787 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.388548e-01 | 0.195 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.130770e-01 | 0.947 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.957405e-01 | 0.225 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.032317e-01 | 0.692 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.541914e-01 | 0.812 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.233803e-01 | 0.281 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.233803e-01 | 0.281 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.233803e-01 | 0.281 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.233803e-01 | 0.281 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.342711e-01 | 0.476 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.772070e-01 | 0.423 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.047747e-01 | 0.689 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.209123e-01 | 0.656 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.883619e-01 | 0.230 | 1 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.363930e-01 | 0.196 | 1 | 0 |
| Autophagy | R-HSA-9612973 | 5.757521e-01 | 0.240 | 1 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.569786e-01 | 0.182 | 1 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.921949e-01 | 0.716 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.534367e-01 | 0.814 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.045039e-01 | 0.297 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.045039e-01 | 0.297 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.859738e-01 | 0.544 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.985517e-01 | 0.525 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.594919e-01 | 0.444 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.666467e-01 | 0.331 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.289772e-01 | 0.277 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.843873e-01 | 0.315 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.471927e-01 | 0.189 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.683210e-01 | 0.175 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.607456e-01 | 0.180 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.676204e-01 | 0.175 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.996051e-01 | 0.398 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.436973e-01 | 0.843 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.143662e-01 | 0.942 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.655812e-01 | 0.576 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.254127e-01 | 0.204 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.532837e-01 | 0.257 | 1 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.298757e-01 | 0.482 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.191914e-01 | 0.659 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.183348e-01 | 0.285 | 1 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.386657e-01 | 0.470 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.732968e-01 | 0.563 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.925917e-01 | 0.534 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.453803e-01 | 0.190 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.214718e-01 | 0.283 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.261867e-01 | 0.279 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 2.177982e-01 | 0.662 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.679764e-01 | 0.246 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.865206e-01 | 0.543 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.057986e-01 | 0.392 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.491806e-01 | 0.457 | 1 | 0 |
| S Phase | R-HSA-69242 | 1.698533e-01 | 0.770 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.838898e-01 | 0.315 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.669262e-01 | 0.246 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.954884e-01 | 0.529 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.939238e-01 | 0.532 | 1 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.212088e-01 | 0.916 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.304955e-01 | 0.481 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.674278e-01 | 0.776 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.438196e-01 | 0.842 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.944010e-01 | 0.404 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.944010e-01 | 0.404 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.944010e-01 | 0.404 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.019181e-01 | 0.695 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.522100e-01 | 0.345 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.522100e-01 | 0.345 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.209123e-01 | 0.656 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.209123e-01 | 0.656 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.655812e-01 | 0.576 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.680026e-01 | 0.775 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.165041e-01 | 0.665 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.610563e-01 | 0.793 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.610563e-01 | 0.793 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.763844e-01 | 0.558 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.520421e-01 | 0.453 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.045039e-01 | 0.297 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.437174e-01 | 0.353 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.437174e-01 | 0.353 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.437174e-01 | 0.353 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.772070e-01 | 0.423 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.518083e-01 | 0.258 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.518083e-01 | 0.258 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.518083e-01 | 0.258 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.042210e-01 | 0.393 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.439057e-01 | 0.353 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.388581e-01 | 0.269 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.679764e-01 | 0.246 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.574333e-01 | 0.254 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.789789e-01 | 0.237 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.333070e-01 | 0.198 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.333070e-01 | 0.198 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.733858e-01 | 0.242 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.114978e-01 | 0.214 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.109088e-01 | 0.676 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.234921e-01 | 0.908 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.666467e-01 | 0.331 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.009756e-01 | 0.697 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.096678e-01 | 0.215 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.939733e-01 | 0.532 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.026711e-01 | 0.220 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.547316e-01 | 0.450 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.947568e-01 | 0.711 | 1 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.538349e-01 | 0.451 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.517275e-01 | 0.819 | 1 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.818047e-01 | 0.740 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.245996e-01 | 0.904 | 1 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 1.674278e-01 | 0.776 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.790453e-01 | 0.421 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.522100e-01 | 0.453 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.564640e-01 | 0.806 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.199737e-01 | 0.921 | 1 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.977619e-01 | 0.526 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.322264e-01 | 0.479 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.831401e-01 | 0.234 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.212088e-01 | 0.916 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.674278e-01 | 0.776 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.711416e-01 | 0.767 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.251581e-01 | 0.648 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.744069e-01 | 0.427 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.388581e-01 | 0.269 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.081179e-01 | 0.294 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.081179e-01 | 0.294 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.663125e-01 | 0.247 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.967808e-01 | 0.706 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.607637e-01 | 0.337 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.050173e-01 | 0.218 | 1 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.019181e-01 | 0.695 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.045039e-01 | 0.297 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.790453e-01 | 0.421 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.007007e-01 | 0.522 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.766732e-01 | 0.322 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.766732e-01 | 0.322 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.766732e-01 | 0.322 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.894458e-01 | 0.310 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.427729e-01 | 0.192 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.763898e-01 | 0.754 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.581582e-01 | 0.339 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.320673e-01 | 0.364 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.386657e-01 | 0.470 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.032317e-01 | 0.692 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.045039e-01 | 0.297 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.525146e-01 | 0.258 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.965151e-01 | 0.402 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.084492e-01 | 0.294 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.837341e-01 | 0.416 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.697154e-01 | 0.569 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.293310e-01 | 0.640 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.217997e-01 | 0.375 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.082688e-01 | 0.294 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.885350e-01 | 0.311 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.436973e-01 | 0.843 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.431217e-01 | 0.192 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 4.057986e-01 | 0.392 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.656897e-01 | 0.332 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.705236e-01 | 0.327 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.308893e-01 | 0.200 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.205375e-01 | 0.919 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.827051e-01 | 0.417 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.212088e-01 | 0.916 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.284690e-01 | 0.641 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.745640e-01 | 0.426 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.045039e-01 | 0.297 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.547316e-01 | 0.450 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.437174e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.518083e-01 | 0.258 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.518083e-01 | 0.258 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.518083e-01 | 0.258 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 3.744069e-01 | 0.427 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.233803e-01 | 0.281 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.222923e-01 | 0.206 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.683210e-01 | 0.175 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.228012e-01 | 0.491 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.391772e-01 | 0.470 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.536591e-01 | 0.257 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.656897e-01 | 0.332 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.581582e-01 | 0.339 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.265091e-01 | 0.279 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.233803e-01 | 0.281 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.536591e-01 | 0.257 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.920298e-01 | 0.717 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.440460e-01 | 0.613 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.477422e-01 | 0.349 | 1 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.734467e-01 | 0.428 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.144456e-01 | 0.502 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.153200e-01 | 0.938 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.321995e-01 | 0.364 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.254127e-01 | 0.204 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.009756e-01 | 0.697 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.875918e-01 | 0.541 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.096378e-01 | 0.388 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.954884e-01 | 0.529 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.538349e-01 | 0.451 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.547506e-01 | 0.450 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.835969e-01 | 0.316 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.945992e-01 | 0.226 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.258339e-01 | 0.900 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.679764e-01 | 0.246 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.026977e-01 | 0.693 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.501805e-01 | 0.602 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.006291e-01 | 0.522 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.033400e-01 | 0.692 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.541914e-01 | 0.812 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.387579e-01 | 0.358 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.304955e-01 | 0.481 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.653152e-01 | 0.576 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.143662e-01 | 0.942 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.386657e-01 | 0.470 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.522100e-01 | 0.345 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.745640e-01 | 0.426 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.875918e-01 | 0.541 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.045039e-01 | 0.297 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.045039e-01 | 0.297 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.322264e-01 | 0.479 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.518083e-01 | 0.258 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.945992e-01 | 0.226 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.082688e-01 | 0.294 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.679764e-01 | 0.246 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.333070e-01 | 0.198 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.333070e-01 | 0.198 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.333070e-01 | 0.198 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.156411e-01 | 0.211 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.683210e-01 | 0.175 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.683210e-01 | 0.175 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 5.403575e-01 | 0.267 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.707570e-01 | 0.567 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.032317e-01 | 0.692 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.079212e-01 | 0.294 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.354498e-01 | 0.474 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.322514e-01 | 0.479 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.689827e-01 | 0.433 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.517566e-01 | 0.819 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.062025e-01 | 0.514 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.338742e-01 | 0.476 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.086461e-01 | 0.389 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 1.564929e-01 | 0.806 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.920298e-01 | 0.717 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.653152e-01 | 0.576 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.653152e-01 | 0.576 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 3.944010e-01 | 0.404 | 0 | 0 |
| NGF processing | R-HSA-167060 | 3.944010e-01 | 0.404 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.707570e-01 | 0.567 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.386657e-01 | 0.470 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.977619e-01 | 0.526 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.977619e-01 | 0.526 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.799158e-01 | 0.745 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.096378e-01 | 0.388 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.045039e-01 | 0.297 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.518083e-01 | 0.258 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.324776e-01 | 0.478 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.835969e-01 | 0.316 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.945992e-01 | 0.226 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.607637e-01 | 0.337 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.679764e-01 | 0.246 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.683210e-01 | 0.175 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.650673e-01 | 0.177 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.390374e-01 | 0.622 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.427729e-01 | 0.192 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.835356e-01 | 0.547 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.019181e-01 | 0.695 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.118143e-01 | 0.952 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.326594e-01 | 0.274 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.313170e-01 | 0.275 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.438196e-01 | 0.842 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.745640e-01 | 0.426 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.766269e-01 | 0.322 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.683210e-01 | 0.175 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.652973e-01 | 0.782 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.945992e-01 | 0.226 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.945992e-01 | 0.226 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.683210e-01 | 0.175 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.683210e-01 | 0.175 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.602708e-01 | 0.180 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.321995e-01 | 0.364 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.254127e-01 | 0.204 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.202989e-01 | 0.657 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.333070e-01 | 0.198 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.427729e-01 | 0.192 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.491548e-01 | 0.348 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.492488e-01 | 0.260 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.745640e-01 | 0.426 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.321995e-01 | 0.364 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.471927e-01 | 0.189 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.304955e-01 | 0.481 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.679764e-01 | 0.246 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.571160e-01 | 0.804 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.050582e-01 | 0.218 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.709054e-01 | 0.173 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.709054e-01 | 0.173 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.709054e-01 | 0.173 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.709054e-01 | 0.173 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.756732e-01 | 0.170 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.756732e-01 | 0.170 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.768525e-01 | 0.170 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.768525e-01 | 0.170 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.768525e-01 | 0.170 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.777268e-01 | 0.169 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.778329e-01 | 0.169 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.790046e-01 | 0.168 | 1 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.813407e-01 | 0.167 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.813407e-01 | 0.167 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.895146e-01 | 0.161 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.900812e-01 | 0.161 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.900812e-01 | 0.161 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.928623e-01 | 0.159 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.928623e-01 | 0.159 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.933085e-01 | 0.159 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.933085e-01 | 0.159 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.933085e-01 | 0.159 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.933085e-01 | 0.159 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.943724e-01 | 0.158 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.953435e-01 | 0.158 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.957917e-01 | 0.158 | 1 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.994268e-01 | 0.155 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.994268e-01 | 0.155 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.994268e-01 | 0.155 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.994268e-01 | 0.155 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.994268e-01 | 0.155 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.999935e-01 | 0.155 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.999935e-01 | 0.155 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.999935e-01 | 0.155 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.999935e-01 | 0.155 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.999935e-01 | 0.155 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.999935e-01 | 0.155 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.999935e-01 | 0.155 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.999935e-01 | 0.155 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.999935e-01 | 0.155 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.999935e-01 | 0.155 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.999935e-01 | 0.155 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.999935e-01 | 0.155 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.999935e-01 | 0.155 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.001966e-01 | 0.155 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.024523e-01 | 0.153 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.027028e-01 | 0.153 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.027960e-01 | 0.153 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.029000e-01 | 0.153 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.144358e-01 | 0.146 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.144358e-01 | 0.146 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.144358e-01 | 0.146 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.144358e-01 | 0.146 | 1 | 1 |
| Signaling by NODAL | R-HSA-1181150 | 7.144358e-01 | 0.146 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.153750e-01 | 0.145 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.163532e-01 | 0.145 | 1 | 1 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.167213e-01 | 0.145 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.167213e-01 | 0.145 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.177818e-01 | 0.144 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.184601e-01 | 0.144 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.231611e-01 | 0.141 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.231611e-01 | 0.141 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.272194e-01 | 0.138 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.286432e-01 | 0.137 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.286432e-01 | 0.137 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.286432e-01 | 0.137 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.286432e-01 | 0.137 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.286432e-01 | 0.137 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.286432e-01 | 0.137 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.286432e-01 | 0.137 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.286432e-01 | 0.137 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.286432e-01 | 0.137 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.286432e-01 | 0.137 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.305010e-01 | 0.136 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.309192e-01 | 0.136 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.323039e-01 | 0.135 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.332337e-01 | 0.135 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.343268e-01 | 0.134 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.343268e-01 | 0.134 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.343268e-01 | 0.134 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.343268e-01 | 0.134 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.344418e-01 | 0.134 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.345397e-01 | 0.134 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.390463e-01 | 0.131 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.400620e-01 | 0.131 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.436075e-01 | 0.129 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.451778e-01 | 0.128 | 1 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.451778e-01 | 0.128 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.489770e-01 | 0.126 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.511813e-01 | 0.124 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.530247e-01 | 0.123 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.530247e-01 | 0.123 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.530247e-01 | 0.123 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 7.545586e-01 | 0.122 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.545586e-01 | 0.122 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.545586e-01 | 0.122 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.545586e-01 | 0.122 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.545586e-01 | 0.122 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.545586e-01 | 0.122 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.545586e-01 | 0.122 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.545586e-01 | 0.122 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.545586e-01 | 0.122 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.545586e-01 | 0.122 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.545586e-01 | 0.122 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.545586e-01 | 0.122 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.545586e-01 | 0.122 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.545586e-01 | 0.122 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.558491e-01 | 0.122 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.639667e-01 | 0.117 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.639667e-01 | 0.117 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.676474e-01 | 0.115 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.676474e-01 | 0.115 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.676474e-01 | 0.115 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.693172e-01 | 0.114 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.705760e-01 | 0.113 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.705760e-01 | 0.113 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.705760e-01 | 0.113 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.711988e-01 | 0.113 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.741366e-01 | 0.111 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.763644e-01 | 0.110 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.769694e-01 | 0.110 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.769694e-01 | 0.110 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.769694e-01 | 0.110 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.780003e-01 | 0.109 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.780003e-01 | 0.109 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 7.780003e-01 | 0.109 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.780003e-01 | 0.109 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.780003e-01 | 0.109 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.780003e-01 | 0.109 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.782204e-01 | 0.109 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.782204e-01 | 0.109 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.782204e-01 | 0.109 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.782204e-01 | 0.109 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.782204e-01 | 0.109 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.785973e-01 | 0.109 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.785973e-01 | 0.109 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.804861e-01 | 0.108 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.834540e-01 | 0.106 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.870292e-01 | 0.104 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.870292e-01 | 0.104 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 7.870292e-01 | 0.104 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.870292e-01 | 0.104 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.870292e-01 | 0.104 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.871496e-01 | 0.104 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.890481e-01 | 0.103 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 7.895928e-01 | 0.103 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.917577e-01 | 0.101 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.917577e-01 | 0.101 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 7.917577e-01 | 0.101 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.926539e-01 | 0.101 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.926539e-01 | 0.101 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.926539e-01 | 0.101 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.928712e-01 | 0.101 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.946770e-01 | 0.100 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.946770e-01 | 0.100 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.992044e-01 | 0.097 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.992044e-01 | 0.097 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.992044e-01 | 0.097 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 7.992044e-01 | 0.097 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.992044e-01 | 0.097 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.992044e-01 | 0.097 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 7.992044e-01 | 0.097 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.992044e-01 | 0.097 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.992044e-01 | 0.097 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.992044e-01 | 0.097 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.992044e-01 | 0.097 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.992044e-01 | 0.097 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.992044e-01 | 0.097 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.992044e-01 | 0.097 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.992044e-01 | 0.097 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.992044e-01 | 0.097 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.992044e-01 | 0.097 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.004352e-01 | 0.097 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.004352e-01 | 0.097 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.005974e-01 | 0.097 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.006286e-01 | 0.097 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.022909e-01 | 0.096 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.022909e-01 | 0.096 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.022909e-01 | 0.096 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.024338e-01 | 0.096 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.024338e-01 | 0.096 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.045995e-01 | 0.094 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.045995e-01 | 0.094 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.075770e-01 | 0.093 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.084527e-01 | 0.092 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.167680e-01 | 0.088 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.168399e-01 | 0.088 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.168399e-01 | 0.088 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.183843e-01 | 0.087 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.183843e-01 | 0.087 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.183843e-01 | 0.087 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.183843e-01 | 0.087 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.183843e-01 | 0.087 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.183843e-01 | 0.087 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.183843e-01 | 0.087 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.183843e-01 | 0.087 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.183843e-01 | 0.087 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.183843e-01 | 0.087 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.183843e-01 | 0.087 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.183843e-01 | 0.087 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.201889e-01 | 0.086 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.205172e-01 | 0.086 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.221566e-01 | 0.085 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.234416e-01 | 0.084 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.291183e-01 | 0.081 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.294587e-01 | 0.081 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.294587e-01 | 0.081 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.302177e-01 | 0.081 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.302978e-01 | 0.081 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.302978e-01 | 0.081 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.302978e-01 | 0.081 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.302978e-01 | 0.081 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.302978e-01 | 0.081 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.321929e-01 | 0.080 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.335931e-01 | 0.079 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.347970e-01 | 0.078 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.357332e-01 | 0.078 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.357332e-01 | 0.078 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.357332e-01 | 0.078 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.357332e-01 | 0.078 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.357332e-01 | 0.078 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.357332e-01 | 0.078 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.357332e-01 | 0.078 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.357332e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.357332e-01 | 0.078 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.357332e-01 | 0.078 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.357332e-01 | 0.078 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.357332e-01 | 0.078 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.357332e-01 | 0.078 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.373867e-01 | 0.077 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.391780e-01 | 0.076 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.391780e-01 | 0.076 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.417525e-01 | 0.075 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.428570e-01 | 0.074 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.428570e-01 | 0.074 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.468302e-01 | 0.072 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.468302e-01 | 0.072 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.468302e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.470378e-01 | 0.072 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.494673e-01 | 0.071 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.494673e-01 | 0.071 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.494673e-01 | 0.071 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.494673e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.508498e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.508498e-01 | 0.070 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.514258e-01 | 0.070 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.514258e-01 | 0.070 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.514258e-01 | 0.070 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.514258e-01 | 0.070 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.514258e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.514258e-01 | 0.070 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.514258e-01 | 0.070 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.514258e-01 | 0.070 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.514258e-01 | 0.070 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.514258e-01 | 0.070 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.514258e-01 | 0.070 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.514258e-01 | 0.070 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.514258e-01 | 0.070 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.514258e-01 | 0.070 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.514258e-01 | 0.070 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.514258e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.514258e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.514258e-01 | 0.070 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.514258e-01 | 0.070 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.532332e-01 | 0.069 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.532332e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.532332e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.532332e-01 | 0.069 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.545665e-01 | 0.068 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.545665e-01 | 0.068 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.545665e-01 | 0.068 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.545665e-01 | 0.068 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.545665e-01 | 0.068 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.545665e-01 | 0.068 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.564868e-01 | 0.067 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.564868e-01 | 0.067 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.591783e-01 | 0.066 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.591783e-01 | 0.066 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.591783e-01 | 0.066 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.629902e-01 | 0.064 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.654739e-01 | 0.063 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.654739e-01 | 0.063 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.654739e-01 | 0.063 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.654739e-01 | 0.063 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.656201e-01 | 0.063 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.656201e-01 | 0.063 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.656201e-01 | 0.063 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.656201e-01 | 0.063 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.656201e-01 | 0.063 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.656201e-01 | 0.063 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.656201e-01 | 0.063 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.660323e-01 | 0.062 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.660323e-01 | 0.062 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.660957e-01 | 0.062 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.674188e-01 | 0.062 | 1 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.677180e-01 | 0.062 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.683354e-01 | 0.061 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.683354e-01 | 0.061 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.683354e-01 | 0.061 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.683354e-01 | 0.061 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.687834e-01 | 0.061 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.701189e-01 | 0.060 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.724694e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.734695e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.734695e-01 | 0.059 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.739929e-01 | 0.058 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.739929e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.739929e-01 | 0.058 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.756255e-01 | 0.058 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.756255e-01 | 0.058 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.756255e-01 | 0.058 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.784590e-01 | 0.056 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.784590e-01 | 0.056 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.784590e-01 | 0.056 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 8.784590e-01 | 0.056 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.784590e-01 | 0.056 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.784590e-01 | 0.056 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.784590e-01 | 0.056 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.784590e-01 | 0.056 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.784590e-01 | 0.056 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.784590e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.784590e-01 | 0.056 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.784590e-01 | 0.056 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.785901e-01 | 0.056 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.844645e-01 | 0.053 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.844645e-01 | 0.053 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.850662e-01 | 0.053 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.850662e-01 | 0.053 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.850844e-01 | 0.053 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.850844e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.850844e-01 | 0.053 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.865716e-01 | 0.052 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.899334e-01 | 0.051 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.900720e-01 | 0.051 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.900720e-01 | 0.051 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.900720e-01 | 0.051 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.900720e-01 | 0.051 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.900720e-01 | 0.051 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.900720e-01 | 0.051 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.903402e-01 | 0.050 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.910472e-01 | 0.050 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.927239e-01 | 0.049 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.927239e-01 | 0.049 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.927239e-01 | 0.049 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 8.927239e-01 | 0.049 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.938391e-01 | 0.049 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.938391e-01 | 0.049 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.938391e-01 | 0.049 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.999044e-01 | 0.046 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.999044e-01 | 0.046 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.999044e-01 | 0.046 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.999044e-01 | 0.046 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.999044e-01 | 0.046 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.999044e-01 | 0.046 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.999044e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.999044e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.005760e-01 | 0.045 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.005760e-01 | 0.045 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.005760e-01 | 0.045 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.005760e-01 | 0.045 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.006761e-01 | 0.045 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.006761e-01 | 0.045 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.019855e-01 | 0.045 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.019855e-01 | 0.045 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.022178e-01 | 0.045 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.022627e-01 | 0.045 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.032092e-01 | 0.044 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.056317e-01 | 0.043 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.066485e-01 | 0.043 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.067980e-01 | 0.042 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.067980e-01 | 0.042 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.085545e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.095451e-01 | 0.041 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.095451e-01 | 0.041 | 1 | 1 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.095451e-01 | 0.041 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.095451e-01 | 0.041 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.100769e-01 | 0.041 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.100769e-01 | 0.041 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.100769e-01 | 0.041 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.100769e-01 | 0.041 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.100769e-01 | 0.041 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.100769e-01 | 0.041 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.100769e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.100769e-01 | 0.041 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.128229e-01 | 0.040 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.129783e-01 | 0.040 | 1 | 1 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.130406e-01 | 0.040 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.148624e-01 | 0.039 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.149109e-01 | 0.039 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.156314e-01 | 0.038 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.156404e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.165556e-01 | 0.038 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.165556e-01 | 0.038 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.165556e-01 | 0.038 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.165556e-01 | 0.038 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.165556e-01 | 0.038 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.165556e-01 | 0.038 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.165556e-01 | 0.038 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.165556e-01 | 0.038 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.165556e-01 | 0.038 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.170392e-01 | 0.038 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.181964e-01 | 0.037 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.182406e-01 | 0.037 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.186704e-01 | 0.037 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.186704e-01 | 0.037 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.186704e-01 | 0.037 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.186704e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.186704e-01 | 0.037 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.186704e-01 | 0.037 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.186704e-01 | 0.037 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.186704e-01 | 0.037 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.189153e-01 | 0.037 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.189153e-01 | 0.037 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.225278e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.230529e-01 | 0.035 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.230529e-01 | 0.035 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.230529e-01 | 0.035 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.230529e-01 | 0.035 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.244800e-01 | 0.034 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.244800e-01 | 0.034 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.244800e-01 | 0.034 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.247567e-01 | 0.034 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.264431e-01 | 0.033 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.264431e-01 | 0.033 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.264431e-01 | 0.033 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.264431e-01 | 0.033 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.264431e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.264431e-01 | 0.033 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.271066e-01 | 0.033 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.280504e-01 | 0.032 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.290710e-01 | 0.032 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.290710e-01 | 0.032 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.290710e-01 | 0.032 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.296927e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.296927e-01 | 0.032 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.311279e-01 | 0.031 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.314127e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.321967e-01 | 0.030 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.334734e-01 | 0.030 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.334734e-01 | 0.030 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.334734e-01 | 0.030 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.334734e-01 | 0.030 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.334734e-01 | 0.030 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.345725e-01 | 0.029 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.345725e-01 | 0.029 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.346421e-01 | 0.029 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.346421e-01 | 0.029 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.346421e-01 | 0.029 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.347326e-01 | 0.029 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.386354e-01 | 0.028 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.388267e-01 | 0.027 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.393433e-01 | 0.027 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.393527e-01 | 0.027 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.397966e-01 | 0.027 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.397966e-01 | 0.027 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.398321e-01 | 0.027 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.398321e-01 | 0.027 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.398321e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.398321e-01 | 0.027 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.398321e-01 | 0.027 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.398321e-01 | 0.027 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.398321e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.419231e-01 | 0.026 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.443941e-01 | 0.025 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.445634e-01 | 0.025 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.445634e-01 | 0.025 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.455834e-01 | 0.024 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.455834e-01 | 0.024 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.455834e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.455834e-01 | 0.024 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.455834e-01 | 0.024 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.455834e-01 | 0.024 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.480748e-01 | 0.023 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.489693e-01 | 0.023 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.489693e-01 | 0.023 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.489693e-01 | 0.023 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.489693e-01 | 0.023 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.503987e-01 | 0.022 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.503987e-01 | 0.022 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.507853e-01 | 0.022 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.507853e-01 | 0.022 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.507853e-01 | 0.022 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.507853e-01 | 0.022 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.507853e-01 | 0.022 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.507853e-01 | 0.022 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.507853e-01 | 0.022 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.507853e-01 | 0.022 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.507853e-01 | 0.022 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.517567e-01 | 0.021 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.517567e-01 | 0.021 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.517567e-01 | 0.021 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.528436e-01 | 0.021 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.530399e-01 | 0.021 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.530399e-01 | 0.021 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.530399e-01 | 0.021 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.530399e-01 | 0.021 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.530399e-01 | 0.021 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.530643e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.538317e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.546023e-01 | 0.020 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.554901e-01 | 0.020 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.554901e-01 | 0.020 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.554901e-01 | 0.020 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.554901e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.556251e-01 | 0.020 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.567988e-01 | 0.019 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.567988e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.567988e-01 | 0.019 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.567988e-01 | 0.019 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.597455e-01 | 0.018 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.597455e-01 | 0.018 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.597455e-01 | 0.018 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.597455e-01 | 0.018 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.602686e-01 | 0.018 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.602686e-01 | 0.018 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.602686e-01 | 0.018 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.602686e-01 | 0.018 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.608759e-01 | 0.017 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.613897e-01 | 0.017 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.635942e-01 | 0.016 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.635942e-01 | 0.016 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.635942e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.635942e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.635942e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.635942e-01 | 0.016 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.635942e-01 | 0.016 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.635942e-01 | 0.016 | 1 | 1 |
| Peroxisomal protein import | R-HSA-9033241 | 9.636981e-01 | 0.016 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.636981e-01 | 0.016 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.641197e-01 | 0.016 | 0 | 0 |
| Translation | R-HSA-72766 | 9.651265e-01 | 0.015 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.663278e-01 | 0.015 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.663345e-01 | 0.015 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.664228e-01 | 0.015 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.664228e-01 | 0.015 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.664228e-01 | 0.015 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.664228e-01 | 0.015 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.670169e-01 | 0.015 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.670752e-01 | 0.015 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.670752e-01 | 0.015 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.677044e-01 | 0.014 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.678037e-01 | 0.014 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.678037e-01 | 0.014 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.683527e-01 | 0.014 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.683527e-01 | 0.014 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.687770e-01 | 0.014 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.687770e-01 | 0.014 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.687770e-01 | 0.014 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.691451e-01 | 0.014 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.697325e-01 | 0.013 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.702235e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.702235e-01 | 0.013 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.702235e-01 | 0.013 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.702235e-01 | 0.013 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.702235e-01 | 0.013 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.702235e-01 | 0.013 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.702235e-01 | 0.013 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.715203e-01 | 0.013 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.715203e-01 | 0.013 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.716540e-01 | 0.012 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.716540e-01 | 0.012 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.716540e-01 | 0.012 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.716540e-01 | 0.012 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.726814e-01 | 0.012 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.726814e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.726814e-01 | 0.012 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.730709e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.730709e-01 | 0.012 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.731787e-01 | 0.012 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.731787e-01 | 0.012 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.731787e-01 | 0.012 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.745349e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.751304e-01 | 0.011 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.756462e-01 | 0.011 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.756462e-01 | 0.011 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.756462e-01 | 0.011 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.756462e-01 | 0.011 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.756462e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.760942e-01 | 0.011 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.760942e-01 | 0.011 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.767207e-01 | 0.010 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.767710e-01 | 0.010 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.779181e-01 | 0.010 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.779754e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.786929e-01 | 0.009 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.795599e-01 | 0.009 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.798579e-01 | 0.009 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.800819e-01 | 0.009 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.800819e-01 | 0.009 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.807069e-01 | 0.008 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.808312e-01 | 0.008 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.808312e-01 | 0.008 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.809141e-01 | 0.008 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.815175e-01 | 0.008 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.815175e-01 | 0.008 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.819160e-01 | 0.008 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.819871e-01 | 0.008 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.819871e-01 | 0.008 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.819871e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.819871e-01 | 0.008 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.821795e-01 | 0.008 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.823144e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.826867e-01 | 0.008 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.830217e-01 | 0.007 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.830789e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.837101e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.837101e-01 | 0.007 | 1 | 1 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.837101e-01 | 0.007 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.837487e-01 | 0.007 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.844343e-01 | 0.007 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.845303e-01 | 0.007 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.851242e-01 | 0.007 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.852684e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.852684e-01 | 0.006 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.852684e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.852684e-01 | 0.006 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.855607e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.855607e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.855951e-01 | 0.006 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.856009e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.857384e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.857894e-01 | 0.006 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.859924e-01 | 0.006 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.864294e-01 | 0.006 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.866520e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.866777e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.866777e-01 | 0.006 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.866777e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.872172e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.872359e-01 | 0.006 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.879523e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.879523e-01 | 0.005 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.884491e-01 | 0.005 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.890517e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.891050e-01 | 0.005 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.891050e-01 | 0.005 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.894208e-01 | 0.005 | 1 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.899343e-01 | 0.004 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.900438e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.901475e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.901475e-01 | 0.004 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.903848e-01 | 0.004 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.903848e-01 | 0.004 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.910212e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.910212e-01 | 0.004 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.910903e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.910903e-01 | 0.004 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.912471e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.914164e-01 | 0.004 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.915529e-01 | 0.004 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.916398e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.919510e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.920899e-01 | 0.003 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.922958e-01 | 0.003 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.923893e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.927140e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.927379e-01 | 0.003 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.927379e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.934113e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.934113e-01 | 0.003 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.934113e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.934113e-01 | 0.003 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.934315e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.934879e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.934879e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.935060e-01 | 0.003 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.939814e-01 | 0.003 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.940998e-01 | 0.003 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.945663e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.946122e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.946122e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.946122e-01 | 0.002 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.949291e-01 | 0.002 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.953005e-01 | 0.002 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.954302e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.957849e-01 | 0.002 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.958303e-01 | 0.002 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.958378e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.962896e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.964029e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.965179e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.967424e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.968158e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.968158e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.970544e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.973364e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.975669e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.976398e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.979903e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.981590e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.982095e-01 | 0.001 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.982194e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.982194e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.982194e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.983033e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.985441e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.986319e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.987823e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.987823e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.987937e-01 | 0.001 | 1 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.988097e-01 | 0.001 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.988097e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.988513e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.989238e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.989238e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.990269e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990269e-01 | 0.000 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.990832e-01 | 0.000 | 1 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990886e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992044e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992509e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993018e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.993090e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.993163e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.993183e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.994683e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994683e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.994683e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994808e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.994966e-01 | 0.000 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.995585e-01 | 0.000 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.995585e-01 | 0.000 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.995585e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.995863e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.996070e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.996447e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.996447e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996447e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.996788e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996844e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997096e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997504e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997512e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.997738e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998029e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998246e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.998286e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998414e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999042e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999043e-01 | 0.000 | 1 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.999422e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999488e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999527e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999572e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999634e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999679e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999684e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999715e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.999715e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999728e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999742e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999780e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.999787e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999861e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999901e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999915e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999932e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999949e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999958e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999970e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999992e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999998e-01 | 0.000 | 1 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.000000e+00 | 0.000 | 1 | 1 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 7.807088e-13 | 12.108 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.915868e-12 | 11.407 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.607292e-11 | 10.794 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.348644e-11 | 10.475 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.805856e-11 | 10.108 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.802692e-11 | 10.108 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.035886e-10 | 9.518 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.796897e-10 | 9.168 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.092775e-09 | 8.961 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.659698e-06 | 5.332 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.149294e-06 | 5.288 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.360408e-06 | 5.197 | 1 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.172378e-05 | 4.663 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.640558e-05 | 4.578 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.717457e-05 | 4.566 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.208729e-05 | 4.494 | 1 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.445842e-05 | 4.352 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.527063e-05 | 4.344 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.032352e-05 | 4.298 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.800791e-05 | 4.055 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.100639e-04 | 3.958 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.765113e-04 | 3.753 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.269812e-04 | 3.644 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.482233e-04 | 3.605 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.513800e-04 | 3.600 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.716384e-04 | 3.566 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.655892e-04 | 3.437 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.931018e-04 | 3.405 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.641060e-04 | 3.333 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.308896e-04 | 3.275 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.447405e-04 | 3.264 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 6.201713e-04 | 3.207 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.693526e-04 | 3.174 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.949867e-04 | 3.158 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.031217e-03 | 2.987 | 1 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.031217e-03 | 2.987 | 1 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.130050e-03 | 2.947 | 1 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.325170e-03 | 2.878 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.513918e-03 | 2.820 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.656904e-03 | 2.781 | 1 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.969049e-03 | 2.706 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.846908e-03 | 2.734 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.970943e-03 | 2.705 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.969049e-03 | 2.706 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.982954e-03 | 2.703 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.900333e-03 | 2.721 | 1 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.114858e-03 | 2.675 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.423623e-03 | 2.616 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.551402e-03 | 2.593 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.538011e-03 | 2.596 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.623711e-03 | 2.581 | 1 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.694874e-03 | 2.432 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.694874e-03 | 2.432 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.694874e-03 | 2.432 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.694874e-03 | 2.432 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.167848e-03 | 2.499 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.676371e-03 | 2.435 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.289948e-03 | 2.483 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.181839e-03 | 2.497 | 1 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.958748e-03 | 2.529 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.467997e-03 | 2.460 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.006764e-03 | 2.522 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.767661e-03 | 2.424 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.770420e-03 | 2.424 | 1 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.005081e-03 | 2.397 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.304461e-03 | 2.366 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.231890e-03 | 2.373 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.892891e-03 | 2.310 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.130665e-03 | 2.290 | 1 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.239180e-03 | 2.281 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.239180e-03 | 2.281 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.358116e-03 | 2.271 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.998561e-03 | 2.222 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.998561e-03 | 2.222 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.128584e-03 | 2.213 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.556848e-03 | 2.183 | 1 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.524598e-03 | 2.124 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.524598e-03 | 2.124 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 7.524598e-03 | 2.124 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.351595e-03 | 2.134 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 7.083760e-03 | 2.150 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.257994e-03 | 2.139 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 7.469555e-03 | 2.127 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.030659e-03 | 2.095 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.498973e-03 | 2.071 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.902811e-03 | 2.050 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 8.822417e-03 | 2.054 | 1 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.209779e-03 | 2.036 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.405496e-03 | 2.027 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.517659e-03 | 2.021 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.610036e-03 | 2.017 | 1 | 0 |
| SDK interactions | R-HSA-373756 | 1.037664e-02 | 1.984 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.023211e-02 | 1.990 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.038835e-02 | 1.983 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.115805e-02 | 1.952 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.085620e-02 | 1.964 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.114114e-02 | 1.953 | 1 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.082242e-02 | 1.966 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.079831e-02 | 1.967 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.144382e-02 | 1.941 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.235522e-02 | 1.908 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.246593e-02 | 1.904 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.281480e-02 | 1.892 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.350277e-02 | 1.870 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.351532e-02 | 1.869 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.404706e-02 | 1.852 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.557230e-02 | 1.808 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.567089e-02 | 1.805 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.520658e-02 | 1.818 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.781800e-02 | 1.749 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.787103e-02 | 1.748 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.802847e-02 | 1.744 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.802847e-02 | 1.744 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.816984e-02 | 1.741 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.816984e-02 | 1.741 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.922815e-02 | 1.716 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.068083e-02 | 1.684 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.911974e-02 | 1.719 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.978964e-02 | 1.704 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.943666e-02 | 1.711 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.124439e-02 | 1.673 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.124439e-02 | 1.673 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.213012e-02 | 1.655 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.272828e-02 | 1.643 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.287793e-02 | 1.641 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.322286e-02 | 1.634 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.398966e-02 | 1.620 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.647973e-02 | 1.577 | 1 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.499174e-02 | 1.602 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.597680e-02 | 1.585 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.489830e-02 | 1.604 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.705721e-02 | 1.568 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.760764e-02 | 1.559 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.844896e-02 | 1.546 | 1 | 1 |
| Integration of provirus | R-HSA-162592 | 2.844896e-02 | 1.546 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.844896e-02 | 1.546 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.192860e-02 | 1.496 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.252069e-02 | 1.488 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.252069e-02 | 1.488 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.110023e-02 | 1.507 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.215026e-02 | 1.493 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.228846e-02 | 1.491 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.051347e-02 | 1.516 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.895023e-02 | 1.538 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.110023e-02 | 1.507 | 1 | 1 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.215026e-02 | 1.493 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.110023e-02 | 1.507 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.924409e-02 | 1.534 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.306326e-02 | 1.481 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.314272e-02 | 1.480 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.435710e-02 | 1.464 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.487737e-02 | 1.457 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.762396e-02 | 1.425 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.840205e-02 | 1.416 | 1 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.894657e-02 | 1.410 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.147266e-02 | 1.382 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.147266e-02 | 1.382 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.346834e-02 | 1.362 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.346834e-02 | 1.362 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.346834e-02 | 1.362 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.346834e-02 | 1.362 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.346834e-02 | 1.362 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.186015e-02 | 1.378 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.186015e-02 | 1.378 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.186015e-02 | 1.378 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.582976e-02 | 1.339 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.346834e-02 | 1.362 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.186015e-02 | 1.378 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.710164e-02 | 1.327 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.710164e-02 | 1.327 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.798639e-02 | 1.319 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.809010e-02 | 1.318 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.961991e-02 | 1.304 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.982757e-02 | 1.303 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.593765e-02 | 1.252 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 5.593765e-02 | 1.252 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.816968e-02 | 1.235 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.816968e-02 | 1.235 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.273164e-02 | 1.278 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.875357e-02 | 1.231 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.643715e-02 | 1.248 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.816968e-02 | 1.235 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.892813e-02 | 1.230 | 1 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.593765e-02 | 1.252 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.816968e-02 | 1.235 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 5.593765e-02 | 1.252 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.593765e-02 | 1.252 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.829614e-02 | 1.234 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.392217e-02 | 1.268 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.430200e-02 | 1.265 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.643715e-02 | 1.248 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.829614e-02 | 1.234 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.296718e-02 | 1.276 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.101397e-02 | 1.215 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.220973e-02 | 1.206 | 1 | 1 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.289204e-02 | 1.201 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.297283e-02 | 1.201 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.333007e-02 | 1.198 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.386841e-02 | 1.195 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.386841e-02 | 1.195 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.430383e-02 | 1.192 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.430383e-02 | 1.192 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 6.430383e-02 | 1.192 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.516920e-02 | 1.186 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.516920e-02 | 1.186 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.536833e-02 | 1.185 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.780325e-02 | 1.169 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.979290e-02 | 1.156 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.979290e-02 | 1.156 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.979290e-02 | 1.156 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.979290e-02 | 1.156 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.296563e-02 | 1.137 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 7.296563e-02 | 1.137 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.747245e-02 | 1.111 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.197862e-02 | 1.143 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.918032e-02 | 1.101 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.633601e-02 | 1.117 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.672584e-02 | 1.115 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.918032e-02 | 1.101 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.483521e-02 | 1.071 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.918032e-02 | 1.101 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 7.672584e-02 | 1.115 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 7.672584e-02 | 1.115 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.745325e-02 | 1.111 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.200835e-02 | 1.143 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.918032e-02 | 1.101 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.602398e-02 | 1.119 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.677121e-02 | 1.062 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.766673e-02 | 1.057 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.814936e-02 | 1.055 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.814936e-02 | 1.055 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.934473e-02 | 1.049 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.934473e-02 | 1.049 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 9.001434e-02 | 1.046 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.073523e-02 | 1.042 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.408407e-02 | 1.026 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.465554e-02 | 1.024 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 9.474669e-02 | 1.023 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 9.474669e-02 | 1.023 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.496733e-02 | 1.022 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.653328e-02 | 1.015 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.875268e-02 | 1.005 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 9.950734e-02 | 1.002 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.951553e-02 | 1.002 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.951553e-02 | 1.002 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.972209e-02 | 1.001 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.011910e-01 | 0.995 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.031007e-01 | 0.987 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.031007e-01 | 0.987 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.238811e-01 | 0.907 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.115223e-01 | 0.953 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.086371e-01 | 0.964 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.189827e-01 | 0.925 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.189827e-01 | 0.925 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.200382e-01 | 0.921 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.176426e-01 | 0.929 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.238949e-01 | 0.907 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.297726e-01 | 0.887 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.238949e-01 | 0.907 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.047516e-01 | 0.980 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 1.119412e-01 | 0.951 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.144011e-01 | 0.942 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.238811e-01 | 0.907 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.297726e-01 | 0.887 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.230829e-01 | 0.910 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.209132e-01 | 0.918 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.238811e-01 | 0.907 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.230829e-01 | 0.910 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.230829e-01 | 0.910 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.230829e-01 | 0.910 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.200382e-01 | 0.921 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.248625e-01 | 0.904 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.046431e-01 | 0.980 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.100705e-01 | 0.958 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.301675e-01 | 0.885 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.303530e-01 | 0.885 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.368256e-01 | 0.864 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.406113e-01 | 0.852 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.406113e-01 | 0.852 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.406113e-01 | 0.852 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.406113e-01 | 0.852 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.406113e-01 | 0.852 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.494940e-01 | 0.825 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.577200e-01 | 0.802 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.760413e-01 | 0.754 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 1.760413e-01 | 0.754 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.510461e-01 | 0.821 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.409879e-01 | 0.851 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.799366e-01 | 0.745 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.799366e-01 | 0.745 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.769782e-01 | 0.752 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.492709e-01 | 0.826 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.844752e-01 | 0.734 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.814742e-01 | 0.741 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.814742e-01 | 0.741 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.659027e-01 | 0.780 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.409879e-01 | 0.851 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.502442e-01 | 0.823 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.502442e-01 | 0.823 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.558531e-01 | 0.807 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.652637e-01 | 0.782 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.502442e-01 | 0.823 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.664835e-01 | 0.779 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.400375e-01 | 0.854 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.666919e-01 | 0.778 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.494940e-01 | 0.825 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.760413e-01 | 0.754 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.577659e-01 | 0.802 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.844752e-01 | 0.734 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.664835e-01 | 0.779 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.760357e-01 | 0.754 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.646128e-01 | 0.784 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.745001e-01 | 0.758 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.586138e-01 | 0.800 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.700300e-01 | 0.769 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.745001e-01 | 0.758 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.494940e-01 | 0.825 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.760413e-01 | 0.754 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.586138e-01 | 0.800 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.646128e-01 | 0.784 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.760357e-01 | 0.754 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.760357e-01 | 0.754 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.760357e-01 | 0.754 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.606703e-01 | 0.794 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.409879e-01 | 0.851 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.760357e-01 | 0.754 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.760357e-01 | 0.754 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.760413e-01 | 0.754 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.492709e-01 | 0.826 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.492709e-01 | 0.826 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.492709e-01 | 0.826 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.492709e-01 | 0.826 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.430473e-01 | 0.845 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.401340e-01 | 0.853 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.400375e-01 | 0.854 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.577200e-01 | 0.802 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.492709e-01 | 0.826 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 1.731976e-01 | 0.761 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 1.896812e-01 | 0.722 | 1 | 1 |
| Translation initiation complex formation | R-HSA-72649 | 1.946798e-01 | 0.711 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.949137e-01 | 0.710 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.949137e-01 | 0.710 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.949137e-01 | 0.710 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.949137e-01 | 0.710 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.950232e-01 | 0.710 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.950232e-01 | 0.710 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.950232e-01 | 0.710 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.033246e-01 | 0.692 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.033246e-01 | 0.692 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.033246e-01 | 0.692 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.614650e-01 | 0.583 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 2.614650e-01 | 0.583 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.614650e-01 | 0.583 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.614650e-01 | 0.583 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.153655e-01 | 0.501 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.153655e-01 | 0.501 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.153655e-01 | 0.501 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.153655e-01 | 0.501 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.153655e-01 | 0.501 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.308540e-01 | 0.637 | 1 | 1 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 3.653353e-01 | 0.437 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.653353e-01 | 0.437 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.653353e-01 | 0.437 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.653353e-01 | 0.437 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.653353e-01 | 0.437 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.653353e-01 | 0.437 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.142515e-01 | 0.669 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 4.116606e-01 | 0.385 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.116606e-01 | 0.385 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.116606e-01 | 0.385 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.116606e-01 | 0.385 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.339718e-01 | 0.631 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.339718e-01 | 0.631 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.539953e-01 | 0.595 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.539953e-01 | 0.595 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.539953e-01 | 0.595 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.742463e-01 | 0.562 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.742463e-01 | 0.562 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.418144e-01 | 0.466 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.418144e-01 | 0.466 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.546071e-01 | 0.342 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.546071e-01 | 0.342 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.546071e-01 | 0.342 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.423473e-01 | 0.616 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.689589e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.151485e-01 | 0.501 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.151485e-01 | 0.501 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.151485e-01 | 0.501 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.752018e-01 | 0.560 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.290311e-01 | 0.640 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.356693e-01 | 0.474 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.356693e-01 | 0.474 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.356693e-01 | 0.474 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 4.944211e-01 | 0.306 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 4.944211e-01 | 0.306 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.047560e-01 | 0.516 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.968215e-01 | 0.401 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 5.313308e-01 | 0.275 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 5.313308e-01 | 0.275 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.313308e-01 | 0.275 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.747448e-01 | 0.561 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.178286e-01 | 0.498 | 1 | 1 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.178286e-01 | 0.498 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.765889e-01 | 0.424 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.169030e-01 | 0.380 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.963049e-01 | 0.528 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 3.889969e-01 | 0.410 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.889969e-01 | 0.410 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.965078e-01 | 0.304 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.655480e-01 | 0.248 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.655480e-01 | 0.248 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.655480e-01 | 0.248 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.504018e-01 | 0.346 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.504018e-01 | 0.346 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.504018e-01 | 0.346 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.532882e-01 | 0.344 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.765327e-01 | 0.322 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.086478e-01 | 0.294 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.086478e-01 | 0.294 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.086478e-01 | 0.294 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.894631e-01 | 0.310 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.647577e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.397707e-01 | 0.268 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.518038e-01 | 0.258 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.698587e-01 | 0.244 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.838906e-01 | 0.234 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.957544e-01 | 0.225 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.957544e-01 | 0.225 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.230322e-01 | 0.652 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.367610e-01 | 0.360 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.523337e-01 | 0.258 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.523337e-01 | 0.258 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 5.859788e-01 | 0.232 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.275136e-01 | 0.485 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.752018e-01 | 0.560 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.647577e-01 | 0.248 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.378845e-01 | 0.471 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 4.946414e-01 | 0.306 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.332345e-01 | 0.363 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.086478e-01 | 0.294 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.698587e-01 | 0.244 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.844840e-01 | 0.233 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.844840e-01 | 0.233 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.844840e-01 | 0.233 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.375612e-01 | 0.624 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 3.150816e-01 | 0.502 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.623204e-01 | 0.250 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.731395e-01 | 0.242 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.367610e-01 | 0.360 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.655480e-01 | 0.248 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.766094e-01 | 0.322 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.217559e-01 | 0.654 | 1 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.653353e-01 | 0.437 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.653353e-01 | 0.437 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.143101e-01 | 0.503 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.539953e-01 | 0.595 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.103937e-01 | 0.387 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.655480e-01 | 0.248 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.121448e-01 | 0.673 | 1 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.243317e-01 | 0.280 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.906936e-01 | 0.229 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 3.418144e-01 | 0.466 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.442043e-01 | 0.463 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.563583e-01 | 0.341 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.865575e-01 | 0.543 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.116606e-01 | 0.385 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 4.116606e-01 | 0.385 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.473708e-01 | 0.349 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.473708e-01 | 0.349 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.313308e-01 | 0.275 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.169030e-01 | 0.380 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.045039e-01 | 0.516 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.181290e-01 | 0.661 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.185454e-01 | 0.378 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.756616e-01 | 0.323 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.844840e-01 | 0.233 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.698587e-01 | 0.244 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 2.032347e-01 | 0.692 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.116606e-01 | 0.385 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.546071e-01 | 0.342 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.944211e-01 | 0.306 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.944211e-01 | 0.306 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.641321e-01 | 0.578 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.128155e-01 | 0.672 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.602911e-01 | 0.337 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.081433e-01 | 0.389 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.731395e-01 | 0.242 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.245626e-01 | 0.489 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.262704e-01 | 0.645 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.906936e-01 | 0.229 | 1 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.151485e-01 | 0.501 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.060203e-01 | 0.686 | 1 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.400296e-01 | 0.268 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.614966e-01 | 0.251 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.363153e-01 | 0.627 | 1 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.536390e-01 | 0.596 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.346972e-01 | 0.362 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.339718e-01 | 0.631 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.563583e-01 | 0.341 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.742463e-01 | 0.562 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.218085e-01 | 0.375 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.033246e-01 | 0.692 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.142515e-01 | 0.669 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.116606e-01 | 0.385 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 3.143101e-01 | 0.503 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.143101e-01 | 0.503 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.262704e-01 | 0.645 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.546071e-01 | 0.342 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.546071e-01 | 0.342 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.546071e-01 | 0.342 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.546071e-01 | 0.342 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.170263e-01 | 0.663 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.918993e-01 | 0.535 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.944211e-01 | 0.306 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.596075e-01 | 0.444 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.968215e-01 | 0.401 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.968215e-01 | 0.401 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.313308e-01 | 0.275 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.313308e-01 | 0.275 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.747448e-01 | 0.561 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 4.965078e-01 | 0.304 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.965078e-01 | 0.304 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.655480e-01 | 0.248 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.200090e-01 | 0.284 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.946414e-01 | 0.306 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.427644e-01 | 0.265 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.315298e-01 | 0.274 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.051335e-01 | 0.297 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.859788e-01 | 0.232 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.200090e-01 | 0.284 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.541063e-01 | 0.343 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.004677e-01 | 0.522 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.138079e-01 | 0.289 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 3.561571e-01 | 0.448 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.523337e-01 | 0.258 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.954414e-01 | 0.530 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.659123e-01 | 0.247 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.438006e-01 | 0.353 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.196609e-01 | 0.284 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.590567e-01 | 0.253 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.308540e-01 | 0.637 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.956497e-01 | 0.403 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.766094e-01 | 0.322 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.766094e-01 | 0.322 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.492474e-01 | 0.260 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.935274e-01 | 0.405 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.647577e-01 | 0.248 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.104817e-01 | 0.677 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.052439e-01 | 0.688 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 3.873407e-01 | 0.412 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.185454e-01 | 0.378 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.655480e-01 | 0.248 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.023933e-01 | 0.395 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.917547e-01 | 0.228 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.868767e-01 | 0.313 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 5.647577e-01 | 0.248 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.116606e-01 | 0.385 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.446946e-01 | 0.352 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.859788e-01 | 0.232 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.946414e-01 | 0.306 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.766094e-01 | 0.322 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.766094e-01 | 0.322 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.752018e-01 | 0.560 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.791217e-01 | 0.421 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.142515e-01 | 0.669 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.116606e-01 | 0.385 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.143101e-01 | 0.503 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.918993e-01 | 0.535 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.765578e-01 | 0.424 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 5.313308e-01 | 0.275 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.655480e-01 | 0.248 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.200090e-01 | 0.284 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.234909e-01 | 0.281 | 1 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.668544e-01 | 0.247 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.859788e-01 | 0.232 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.185454e-01 | 0.378 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.300937e-01 | 0.481 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.731395e-01 | 0.242 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.765479e-01 | 0.558 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.855568e-01 | 0.314 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.684965e-01 | 0.571 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.693624e-01 | 0.245 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.426143e-01 | 0.465 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.426143e-01 | 0.465 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.107173e-01 | 0.386 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.194593e-01 | 0.377 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.668544e-01 | 0.247 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.427644e-01 | 0.265 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.121472e-01 | 0.506 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.539953e-01 | 0.595 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.935274e-01 | 0.405 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.479817e-01 | 0.261 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.970436e-01 | 0.304 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.132717e-01 | 0.290 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.170263e-01 | 0.663 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.064412e-01 | 0.514 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 3.653353e-01 | 0.437 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.586876e-01 | 0.587 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.586876e-01 | 0.587 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.116606e-01 | 0.385 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.116606e-01 | 0.385 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.143101e-01 | 0.503 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.104817e-01 | 0.677 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.689589e-01 | 0.433 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.218085e-01 | 0.375 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.765578e-01 | 0.424 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.563583e-01 | 0.341 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.655480e-01 | 0.248 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.655480e-01 | 0.248 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.693894e-01 | 0.433 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.329706e-01 | 0.364 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.946532e-01 | 0.531 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.004677e-01 | 0.522 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.096694e-01 | 0.678 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.117569e-01 | 0.291 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.865575e-01 | 0.543 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.150816e-01 | 0.502 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.107173e-01 | 0.386 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.561571e-01 | 0.448 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.380496e-01 | 0.358 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.374417e-01 | 0.270 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.019800e-01 | 0.695 | 0 | 0 |
| NGF processing | R-HSA-167060 | 3.153655e-01 | 0.501 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 3.153655e-01 | 0.501 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.308540e-01 | 0.637 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.865575e-01 | 0.543 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.116606e-01 | 0.385 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.143101e-01 | 0.503 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 4.546071e-01 | 0.342 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.546071e-01 | 0.342 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.946532e-01 | 0.531 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.944211e-01 | 0.306 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.218085e-01 | 0.375 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.218085e-01 | 0.375 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.965078e-01 | 0.304 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.885896e-01 | 0.411 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.350765e-01 | 0.272 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.838906e-01 | 0.234 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.539953e-01 | 0.595 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.132717e-01 | 0.290 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.800581e-01 | 0.553 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.308540e-01 | 0.637 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 2.865575e-01 | 0.543 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.539953e-01 | 0.595 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.539953e-01 | 0.595 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.689589e-01 | 0.433 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.356693e-01 | 0.474 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.655480e-01 | 0.248 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 5.655480e-01 | 0.248 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.107173e-01 | 0.386 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.742463e-01 | 0.562 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.367610e-01 | 0.360 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.146689e-01 | 0.382 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.948718e-01 | 0.530 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.143101e-01 | 0.503 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.946532e-01 | 0.531 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.356693e-01 | 0.474 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.563583e-01 | 0.341 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.655480e-01 | 0.248 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.427644e-01 | 0.265 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.339718e-01 | 0.631 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 4.169030e-01 | 0.380 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.859788e-01 | 0.232 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.889969e-01 | 0.410 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.418144e-01 | 0.466 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.132717e-01 | 0.290 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.226826e-01 | 0.282 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.465020e-01 | 0.262 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.150816e-01 | 0.502 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.473708e-01 | 0.349 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.200090e-01 | 0.284 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.379614e-01 | 0.359 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.742463e-01 | 0.562 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 2.614650e-01 | 0.583 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.689589e-01 | 0.433 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.689589e-01 | 0.433 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.326220e-01 | 0.364 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.797833e-01 | 0.237 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.765327e-01 | 0.322 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.932003e-01 | 0.227 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 5.599217e-01 | 0.252 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.032322e-01 | 0.394 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 3.418144e-01 | 0.466 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.169030e-01 | 0.380 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.906936e-01 | 0.229 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.761418e-01 | 0.322 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.668544e-01 | 0.247 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 4.722844e-01 | 0.326 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 4.218085e-01 | 0.375 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.116606e-01 | 0.385 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.602911e-01 | 0.337 | 1 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.972689e-01 | 0.224 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.972689e-01 | 0.224 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.972689e-01 | 0.224 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.972689e-01 | 0.224 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.972689e-01 | 0.224 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.972689e-01 | 0.224 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.972689e-01 | 0.224 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.972689e-01 | 0.224 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 5.972689e-01 | 0.224 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 5.972689e-01 | 0.224 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.972689e-01 | 0.224 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.972689e-01 | 0.224 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.972689e-01 | 0.224 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 5.972689e-01 | 0.224 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 5.972689e-01 | 0.224 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.988167e-01 | 0.223 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.988167e-01 | 0.223 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.004936e-01 | 0.221 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.004936e-01 | 0.221 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.004936e-01 | 0.221 | 1 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.004936e-01 | 0.221 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.064232e-01 | 0.217 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.114225e-01 | 0.214 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.114985e-01 | 0.214 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.114985e-01 | 0.214 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.114985e-01 | 0.214 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.114985e-01 | 0.214 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 6.128484e-01 | 0.213 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.161467e-01 | 0.210 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.166546e-01 | 0.210 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.229763e-01 | 0.206 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.260913e-01 | 0.203 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.260913e-01 | 0.203 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.265721e-01 | 0.203 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.265721e-01 | 0.203 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.265721e-01 | 0.203 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.266756e-01 | 0.203 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.266756e-01 | 0.203 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.266756e-01 | 0.203 | 1 | 1 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.266756e-01 | 0.203 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.266756e-01 | 0.203 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.266756e-01 | 0.203 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.266756e-01 | 0.203 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.266756e-01 | 0.203 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.266756e-01 | 0.203 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.266756e-01 | 0.203 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.266756e-01 | 0.203 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.266756e-01 | 0.203 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.266756e-01 | 0.203 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.323670e-01 | 0.199 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.323670e-01 | 0.199 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.323670e-01 | 0.199 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.409012e-01 | 0.193 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.429929e-01 | 0.192 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.433559e-01 | 0.192 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.447065e-01 | 0.191 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 6.449873e-01 | 0.190 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.449873e-01 | 0.190 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.449873e-01 | 0.190 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.476264e-01 | 0.189 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.476264e-01 | 0.189 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.476264e-01 | 0.189 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.506883e-01 | 0.187 | 1 | 0 |
| Protein folding | R-HSA-391251 | 6.529728e-01 | 0.185 | 1 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.530727e-01 | 0.185 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.539366e-01 | 0.184 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.539366e-01 | 0.184 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.539366e-01 | 0.184 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.539366e-01 | 0.184 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.539366e-01 | 0.184 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.539366e-01 | 0.184 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.539366e-01 | 0.184 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.539366e-01 | 0.184 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.539366e-01 | 0.184 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.539366e-01 | 0.184 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.539366e-01 | 0.184 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.539366e-01 | 0.184 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 6.539366e-01 | 0.184 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.539366e-01 | 0.184 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.539366e-01 | 0.184 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 6.624300e-01 | 0.179 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.624300e-01 | 0.179 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.631192e-01 | 0.178 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.631192e-01 | 0.178 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.631192e-01 | 0.178 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.631192e-01 | 0.178 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.658411e-01 | 0.177 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.658411e-01 | 0.177 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.662748e-01 | 0.176 | 1 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.681777e-01 | 0.175 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.767770e-01 | 0.170 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.782844e-01 | 0.169 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 6.782844e-01 | 0.169 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.792085e-01 | 0.168 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 6.792085e-01 | 0.168 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.792085e-01 | 0.168 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.792085e-01 | 0.168 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.792085e-01 | 0.168 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 6.792085e-01 | 0.168 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.792085e-01 | 0.168 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.792085e-01 | 0.168 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 6.792085e-01 | 0.168 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.792085e-01 | 0.168 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.804977e-01 | 0.167 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.804977e-01 | 0.167 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.804977e-01 | 0.167 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.906678e-01 | 0.161 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.932568e-01 | 0.159 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.961876e-01 | 0.157 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 6.961876e-01 | 0.157 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.971362e-01 | 0.157 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.971362e-01 | 0.157 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.003020e-01 | 0.155 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.021898e-01 | 0.154 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.021898e-01 | 0.154 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.026362e-01 | 0.153 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.026362e-01 | 0.153 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.026362e-01 | 0.153 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.026362e-01 | 0.153 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.026362e-01 | 0.153 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.026362e-01 | 0.153 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.026362e-01 | 0.153 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.026362e-01 | 0.153 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.026362e-01 | 0.153 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.026362e-01 | 0.153 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 7.026362e-01 | 0.153 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.026362e-01 | 0.153 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.026362e-01 | 0.153 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.026362e-01 | 0.153 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.026362e-01 | 0.153 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.041045e-01 | 0.152 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.042317e-01 | 0.152 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.058613e-01 | 0.151 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.092395e-01 | 0.149 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.130501e-01 | 0.147 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.130501e-01 | 0.147 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.130501e-01 | 0.147 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.130501e-01 | 0.147 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.136169e-01 | 0.147 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.136510e-01 | 0.147 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.136510e-01 | 0.147 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.170903e-01 | 0.144 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.213049e-01 | 0.142 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.236962e-01 | 0.140 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.243543e-01 | 0.140 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.243543e-01 | 0.140 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.243543e-01 | 0.140 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.243543e-01 | 0.140 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 7.243543e-01 | 0.140 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.243543e-01 | 0.140 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.243543e-01 | 0.140 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.243543e-01 | 0.140 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.243543e-01 | 0.140 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.243543e-01 | 0.140 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.247853e-01 | 0.140 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.282563e-01 | 0.138 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.282563e-01 | 0.138 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.282563e-01 | 0.138 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.282563e-01 | 0.138 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.282563e-01 | 0.138 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.296297e-01 | 0.137 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.324198e-01 | 0.135 | 1 | 1 |
| Ca2+ pathway | R-HSA-4086398 | 7.335184e-01 | 0.135 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.349724e-01 | 0.134 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.371083e-01 | 0.132 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.417280e-01 | 0.130 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.427734e-01 | 0.129 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 7.444875e-01 | 0.128 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.444875e-01 | 0.128 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.444875e-01 | 0.128 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.444875e-01 | 0.128 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.444875e-01 | 0.128 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.444875e-01 | 0.128 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.444875e-01 | 0.128 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.444875e-01 | 0.128 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.444875e-01 | 0.128 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.523526e-01 | 0.124 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 7.533916e-01 | 0.123 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.566209e-01 | 0.121 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.566209e-01 | 0.121 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.566209e-01 | 0.121 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 7.594575e-01 | 0.119 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.631512e-01 | 0.117 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.631512e-01 | 0.117 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.631512e-01 | 0.117 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.631512e-01 | 0.117 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.631512e-01 | 0.117 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 7.631512e-01 | 0.117 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.631512e-01 | 0.117 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.631512e-01 | 0.117 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.646275e-01 | 0.117 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.660924e-01 | 0.116 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.667514e-01 | 0.115 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.667514e-01 | 0.115 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.676504e-01 | 0.115 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.698191e-01 | 0.114 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.698191e-01 | 0.114 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.698191e-01 | 0.114 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.698191e-01 | 0.114 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.698191e-01 | 0.114 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.698191e-01 | 0.114 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.740344e-01 | 0.111 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.756265e-01 | 0.110 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.756342e-01 | 0.110 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.788109e-01 | 0.109 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.792173e-01 | 0.108 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.804527e-01 | 0.108 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.804527e-01 | 0.108 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.804527e-01 | 0.108 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.804527e-01 | 0.108 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.804527e-01 | 0.108 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.804527e-01 | 0.108 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.804527e-01 | 0.108 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 7.804527e-01 | 0.108 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.823890e-01 | 0.107 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.823890e-01 | 0.107 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.834103e-01 | 0.106 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.848514e-01 | 0.105 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.858481e-01 | 0.105 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.877037e-01 | 0.104 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.943518e-01 | 0.100 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.943518e-01 | 0.100 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.943518e-01 | 0.100 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.943518e-01 | 0.100 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.958501e-01 | 0.099 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.964912e-01 | 0.099 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.964912e-01 | 0.099 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.964912e-01 | 0.099 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.964912e-01 | 0.099 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.964912e-01 | 0.099 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.964912e-01 | 0.099 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.964912e-01 | 0.099 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.964912e-01 | 0.099 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.964912e-01 | 0.099 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.964912e-01 | 0.099 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.964912e-01 | 0.099 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.023917e-01 | 0.096 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.054586e-01 | 0.094 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.054586e-01 | 0.094 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.055104e-01 | 0.094 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.057293e-01 | 0.094 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.057293e-01 | 0.094 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.057293e-01 | 0.094 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.057293e-01 | 0.094 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.103580e-01 | 0.091 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.113590e-01 | 0.091 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.113590e-01 | 0.091 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.113590e-01 | 0.091 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.113590e-01 | 0.091 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.113590e-01 | 0.091 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.113590e-01 | 0.091 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.124748e-01 | 0.090 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.131871e-01 | 0.090 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.146835e-01 | 0.089 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.165429e-01 | 0.088 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.165429e-01 | 0.088 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.165429e-01 | 0.088 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.165429e-01 | 0.088 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.165429e-01 | 0.088 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.165429e-01 | 0.088 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.187545e-01 | 0.087 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.235346e-01 | 0.084 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.235346e-01 | 0.084 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.251415e-01 | 0.083 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.251415e-01 | 0.083 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.251415e-01 | 0.083 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.251415e-01 | 0.083 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.251415e-01 | 0.083 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.251415e-01 | 0.083 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.265082e-01 | 0.083 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.267778e-01 | 0.083 | 1 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.268144e-01 | 0.083 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.268144e-01 | 0.083 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.268144e-01 | 0.083 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.287008e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.320220e-01 | 0.080 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.320220e-01 | 0.080 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.346296e-01 | 0.079 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.365653e-01 | 0.078 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.365653e-01 | 0.078 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.365653e-01 | 0.078 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.379177e-01 | 0.077 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.379177e-01 | 0.077 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.379177e-01 | 0.077 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.379177e-01 | 0.077 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.411906e-01 | 0.075 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.443946e-01 | 0.073 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.443946e-01 | 0.073 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.458166e-01 | 0.073 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.458166e-01 | 0.073 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.460516e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.497611e-01 | 0.071 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.497611e-01 | 0.071 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.497611e-01 | 0.071 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.497611e-01 | 0.071 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.497611e-01 | 0.071 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.497611e-01 | 0.071 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 8.497611e-01 | 0.071 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.497611e-01 | 0.071 | 1 | 1 |
| Signaling by NODAL | R-HSA-1181150 | 8.497611e-01 | 0.071 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.497611e-01 | 0.071 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.502186e-01 | 0.070 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.536791e-01 | 0.069 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.545895e-01 | 0.068 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.558633e-01 | 0.068 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.565568e-01 | 0.067 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.574003e-01 | 0.067 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.607398e-01 | 0.065 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.607398e-01 | 0.065 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.607398e-01 | 0.065 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.607398e-01 | 0.065 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.625428e-01 | 0.064 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.625428e-01 | 0.064 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.666034e-01 | 0.062 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.666280e-01 | 0.062 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.666280e-01 | 0.062 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.674317e-01 | 0.062 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.674317e-01 | 0.062 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.687579e-01 | 0.061 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.707810e-01 | 0.060 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.707810e-01 | 0.060 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.707810e-01 | 0.060 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.707810e-01 | 0.060 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 8.709168e-01 | 0.060 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.709168e-01 | 0.060 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.709168e-01 | 0.060 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.709168e-01 | 0.060 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.709168e-01 | 0.060 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.709168e-01 | 0.060 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.709168e-01 | 0.060 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.741809e-01 | 0.058 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.782395e-01 | 0.056 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.782395e-01 | 0.056 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.782395e-01 | 0.056 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.782395e-01 | 0.056 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.782395e-01 | 0.056 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.803507e-01 | 0.055 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.803507e-01 | 0.055 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.803507e-01 | 0.055 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.803507e-01 | 0.055 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.803507e-01 | 0.055 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.805103e-01 | 0.055 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.844575e-01 | 0.053 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.845857e-01 | 0.053 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.846077e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.852986e-01 | 0.053 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.852986e-01 | 0.053 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.883026e-01 | 0.051 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.890956e-01 | 0.051 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.890956e-01 | 0.051 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.890956e-01 | 0.051 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.898577e-01 | 0.051 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.919768e-01 | 0.050 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.919768e-01 | 0.050 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.940743e-01 | 0.049 | 1 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.949178e-01 | 0.048 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.960453e-01 | 0.048 | 1 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.972019e-01 | 0.047 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.972019e-01 | 0.047 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.972019e-01 | 0.047 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.972019e-01 | 0.047 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.972019e-01 | 0.047 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.982922e-01 | 0.047 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.982922e-01 | 0.047 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.991840e-01 | 0.046 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.997725e-01 | 0.046 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.013081e-01 | 0.045 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.028663e-01 | 0.044 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.042621e-01 | 0.044 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.042621e-01 | 0.044 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.042621e-01 | 0.044 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.042621e-01 | 0.044 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.042621e-01 | 0.044 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.042621e-01 | 0.044 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.042621e-01 | 0.044 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.047161e-01 | 0.043 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.047161e-01 | 0.043 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.047161e-01 | 0.043 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.070163e-01 | 0.042 | 1 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.070494e-01 | 0.042 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.088915e-01 | 0.041 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.092861e-01 | 0.041 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.099031e-01 | 0.041 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.099031e-01 | 0.041 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.099031e-01 | 0.041 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.099031e-01 | 0.041 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.099031e-01 | 0.041 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.099031e-01 | 0.041 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.099031e-01 | 0.041 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.099031e-01 | 0.041 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.116814e-01 | 0.040 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.116814e-01 | 0.040 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.116814e-01 | 0.040 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.116814e-01 | 0.040 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.116814e-01 | 0.040 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.116814e-01 | 0.040 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.118519e-01 | 0.040 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.118919e-01 | 0.040 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.131687e-01 | 0.039 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.152315e-01 | 0.038 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.152315e-01 | 0.038 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.152315e-01 | 0.038 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.152537e-01 | 0.038 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.181380e-01 | 0.037 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.181380e-01 | 0.037 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.181380e-01 | 0.037 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.181380e-01 | 0.037 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.181380e-01 | 0.037 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.181380e-01 | 0.037 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.181380e-01 | 0.037 | 1 | 1 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.202629e-01 | 0.036 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.202629e-01 | 0.036 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.202629e-01 | 0.036 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.210011e-01 | 0.036 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.241229e-01 | 0.034 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.241229e-01 | 0.034 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.241229e-01 | 0.034 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.241229e-01 | 0.034 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.256824e-01 | 0.034 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.267816e-01 | 0.033 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.296706e-01 | 0.032 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.296706e-01 | 0.032 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.296706e-01 | 0.032 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.296706e-01 | 0.032 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.296706e-01 | 0.032 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.308046e-01 | 0.031 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.333732e-01 | 0.030 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.343160e-01 | 0.030 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.348130e-01 | 0.029 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.352644e-01 | 0.029 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.377072e-01 | 0.028 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.378090e-01 | 0.028 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.378090e-01 | 0.028 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.395797e-01 | 0.027 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.395797e-01 | 0.027 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.395797e-01 | 0.027 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.395797e-01 | 0.027 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.395797e-01 | 0.027 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.414105e-01 | 0.026 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.414653e-01 | 0.026 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.434109e-01 | 0.025 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.439981e-01 | 0.025 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.439981e-01 | 0.025 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.458369e-01 | 0.024 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.467251e-01 | 0.024 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.479971e-01 | 0.023 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 9.480936e-01 | 0.023 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.483446e-01 | 0.023 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.518898e-01 | 0.021 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.518898e-01 | 0.021 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.518898e-01 | 0.021 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.528334e-01 | 0.021 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.533335e-01 | 0.021 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.533335e-01 | 0.021 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.533335e-01 | 0.021 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.536714e-01 | 0.021 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.537339e-01 | 0.021 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.541760e-01 | 0.020 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.544484e-01 | 0.020 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.553993e-01 | 0.020 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.554086e-01 | 0.020 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.554086e-01 | 0.020 | 1 | 1 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.554086e-01 | 0.020 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.554086e-01 | 0.020 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.554086e-01 | 0.020 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.554086e-01 | 0.020 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.554086e-01 | 0.020 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.554086e-01 | 0.020 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.554086e-01 | 0.020 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.554086e-01 | 0.020 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.567899e-01 | 0.019 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.572355e-01 | 0.019 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.586702e-01 | 0.018 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.586702e-01 | 0.018 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.586702e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.586702e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.586702e-01 | 0.018 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.595242e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.610247e-01 | 0.017 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.616935e-01 | 0.017 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.616935e-01 | 0.017 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.616935e-01 | 0.017 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.616935e-01 | 0.017 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.616935e-01 | 0.017 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.616935e-01 | 0.017 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.623273e-01 | 0.017 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.623344e-01 | 0.017 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.627627e-01 | 0.016 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.644113e-01 | 0.016 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.644958e-01 | 0.016 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.644958e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.644958e-01 | 0.016 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.644958e-01 | 0.016 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.666559e-01 | 0.015 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.668341e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.668341e-01 | 0.015 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.670932e-01 | 0.015 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.675511e-01 | 0.014 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.682455e-01 | 0.014 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.695007e-01 | 0.013 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.695007e-01 | 0.013 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.695007e-01 | 0.013 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.695007e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.695007e-01 | 0.013 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.699854e-01 | 0.013 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.708196e-01 | 0.013 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.708196e-01 | 0.013 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.709143e-01 | 0.013 | 1 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.717323e-01 | 0.012 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.717323e-01 | 0.012 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.718082e-01 | 0.012 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.726350e-01 | 0.012 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.728138e-01 | 0.012 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.729985e-01 | 0.012 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.732724e-01 | 0.012 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.738006e-01 | 0.012 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.738006e-01 | 0.012 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.743411e-01 | 0.011 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.749231e-01 | 0.011 | 1 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.757178e-01 | 0.011 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.757178e-01 | 0.011 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.757178e-01 | 0.011 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.757178e-01 | 0.011 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.757178e-01 | 0.011 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.757178e-01 | 0.011 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.757178e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.757178e-01 | 0.011 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.757264e-01 | 0.011 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.757264e-01 | 0.011 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.759442e-01 | 0.011 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.774502e-01 | 0.010 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.774948e-01 | 0.010 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.774948e-01 | 0.010 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.774948e-01 | 0.010 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.774948e-01 | 0.010 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.775381e-01 | 0.010 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.775675e-01 | 0.010 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.781937e-01 | 0.010 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.782358e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.782847e-01 | 0.010 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.791418e-01 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.791418e-01 | 0.009 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.793049e-01 | 0.009 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.793369e-01 | 0.009 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.798346e-01 | 0.009 | 1 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.801932e-01 | 0.009 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.806684e-01 | 0.008 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.806684e-01 | 0.008 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.811506e-01 | 0.008 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.813299e-01 | 0.008 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.816995e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.816995e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.820833e-01 | 0.008 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.820833e-01 | 0.008 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.820833e-01 | 0.008 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.833948e-01 | 0.007 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.837104e-01 | 0.007 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.846103e-01 | 0.007 | 1 | 1 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.857095e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.857369e-01 | 0.006 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.863055e-01 | 0.006 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.865218e-01 | 0.006 | 1 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.866175e-01 | 0.006 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.877490e-01 | 0.005 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.877490e-01 | 0.005 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.877490e-01 | 0.005 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.886460e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.889506e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.889506e-01 | 0.005 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.889506e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.889506e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.889506e-01 | 0.005 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.890169e-01 | 0.005 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.890169e-01 | 0.005 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.891842e-01 | 0.005 | 0 | 0 |
| Translation | R-HSA-72766 | 9.896770e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.897192e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.901080e-01 | 0.004 | 1 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.902729e-01 | 0.004 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.903776e-01 | 0.004 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.904353e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.904353e-01 | 0.004 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.908870e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.909621e-01 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.909948e-01 | 0.004 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.916240e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.916240e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.919205e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.919205e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.920382e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.920382e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.920382e-01 | 0.003 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.922375e-01 | 0.003 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.922375e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.927619e-01 | 0.003 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.928060e-01 | 0.003 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.931897e-01 | 0.003 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.933330e-01 | 0.003 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.937770e-01 | 0.003 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.938214e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.938214e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.939172e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.939622e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.942740e-01 | 0.002 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.943314e-01 | 0.002 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.943314e-01 | 0.002 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.946690e-01 | 0.002 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.946935e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.946935e-01 | 0.002 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.946935e-01 | 0.002 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.949870e-01 | 0.002 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.949870e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.950622e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.950823e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.955687e-01 | 0.002 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.957766e-01 | 0.002 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.957766e-01 | 0.002 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.958345e-01 | 0.002 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.962282e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.962685e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.963302e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.963302e-01 | 0.002 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.963936e-01 | 0.002 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.964143e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.964745e-01 | 0.002 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.965420e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.966388e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.966388e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.966388e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.967507e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.968851e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.969603e-01 | 0.001 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.971319e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.971695e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.973250e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.975211e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.975211e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.975468e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.977861e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.978074e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.978713e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.980274e-01 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.980323e-01 | 0.001 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.981720e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.981720e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.983056e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.983312e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.985454e-01 | 0.001 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.985915e-01 | 0.001 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.985983e-01 | 0.001 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.986963e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.987312e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.988941e-01 | 0.000 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.988941e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.990220e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.990363e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.990791e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.994653e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.995228e-01 | 0.000 | 1 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.995703e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996038e-01 | 0.000 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.996310e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.996310e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.996310e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.996503e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.996732e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997065e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.997311e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.997322e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.997425e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.997480e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.998306e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998433e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.998518e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998991e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999012e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999035e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999452e-01 | 0.000 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.999493e-01 | 0.000 | 1 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999530e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999654e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.999666e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999666e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999703e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999725e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999788e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.999813e-01 | 0.000 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.999819e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999862e-01 | 0.000 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.999880e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999884e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999952e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999954e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999965e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999969e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999974e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999994e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999998e-01 | 0.000 | 1 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.000000e+00 | 0.000 | 1 | 1 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.000000e+00 | 0.000 | 1 | 1 |